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Abstract 
Pigmentation and the cutaneous response to ultraviolet radiation 
 
Variation in pigmentation of hair and skin is one of the most striking forms of human 
diversity. Human pigmentation and sun sensitivity is a complex trait. The 
melanocortin 1 receptor gene (MC1R) (OMIM 15555) has been shown to be a key 
determinant of hair and skin colour. Recently a number of other genes have been 
implicated in human pigmentation. 
This thesis presents the relationship between human pigmentary phenotypes and 
genetic variation at MC1R and 34 other candidate loci from 159 individuals. The 
relationship between experimentally induced cutaneous erythemal and facultative 
pigmentary response to UVB radiation and MC1R and other pigmentation genotypes 
was investigated in a subset of 98 individuals. Some of this work involved the 
development of novel methods of assaying phenotype. 
I present a detailed description of human pigmentation and facultative pigmentation 
with respect to a number of key variables (e.g. sex, site, freckling, skin type) and 
seek to explain the variation in pigmentation in relation to these factors. 
The effect of MC1R on hair colour is large, but MC1R explains a smaller amount of 
the variation for skin colour. 
I found that a number of loci including MC1R, oculocutaneous albinism type 2 
OCA2 (OMIM 611409), KIT oncogene ligand KITLG (OMIM 184745) and the 
Hermansky-Pudlak syndrome 3 HPS3 (OMIM 606118) are determinants of 
pigmentary phenotype. Some of these findings are in keeping with previous work 
and some are novel. 
I present data showing novel SNPs in genes Hermansky-Pudlak syndrome 3 (HPS3) 
and KIT ligand (KITLG) to be associated with human skin and hair colour variation. 
Association of HPS3 to eye colour was also found and has to be confirmed in another 
population. The possible putative mechanisms for the novel association finding in 
HPS3 are discussed. I am in the process of confirming these positive significant 
findings in collaboration with another laboratory in Denmark. Further experiments 
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Chapter 1 Introduction 
 
1.1 Skin 
Skin is the most conspicuous part of human body. It is the largest organ in humans, 
measuring 1.94-1.95 square metres in area (Boyd, 1935; Dubois and Dubois, 1916) 
and weighing approximately 4 kg. Imagine a life without skin, our muscles, bones 
and internal structures would be freely exposed to various environmental insults. 
Skin therefore has numerous functions in humans including protection of our internal 
organs against injury, thermoregulation through sweating, innate immune response 
against pathogenic organisms, barrier against fluid loss and protection from the 
damaging UV radiation from the sun (Fitzpatrick, 2003). In addition, skin has other 
roles including 
i) Sensory; the detection of light touch, temperature, pressure, itch and pain stimuli 
by mechanoreceptors e.g. Meissner’s corpuscles, Pacinian corpuscles and the nerve 
fibres within. 
ii) Homeostasis by acting as an external covering and barrier to integrate other 
deeper structures. 
iii) The biochemical role of skin involving vitamin D synthesis and therefore the 
prevention of rickets and may be other diseases. This was previously of more 
importance where dietary vitamin D was not plentiful. Nowadays that food is 
regularly fortified with vitamin D, the cutaneous contribution is less essential 
(Holick, 2008). Loomis argued that variation in UV radiation from different latitudes 
away from the equator sun might favour lighter pigmented individuals against 
vitamin D deficiency and rickets (Loomis, 1967, 1970) whereas, UV radiation at the 
equator favoured darker pigmented individuals who possessed enough melanin to 
protect against burning and skin cancers (Harrison, 1973). Bodmer and Cavalli-
Sforza hypothesized that lighter skin pigmentation prevented rickets in higher 
latitudes by encouraging higher levels of vitamin D production and also allowed 
individuals to retain heat better than someone with darker skin (Bodmer WF, 1976). 
iv) Role in human sexual selection (Darwin, 1859; Frost, 1988, 2007; Madrigal and 
Kelly, 2007). 
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v) Social appearance. Despite the various roles, the macroscopic appearance of our 
skin together with other phenotypes including hair colour and eye colour form our 
external image. 
 
1.2. Skin layers 
Skin varies in thickness. Our eyelids have the thinnest skin whereas our palms and 
soles have the thickest. Microscopically, our skin consists of 3 layers – epidermis, 
dermis and subcutis. The stratum corneum is the outermost horny layer. Dividing 
cells from the deepest layer stratum basale (basal cell layer) move upwards, through 
stratum spinulosum (prickle cell layer) and stratum granulosum (granular cell layer). 
 
1.2.1. Skin levels and cell types 
Keratinocytes are keratin-producing cells at the stratum spinulosum. They are held 
together and to each other via gap junctions and a range of desmosomal proteins 
including desmogleins, desmoplakins and desmocollins (Dusek et al., 2007). 
Melanocytes are melanin-producing cells of neural crest origin (Boissy, 1988; 
Vancoillie et al., 1999). Each melanocyte is associated with about 36 keratinocytes 
(Fitzpatrick, 2003). They account for our skin colour, pigmentation and tanning. 
Melanocytes transfer melanin that is packaged within membrane-bound organelles 
called melanosomes. Langerhans cells are dendritic cells originating from the bone 
marrow. They have a role in immune mediated responses and antigen presentation. 
Merkel cells are cells that mediate fine touch sensation (Winkelmann, 1977; 
Winkelmann and Breathnach, 1973). They are located around the stratum basale. 
Africans are darkly pigmented because their melanocytes produce larger and more 
melanosomes, not because they have more melanocytes (Szabo et al., 1969). The 
number of melanocytes for both Caucasians and Africans are the same. 
 
1.3. Ultraviolet radiation 
Human skin is exposed to various stimuli and insults. It is our first contact to the 
outside world, including UV radiation. Johann Ritter first discovered the UV region 
of the solar spectrum in 1801 (Hockberger, 2002). Charcot first determined that UV 
radiation caused erythema in 1858 (Urbach, 2001) and Unna determined that UV 
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radiation can cause pigmentation in 1894 (Hockberger, 2002). Unna also related 
changes in the stratum corneum, epidermis and dermis to chronic UV radiation 
exposure. Miescher in 1930 showed that stratum corneum thickening provided 
photoprotection to further UV radiation (Diffey, 1991). 
UV radiation is divided into 3 regions: UVA 320-400nm, UVB 290-320nm, UVC 
200-290nm. These are arbitrary divisions and differ depending on the discipline 
involved (Diffey, 1991). UVB is capable of penetrating the epidermis and up to 
superficial dermis. It stimulates the production of prostaglandin E2 (PGE2) (Black et 
al., 1978), leukotrienes (Sondergaard et al., 1985), histamine (Soter, 1990), 
interleukin-1 (IL-1) (Granstein and Sauder, 1987; Oxholm et al., 1988) and TNF-




 The erythemal response can be attenuated or blocked completely by prostaglandin 
inhibitors (Rhodes et al., 2001). Nitric oxide is also involved as a mediator (Rhodes 
et al., 2001). 
An action spectrum is a plot of the relative effectiveness of radiation of different 
wavelengths to produce a particular biological effect. Thus an erythema action 
spectrum shows the erythemal effectiveness of UV radiation. 
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Figure 1.3.1. Erythema action spectrum 
 
Figure 1.3.1 shows the reference CIE erythemal action spectrum and that the 
effectiveness drops off very quickly at wavelengths greater than 300nm (Diffey, 
1991). The erythemal action spectrum and DNA damage action spectrum overlap 
(Figure 1.3.2), (Parrish et al., 1982) since erythema is a visible trait and is 
exemplified with burning. This in turn is associated with DNA damage and the 
erythema action spectrum (McKinley A, 1987) mirrors the DNA action spectrum 
(Diffey, 1991).  DNA is the chromophore for erythema (Young et al., 1998). This in 
turn linked erythema or sunburn with skin cancer (Elwood, 1996; Kricker et al., 
1995; Whiteman and Green, 1994). Thus erythema is a useful endpoint as it is 
associated with DNA damage. 
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Figure 1.3.2. DNA action spectrum – the rate of a physiological activity 




The effect of UV radiation on the skin can be classified as: 
i) acute (sunburn / erythema, tanning, vitamin D production, immunosuppression) 
and 
ii) chronic (photo-ageing and skin cancer). 
 
1.4. Control of tanning 
1.4.1. Immediate pigment darkening (IPD) 
Immediate pigment darkening (IPD) is a transient darkening of the skin observed 
after UVA exposure and visible radiation, reviewed in (Young, 2006). The 
melanocytic system is implicated in its development. It may involve structural 
changes in melanocytes and keratinocytes (Routaboul et al., 1999) or a chemical 
modification or redistribution of pre-existing melanin (Brenner and Hearing, 2008; 
Lavker and Kaidbey, 1982). Darkening intensity is maximal immediately after 
exposure and decreases rapidly. The maximum efficiency wavelength for induction 
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of IPD is around 340 nm (Irwin et al., 1993). The phenomenon is inhibited by 
oxygen deprivation (Auletta et al., 1986). Dose-response curves are linear for doses 
above 4 J/cm2 (Chardon et al., 1991). Minimum dose for induction of IPD (MIPDD) 
varies with the subject according to phototype, melanotype and skin colour 
(Routaboul et al., 1999). The best criterion for predicting MIPDD seems to be 
chromametrically determined skin colour. The greater the constitutive skin colour, 
the greater the ability to exhibit IPD. The biological role of IPD is poorly understood, 
there are several hypotheses (Routaboul et al., 1999): 
Descamps et al suggested that IPD may be implicated in the appearance of delayed 
UVA-induced tanning (Descamps et al., 1990). Black et al found that pre-exposure 
to UVA increases MED and therefore IPD may confer erythemal protection against 
UVB-erythema (Black et al., 1985). 
 
1.4.2. Delayed pigment darkening (DPD) 
This is delayed tanning or facultative pigmentation (tanning) noticeable around 1-2 
days after solar exposure and continues to increase for days and may persist for 
weeks or months (Diffey, 1991). The persistent tanning involves the activation of 
melanocyte function. Exposure to UV leads to increased expression of MITF (the 
master transcriptional regulator of pigmentation) and its downstream melanogenic 
proteins, including tyrosinase (TYR), tyrosinase-related protein 1 (TYRP1), 
melanocyte-specific glycoprotein Pmel17, melanoma-associated antigen recognized 
by T cells-1 (MART-1) and dopachrome tautomerase (DCT) (Miyamura et al., 2007; 
Yamaguchi and Hearing, 2005), leading eventually to increases in melanin content. 
Increased levels of protease activated receptor-2 (PAR2) in keratinocytes also result 
from exposure to UV, which increases uptake and distribution of melanosomes by 
keratinocytes in the epidermis (Scott et al., 2001). This is schematically represented 
in Figure 1.4.2. The release of Diacylglycerol (DAG) (Gordon and Gilchrest, 1989) 
and arachidonic acid also play a role in the tanning response (Gilchrest et al., 1996). 
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Figure 1.4.2. Receptors, ligands and factors that regulate pigmentation of 
human skin 
 
Figure Legend: LRO, lysosome-related organelle; ACTH, adrenocorticotropic hormone; ASP, 
Agouti signal protein; DCT, DOPAchrome tautomerase; DKK, Dickkopf; DHI, 5,6-
dihydroxyindole; DHICA, DHI-2-carboxylic acid; DOPA, L-3,4-dihydroxyphenylalanine; EMI, 
epithelial-mesenchymal interactions; EMT, epithelial-mesenchymal transitions; bFGF, basic 
fibroblast growth factor; HGF, hepatocyte growth factor; HOX, homeobox; MC1R, 
melanocortin 1 receptor; MITF, microphthalmia transcription factor; MSH, melanocyte-
stimulating hormone; NGF, nerve growth factor; POMC, pro-opiomelanocortin; SCF, stem 
cell factor; TYR, tyrosinase; UV ultraviolet radiation. Figure adapted from (Yamaguchi et al., 
2007). 
 
1.4.3. Sunburn cells and apoptosis 
When UV radiation caused severe DNA damage to cells and cannot be repaired, 
apoptotic pathways are used to remove damaged cells, involving p53 (de Gruijl and 
Rebel, 2008), upregulation of pro-apoptotic genes Bax and Fas (Banerjee et al., 
2005), p21 (Beattie et al., 2005) and Bcl-2 downregulation (Knezevic et al., 2007).  
 31
1.4.4. Non-pigmentary photoadaptation 
Apart from erythema and tanning, thickening or hyperplasia of the epidermis is a 
significant component of photoadaptation (Diffey, 1991). A single moderate 
exposure to UVB can result in up to a 3-fold thickening of the stratum corneum 
within 1-3 weeks. Diffey et al discussed that Miescher in 1930 demonstrated that 
repeated exposures every 1 to 2 days for up to 7 weeks will lead to 3-5 fold 
thickening (Diffey, 1991). 
 
1.5. Genetics of red hair and blonde hair  
Davenport first studied and described the inheritance of red hair in 1909 at the Cold 
Spring Harbor Laboratory (Davenport and Davenport, 1909). Other researchers 
studied and found that red hair appeared to be dominantly inherited due to the high 
carrier rate in their red hair family studies (Davenport and Davenport, 1909). Reed 
argued that Schiedt (1925) suggested that red hair was dominant over blonde. 
Subsequent studies approximated red hair to an autosomal recessive trait. Reed 
agreed with Conitzer et al and others that red hair was more consistent with a 
recessive hypothesis (Neel, 1943; Reed, 1952; Singleton and Ellis, 1964). There were 
subsequent studies on red hair (Barnicot, 1953; Nicholis, 1969; Rife, 1967; 
Yamamoto and Neel, 1967). There was little uniformity in their methodology of 
defining “red hair”, sometimes with or without the use of a colour standard. 
Remarkably, little is known about the mode of inheritance of blonde hair. 
 
1.6. Hair greying and age 
The greying of hair is an age-related process in humans. It is generally accepted that 
grey hair is a combination of black and white hairs. It has been described that, as an 
average, 50% of people have at least 50% grey hair at age 50, in a cohort of 
Caucasians (Keogh and Walsh, 1965). This greying incidence appears irrespective of 
sex and initial hair colour. It is therefore important to measure hair colours before 
they change. 
The mechanism of hair greying was described by Nishimura et al and involved the 
genes bcl2 and mitf (Nishimura et al., 2005). A theory involving free radicals has 
been proposed (Arck et al., 2006). Arch et al showed that there was an increased 
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incidence of hair bulb melanocyte apoptosis associated with oxidative stress in the 
grey hair from aging individuals. There was also an absence of oxidative stress 
protectors such as Bcl-s and melanocyte growth factors such as c-Kit. There was a 
higher frequency of oxidative stress associated mitochondrial DNA damage in grey 
hair follicles. 
The reduction in pigment is due to melanin not being produced at the hair root. Hair 
colour was found to be lighter in colour during early child life and darkened with age 
(Matheny and Dolan, 1975). The reason for the darkening is unclear. Redheads have 
a more fiery shade of red during early childhood. 
 
1.7. Eye colour 
Eye colour was initially studied by Davenport in 1907 (Davenport and Davenport, 
1907) and Hurst in 1908 (Hurst, 1908). The genetics of eye colour is poorly 
understood. Genes that are known have limited effects. However a number of loci are 
implicated in eye colour recently. These include: OCA2 (OMIM 203200) (Duffy et 
al., 2007), HERC2 (Kayser et al., 2008), SLC24A4 (Sulem et al., 2007), TYR (Sulem 
et al., 2007), SLC45A2 or MATP (OMIM 606202), ASIP (OMIM 600201), TYRP1 
(OMIM 115501), CYP1A2 (OMIM 124060), CYP2C8 (OMIM 601129) and CYP2C9 
(OMIM 601130). 
 
1.8. Genetics of skin pigmentation 
Davenport in 1910 first studied the genetics of skin pigmentation (Davenport and 
Davenport, 1910a, b). Subsequently other studies investigated the inheritance in 
other populations (Davenport and Danielson, 1913). Further studies revealed that a 
number of genes were involved in human pigmentation. This was reviewed in 
(Barsh, 2003; Rees, 2003; Sturm et al., 2001). Human genetic variation was diverse. 
The predominant view of genetic variation occurred when major world groups 
(Europeans, Asians) moved out of Africa (Out of Africa Model), reviewed in (Liu et 
al., 2006a). The other competing hypothesis is the Multiregional Continuity Model, 
reviewed in (Stringer, 2002), which differs from the Out of Africa Model in denying 
a recent African origin for modern humans. The Multiregional Continuity Model 
emphasizes the role of both genetic continuity over time and gene flow between 
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contemporaneous populations in arguing that modern humans arose not only in 
Africa but also in Europe and Asia. 
 
Pigmentation is one of the most obvious and varied human characteristics visible. 
Why are skin pigmentation and hair pigmentation so diverse? Why do humans differ 
so much in skin colour and hair colour? Melanocortin 1 receptor (MC1R) gene is one 
of the main genes identified that plays an important role in determining physiological 
variation in human skin and hair colours (Rees, 2003). How does a single gene give 
rise to a multitude of phenotypes? How is the diversity achieved at a molecular 
level? Are there other genetic interactions at play? Other pigmentation genes have 
been identified which contributed to skin colour in humans, zebrafish golden 
mutation and human homologue Solute Carrier Family 24 
(Sodium/Potassium/Calcium Exchanger) Member 5 SLC24A5 (Lamason et al., 
2005). Zebrafish golden and human SLC24A5 explains 25-38% of the skin colour 
difference between Europeans and Africans (Lamason et al., 2005). 
People respond differently to sunlight. Understanding the cutaneous response to 
ultraviolet radiation (UVR) precisely is of great importance scientifically and 
medically. The chief environmental cause for melanoma and non-melanoma skin 
cancers is ultraviolet radiation. Malignant melanoma of the skin was the 12th most 
common cancer in males and the 8th most common in females in Scotland in 2000 
(Scottish Health Statistics 2000). The incidence increased for both males (34.1%) 
and females (16.4%) over the 10-year period from 1991 to 2000. In 2002 there were 
132 deaths. There was no significant change in mortality over the most recent 10-
year period. Non-melanoma skin cancer showed a similar increase in incidence 
(Scottish Health Statistics 2000). Furthermore UVR is increasingly used as a 
treatment modality in a wide range of skin diseases including psoriasis, atopic 
eczema and polymorphic light eruption. A better understanding in people’s response 
to UVR would improve the way we utilise UVR as a therapeutic option and our 
treatment regimes. 
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Scientific background and review of literature 
1.9. Pigmentation and UVR 
There is considerable variation in the cutaneous sensitivity to UVR between persons. 
Even within a North-European population, a five-fold variation in magnitude is 
evident (Farr and Diffey, 1984; Ha et al., 2003). The main known determinant of this 
variation is skin colour due to melanin pigmentation. In turn, skin colour is the main 
host determinant of skin cancer, and for most skin cancers, rates vary by more than 
two orders of magnitude depending on skin colour (Marks, 1995, 2000; Marks and 
Whiteman, 1994; Rees and Healy, 1997). Skin colour is a highly heritable trait 
(Clark et al., 1981). Understanding these differences in skin colour is therefore of 
interest for a number of different reasons: as a determinant of skin cancer; as a 
determinant of sunburn; as a determinant of dose when UVR is given therapeutically 
for skin diseases such as psoriasis; and finally because understanding the variation in 
human skin colour is one of the classical evolutionary questions about man’s history. 
Skin colour measurements historically involved the use of colour standards e.g. Von 
Luschan tiles or coloured papers by Gates et al (Gates, 1952) and visual matching. 
This is limited by subjectivity and the problem of giving discrete values to a 
continuous variable. 
 
1.10. Melanocortin 1 receptor (MC1R) 
The MC1R (OMIM 155555) maps to chromosome 16q24.3 (Gantz et al., 1994; 
Magenis et al., 1994) and codes for a 317 amino acid product of 7-pass 
transmembrane G-protein coupled receptor (Chhajlani and Wikberg, 1992; Mountjoy 
et al., 1992). The MC1R is a member of the Class A Rhodopsin family of G-coupled 
receptors found within a sub-class of melanocortin receptors – MC1-5R. Two natural 
ligands are known for the MC1R, alpha-melanocyte stimulating hormone (α-MSH) 
and ACTH. These are produced by sequential cleavage from the larger precursor 
peptide pro-opiomelanocortin (POMC) by prohormone convertases 1 [EC 3.4.21.93] 
and 2 [EC3.4.21.94] to form ACTH and α-MSH. MC1R receptor binding to α-MSH 
in melanocytes causes activation of Gαs protein, which then activates adenylate 
cyclase and increases intracellular cAMP production (Chhajlani and Wikberg, 1992; 
Mountjoy et al., 1992). The exact mechanism whereby the increased cAMP causes 
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upregulation of tyrosinase is unclear. Bertolotto et al provided evidence from murine 
B16 melanoma cells that increased cAMP level allow binding of microphthalmia 
protein to tyrosinase gene promoter region (Bertolotto et al., 1996). Yasumoto et al 
also showed that the human homologue microphthalmia-associated transcription 
factor (MITF) can bind and upregulate tyrosinase promoter (Yasumoto et al., 1994). 
Tyrosinase-related protein 1 (TYRP1), tyrosinase-related protein 2 (TYRP2) levels 
and other pathways may also play a role. All these in turn control the regulatory 
switch between eumelanin synthesis and phaeomelanin synthesis. MC1R is therefore 
a key regulator determining the regulatory switch point in the synthesis of eumelanin 
and phaeomelanin (Aroca et al., 1993; Hunt et al., 1994; Kuzumaki et al., 1993). To 
date, over 70 allelic variants of the human MC1R have been identified in the world 
population (Box et al., 1997; Rees, 2000; Smith et al., 1998; Valverde et al., 1995; 
Wong and Rees, 2005). 
Candille et al identified a role for β-defensin in pigmentation (Candille et al., 2007). 
A mutation at the KB locus was shown to be the cause of dominant inheritance of 
black coat colour in dogs (Kerns et al., 2004). The gene at the locus is CBD103, 
which is the canine ortholog of human DEFB103, which encodes the human β-
defensin 3 (HBD3). Human β-defensin 1 (HBD1) and HBD3 both bind to MC1R 
(Pazgier et al., 2006). Together these suggest that β-defensins interact with MC1R to 
mediate pigmentary, immunological and antimicrobial effects (Harder et al., 2001). 
 
1.11. The identification and cloning of the MC1R gene 
The discovery of MC1R owes its origins stemming from mouse fancy communities 
since 18th century which developed into the basis of modern mouse coat colour 
genetics. A large number of murine coat colour variants (e.g. yellow, pink-eyed 
dilution, silver) provided the initial tools for fuelling the development and discovery 
of pigmentary genetics. To date, around 100 genes have been identified that 
influence murine coat colours (Barsh, 1996; Jackson, 1994; Silvers, 1979). Two 
genetic loci have been the focus of attention; extension and agouti, despite they have 
been known for years that they control the regional distribution of brown-black 
eumelanin and yellow-red phaeomelanin pigments in animal coating and along hair 
shafts (Searle, 1968). There are four extension alleles: wildtype (E+), sombre (Eso, 
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Eso-3J), tobacco (Etob), and recessive yellow (e). Loss of function mutations at the 
extension locus result in mice with yellow hair, while dominant gain of function 
mutations result in black hair (Robbins et al., 1993). On the contrary, wild type 
agouti mice have subapical yellow hair and that overexpression of murine agouti 
product results in yellow haired mice (Barsh, 1996; Jackson, 1994). The MC1R gene, 
previously known as the melanocyte stimulating hormone (MSH) receptor gene, has 
been cloned independently by two groups in 1992 (Chhajlani and Wikberg, 1992; 
Mountjoy et al., 1992). The extension locus in mice underlies the human MC1 
receptor. 
 
1.12. Evidence implicating MC1R as a candidate gene 
The discovery and progress from murine coat colour studies, the cloning of the 
human MC1R, followed by the demonstration of the action of melanotropins (MSH) 
in man (Lerner, 1993), namely their pigmentary actions, suggested and pointed to 
MSH receptor as a candidate gene for red hair and pigmentation. Shortly after MC1R 
had been cloned, confirmatory experiments were also reported relating Mc1r 
mutation with murine phenotype of recessive yellow (e) mouse (Robbins et al., 
1993). Subsequently a number of studies reported on the various human phenotypes 
associated with mutations in human MC1R. 
MC1R allelic variants affect pain and analgesia in mice and humans (Mogil et al., 
2005). Humans with MC1R allelic variants showed reduced sensitivity to pain 
stimuli and increased analgesic responsiveness to mu-opioid morphine metabolite 
(Mogil et al., 2005). Females with two variant MC1R alleles showed greater 
analgesia to kappa opioid (Mogil et al., 2003). 
Melanocortin 2 receptor (MC2R) is the physiological receptor for 
adrenocorticotropin hormone (ACTH) and is responsible for glucocorticoid function 
(Clark et al., 1993). 
Melanocortin 3 receptor (MC3R) (Gantz et al., 1993) is expressed in brain, placenta 
and gut tissues and is involved in energy homeostasis (Chen et al., 2000). 
Melanocortin 4 receptor (MC4R) is primarily localized to the brain and is involved in 
obesity and energy homeostasis (Branson et al., 2003; Chambers et al., 2008). 
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MC5R has a potential role in sebum production and exocrine gland function (Chen et 
al., 1997). 
Melanotropins have various actions by acting on human melanocortin 1-5 receptors: 
pigmentation, anti-inflammation, steroidogenesis, lipogenesis and energy 
homeostasis (Bohm et al., 2006; Brzoska et al., 2008). 
 
1.13. Allelic studies and MC1R phenotypes 
The first report describing a functional role of MC1R in man was a case control study 
associating several MC1R variant alleles with red hair and fair skin (Valverde et al., 
1995). Some parts of the human MC1R were sequenced from 30 Northern European 
redheads with a strong family history of red hair, pale skin and burning easily in 
response to UVR and compared them against control individuals without these traits. 
Interestingly MC1R allelic variations are common (>65%) and the allelic frequency 
of variants was higher in redheads. Subsequent study by Smith et al confirmed that 
over 75% of Irish population possesses MC1R allelic variants (Smith et al., 1998). 
Some MC1R variants seem to be more common in individuals with red hair e.g. 
Arg151Cys, Arg160Trp, Asp294His (Box et al., 1997; Smith et al., 1998; Valverde 
et al., 1995). Although many redheads have two MC1R allelic variants, some showed 
only one. Furthermore some individuals have more than one MC1R sequence variant 
on the same allele. 
Other genetic association studies have expanded this data to include a larger number 
of MC1R alleles. These include twin analysis (Box et al., 1997), several large 
population studies (Bastiaens et al., 2001b; Box et al., 2001; Kennedy et al., 2001; 
Palmer et al., 2000; Smith et al., 1998), a family inheritance study (Flanagan et al., 
2000) and have the following findings: The red hair pale skin freckling phenotype is 
commonly associated with MC1R variant allele homozygosity or compound 
heterozygosity. Red hair can also manifest in single variant allele carriers, or even in 
a dark skin background (McKenzie et al., 2003). There is a dosage effect for red hair 
phenotype. The presence of MC1R allelic variants is necessary but not sufficient for 
the red hair phenotype (Box et al., 1997). Other loci may be involved in expressing 
or masking of the phenotypic trait. 
 
 38
What about other MC1R alleles? Arg142His, 86insA and 537insC mutations are 
found to be associated with the RHC in red hair kindred, whereas Val92Met and 
Arg163Gln variants seem to be genetically neutral (Sturm, 2002). MC1R gene 
variants can modify the phenotype of oculocutaneous albinism (OCA) type 2 (King 
et al., 2003). King et al (King et al., 2003) found MC1R mutations to be responsible 
for red rather than yellow/blond hair in six patients with OCA type 2. One of the 
patients was a compound heterozygote for R151C and R160W, as well as for two 
mutations in the P gene (King et al., 2003). However MC1R is not the only gene 
mutation that leads to red hair. Two siblings with red hair, early onset obesity and 
adrenal insufficiency were shown to be homozygous or compound heterozygotes for 
loss of function POMC gene [OMIM 176830] mutations (Krude et al., 1998). 
As highlighted previously, studies have shown that there is an association between 
sequence variation of the coding region of MC1R locus and hair colour (Box et al., 
1997; Flanagan et al., 2000; Smith et al., 1998; Valverde et al., 1995). Three 
particular MC1R variants Arg151Cys, Arg160Trp and Asp294His are strongly 
associated with red hair and most subjects being homozygous or compound 
heterozygote for one of the three alleles. What about other hair colour phenotypes? 
Box et al reported an association between the MC1R allelic variant Val60Leu and 
blond/light brown hair and/or fair skin (Box et al., 1997). The agouti signaling 
protein gene (G allele: position 8818) carriage appears to be more common in 
individuals with dark hair (OR 1.8 95% CI 1.2-2.8) and brown eyes (OR 1.9 95% CI 
1.3-2.8) (Kanetsky et al., 2002). The inheritance of blond hair is unclear at present. 
One mechanistic problem with measuring hair colour phenotype is the lack of 
quantitative methodology. Naysmith et al recently showed that a quantitative 
approach can be used, and hair colour phenotype can be objectively, quantitatively 
measured with the effect of MC1R assessed (Naysmith et al., 2004). 
 
1.14. Family studies 
Subsequent genetic studies have extended to include a larger number of MC1R 
alleles, including a twin family study with red hair (Box et al., 1997) and 174 
individuals from 11 families (Flanagan et al., 2000). These confirmed the MC1R 
allelic variants associated with red hair. The inheritance of red hair approximates to a 
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Mendelian recessive model (Davenport and Davenport, 1909; Michelson, 1934; 
Neel, 1943; Reed, 1952; Singleton and Ellis, 1964; Smith et al., 1998). Interestingly 
the Val60Leu variant may act as a partially penetrant recessive allele in these 
families, and so may Asp84Glu with regards to the whole population (Ringholm et 
al., 2004; Schioth et al., 1999). 
 
1.15. Functional Ligand Binding Transfection studies 
Human MC1R transfection into cultured cells in vitro has allowed ligand binding 
studies to study the function of MC1R receptor. These are mainly based on natural 
and synthetic ligand binding or displacement of radiolabeled MSH analogue 
(Chhajlani and Wikberg, 1992; Mountjoy et al., 1992; Ringholm et al., 2004; 
Robbins et al., 1993; Schioth et al., 1995; Schioth et al., 1999). In vitro site directed 
mutagenesis studies have been performed on the murine and human MC1R with 
several residues mutated and the resultant mutants tested for binding to α-MSH and 
NDP-α-MSH (Frandberg et al., 1994). NDP-α-MSH gave binding affinities similar 
to wildtype, whereas α-MSH showed greatly reduced binding affinities for 
Asp117Ala (267-fold), His260Ala (132-fold). Other studies have been performed to 
investigate the functional status of MC1R allelic variants. Expression of MC1R 
variants in heterologous cell cultures reduced the functional coupling of the MC1R to 
adenylate cyclase (Frandberg et al., 1998; Koppula et al., 1997; Schioth et al., 1999). 
Franberg et al identified a Arg151Cys variant of the MC1R gene in genomic DNA of 
a person with red hair and skin type I (Frandberg et al., 1998). This variant bound to 
radiolabeled α-MSH analogue with identical affinity as wildtype MC1R but could not 
be stimulated to produce any cyclic AMP, rendering the MC1R completely non-
functional (Frandberg et al., 1998). Transfection assays for Val60Leu allelic variant 
showed diminished signaling (Schioth et al., 1999).  
The conclusions of functional status of MC1R from transfection experiments may be 
limited. The limitations arise because the relative amounts of peptides in vivo may 
differ from those in vitro. Stable transfection assay into B16G4F melanoma cells 
showed that cAMP response was still compromised in the variant MC1R transfected 
clones with similar MC1R numbers per cell (Robinson and Healy, 2002). 
 40
Bacterial artificial chromosome (BAC) rescue assay of MC1R homozygous null mice 
has also been performed to define the nature of MC1R allelic variants (Healy et al., 
2001). These alleles were found not to be complete loss of function but rather impair 
signaling to various degrees, e.g. D294H with greater functional impairment than 
R151C or R160W. The functional status of D84E is still unclear with different 
findings (Bastiaens et al., 2001b; Healy et al., 1999; Kennedy et al., 2001; Valverde 
et al., 1996). Further functional studies are required to assess cellular responses in 
relation to MC1R gene variants and the different phenotypic traits. 
Beaumont et al showed that melanocytic cells exogenously or endogenously 
expressing MC1R show strong surface localization of the wildtype and D294H 
alleles but markedly reduced cell surface expression of the R151C and R160W 
receptors. D84E and I155T variants demonstrated a reduction in plasma membrane 
receptor numbers. These results raised the possibility that MC1R gene variants can 
be linked to an altered cell surface or cellular localization of MC1R numbers 
(Beaumont et al., 2005). 
 
What is the true null phenotype of MC1R in humans? This question has been debated 
but due to the rarity of MC1R null alleles, they have only been found in the 
heterozygous state until recently. Recently the case of a homozygous MC1R null 
individual with two MC1R loss of function alleles (86_87insA, 537_538insC 
resulting in frameshift stop codons), indicated that red hair and fair skin is the null 
phenotype of MC1R in the absence of MC1R function (Beaumont et al., 2008). 
 
1.16. Phenotype definition and skin type 
 There has been much progress with MC1R genetics despite crude phenotypic 
definition currently. In order to relate the multitude phenotypic traits (e.g. hair 
colour, skin colour, eye colour, skin cancer, freckling, moleliness, immune 
phenotypes and others) relevant to MC1R genotypes and the cutaneous response to 
UVR, one has to attempt to define these phenotypes precisely, quantitatively, 
objectively, easily, quickly, accurately and reproducibly. To put it slightly differently 
as an overview, we have a gene - MC1R - that varies between individuals and the 
variation in expression results in a number of phenotypic endpoints. How do we 
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explain these? The difficulty in attempting to explain the precise relationship also 
stems from the inherent problems associated with the definition of the skin type. 
 
1.17. Fitzpatrick Skin Type 
Skin type has been assessed routinely according to the Fitzpatrick classification 
(Fitzpatrick, 1975, 1988) as: I, always burns and never tans; II, always burns and 
then tans; III, always tans and sometimes burns; IV, always tans and never burns. In 
addition to white skinned persons, brown and black skinned persons were included 
later in the classification to give skin types V and VI (Pathak MA, 1976). A separate 
system was introduced by Satoh and Kawada in 1986 for the classification of 
Japanese skin type (Satoh, 1986). Although Fitzpatrick classification has been 
utilized widely in clinical practice, there have been suggestions that this has low 
reproducibility (Rampen et al., 1988). This classification only deals with the 2 
variables erythema and tanning (pigmentation) together. The 2 variables “erythema” 
and “tanning” may confound each other. It would be better to be able to measure 
each of these variables separately and quantitatively. Also this ordinal classification 
based on anamnestic recall has limitations for quantitative phenotypic use.  
 
1.18. Cancer syndromes 
There are a number of cancer syndromes with special clinical relevance to 
pigmentation, genetics and UV radiation. 
 
Naevoid basal cell carcinoma (Gorlin) syndrome (OMIM 109400) 
This syndrome involved 9q22-31, the PTCH gene. The gene was mapped to 9q22-31 
and identified as a human homologue of the Drosophila gene patched.  
 
Ferguson Smith syndrome (self healing epitheliomata of Ferguson Smith) 
(OMIM 132800) 
This syndrome is characterized by lesions that resemble SCCs but they resolve 
spontaneously. The gene was mapped to same locus (9q31) as naevoid basal cell 
carcinoma (Gorlin) syndrome. 
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Bazex-Dupre-Christol syndrome (OMIM 301845) 
This syndrome is an X-linked dominant condition characterized by congenital 
hypotrichosis, follicular atrophoderma and basal cell carcinomas from the second 
decade. This maps to Xq24-27. 
 
Rombo syndrome (OMIM 180730) 
This syndrome is characterized by vermiculate atrophoderma, milia, hypotrichosis, 
trichoepitheliomas, basal cell carcinomas and peripheral vasodilation with cyanosis 
(Michaelsson et al., 1981; van Steensel et al., 2001). 
 
Muir Torre syndrome (OMIM 158320) 
This syndrome is the association of sebaceous skin tumours with internal malignancy 
(Muir et al., 1967; Torre, 1968). The gene locus was mapped to 3p21.3 and 2p21-22 
and caused by mutations in the DNA mismatch repair genes MLH1 (Bapat et al., 
1996) and MSH2 (Kruse et al., 1996) genes respectively.  
 
Epidermodysplasia verruciformis (OMIM 226400) 
This syndrome is associated with a high risk of skin cancer and results from an 
abnormal susceptibility to specific related HPV genotypes, causing intraepithelial 
carcinomas and squamous cell carcinomas on photoexposed sites. The gene was 
mapped to 17q25 and caused by mutations in either EVER1 or EVER2 (Ramoz et 
al., 2002). 
 
Dyskeratosis Congenita (OMIM 305000) 
This syndrome is caused by mutation in the gene dyskerin DKC1 and characterized 
clinically by cutaneous pigmentation, nail dystrophy, oral leukoplakia, lacrimal duct 
atresia-induced lacrimation, often thrombocytopenia, anaemia and testicular atrophy. 
 
Xeroderma Pigmentosum (OMIM 194400, 133510, 216400, 278700-278720-
278730-278740-278780-278800, 314700, 610551, 610651) 
This is a group of autosomal recessive disorders that comprises of DNA repair gene 
polymorphisms. XP is characterised by extreme photosensitivity to UV radiation and 
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early appearance of non-melanoma and melanoma skin cancers. These patients have 
an exaggerated erythemal response too. 
 
1.19. Project objective 
This project aims to assess clinical phenotypes quantitatively and the effects of the 
skin’s response to UVR in order to relate to human genotypes in man. Objective 
measures are used to see how sensitive skin is to UVR and to measure objectively 
hair and skin colour, and study changes in the MC1R and other genes that may 
influence such sensitivity. Key questions include: 
What is the difference between heterozygote individuals with red hair and 
homozygotes with red hair? 
Define the pigmentary effects of the V60L (and other less common alleles) on skin’s 
response to UVR and hair colour and hair melanins. 
Do genetic differences at the agouti locus account for objective pigmentary 
characteristics that are different between individuals with identical MC1R genotypes? 
Search for further SNPs in the G-proteins thought to be downstream of MC1R, and 
ask if these can account for different phenotypes in individuals with the same MC1R 
genotypes. 
How does variation within European populations (with varying MC1R status) fit 
within the range of objective responses seen in those with different genetic ancestries 
with respect to response to irradiation? 
The goal is a quantitative understanding of the skin’s response to ultraviolet 
radiation. 
 
1.2. Thesis Outline 
This project aims to quantitatively measure human pigmentary phenotypes including 
hair colour, skin colour and eye colour and then quantify the cutaneous facultative 
pigmentary change after UVB irradiation. The detailed quantitative phenotypes were 
studied in relation to MC1R and other genotypes using a candidate gene approach. 
 
In this thesis, the phenotype of 159 individuals was investigated. The static 
phenotypes were quantitatively measured and will be described in Chapter 3. The 
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induced phenotypes from a subset of 98 individuals who underwent UVB irradiation 
will be described in Chapter 4. Their facultative pigmentary response will be detailed 
in Chapter 5. MC1R genotypes will be described in Chapter 6. The other candidate 
gene loci genotypes will be described in Chapter 7. Blondes will be discussed in                           
Chapter 8.
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Figure 1.4. A two-dimensional model of the human MC1R. 
 
 
Source: (Ringholm et al., 2004). Amino acids are shown in the circles. The residues shown 
in filled circles indicate positions for MC1R allelic variants, where a mutation results in amino 
acid exchange. Double circles = synonymous mutations. 
Cytoplasmatic loops (IL). Extracellular loops (EL). 
 
 
Table 1 summarizes the MC1R sequence changes associated with 
phenotypic changes (Wong and Rees, 2005). 




Cancer Freckling Hair and skin colour In vitro studies Murine studies 
Major      
D84E ++ ++ Red hair+++, pale skin+++ b↓↓, AMP↓↓↓ - 
R142H ++ ++ Red hair+++, pale skin+++ b↓, cAMP↓↓↓ - 
R151C ++  ++ Red hair+++, pale skin+++ bN, ↓R, cAMP↓↓↓ Melanogenic response ↓↓↓ 
R160W ++  ++ Red hair+++, pale skin+++ bN, ↓R, cAMP↓↓↓  Melanogenic response ↓↓↓ 
D294H ++ ++ Red hair+++, pale skin+++ b↓↓↓, cAMP↓↓↓  Melanogenic response ↓↓↓ 
      
Minor      
V60L + + Red hair+, pale skin++ bN, cAMP↓↓ - 
V92M + + Red hair+, pale skin+ b↓↓↓, cAMP↓ - 
R163Q - + Pale skin+ b↓, cAMPN - 
H260A - -  -  b↓ - 
H260P + +  Red hair+ - - 
      
Others      
A2V - - - - - 
P18A - - - - - 
C35Y - - - - - 
V38M - - - - - 
I40T - - - b↓, cAMP↓ - 
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L44V - - - - - 
V51A* - - - - - 
I63M* - - - - - 
A64S - - - - - 
K65N - - - - - 
R67Q - - - - - 
R67V - - - - - 
F76Y - - - - - 
L80P - - - - - 
A81P - - - - - 
S83P - - - - - 
G89R - - - - - 
T90S - - - - - 
N91D - - - - - 
V92L - - - - - 
L93R - - - b↓, cAMP↓ - 
T95M - - - - - 
V97I - - - - - 
A103V - - - - - 
G104S - - - - - 
L106Q - - - - - 
D117A - - - b↓ - 
I120T - - - - - 
V122M - - - b↓, cAMP↓ - 
S131N* - - - - - 
R142C ++ - - - - 
I155T - - Fair/blonde hair+ - - 
R162P - - - bN, cAMP↓↓↓ - 
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A164R - - - - - 
A171D - - - - - 
V174I - - - - - 
F179A - - - Yes - 
V180I - - - - - 
H209A - - - Yes - 
A212S* - - - - - 
R213W - - - - - 
P230L - - - - - 
P256S - - - - - 
V265I - - - - - 
K278E - - - - - 
N279S - - - - - 
N279K - - - - - 
I287M - - - - - 
Y298H - - - - - 
A299T - - - - - 
A299V - - - - - 
A306V - - - - - 




     
Q23X - - - - - 
29insA - - - - - 
Y152X - - Red hair+, pale skin+ - - 
Y152OCH - - - - - 
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V173del - - - - - 
179insC - - - - - 
F195del 
/ F196del 
- - - - - 
      
Silent      
L106L - - - - - 
I138I - - - - - 
R151R - - - - - 
L158L - - - - - 
A166A - - - - - 
P230P - - - - - 
Q233Q - - - - - 
I264I - - - - - 
C273C - - - - - 
F300F - - - - - 
T314T - - - - - 
S316S - - - - - 
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Table 1 – MC1R sequence changes and phenotypic variation 
Table 1 summarises 81 MC1R codon sequence changes reported in the literature to 
date and their functional significance in relation to phenotypic variations – cancer 
phenotype, freckling, hair and skin colour, modified from (Wong and Rees, 2005). In 
vitro data and murine studies are also summarised when available. These codon 
sequence changes are grouped and interpreted according to the evidence available 
into major function alleles and minor function alleles for MC1R. Other newly 
reported and unpublished sequence changes are also included. Frame shift, stop, 
deletion and silent mutations are summarised separately. A one-letter code has been 
used for the codon sequence changes.  
The relative degree of functional impairment is represented by N (normal), + (slight), 
++ (moderate) and +++ (severe). - denotes no known studies or evidence available. 
In vitro data with binding (b), cAMP response (cAMP) and reduced receptor activity 
(↓R) are symbolised respectively. The relative degree of functional impairment is 
represented by N (normal), ↓ (slight), ↓↓ (moderate) and ↓↓↓ (severe). Some of 
these allelic changes (V60L, D84E, R142H, R151C, R160W and D294H) were 
claimed to have association with fair / blonde hair although with a relatively low risk 
ratio. Note also that whether the R163Q is a ‘r’ allele or has equivalent status to 
consensus sequence is unclear. 
4 new sequence variants (V51A, I63M, S131N and A212S) from this study were 
added into Table 1. * denotes these new unpublished observations. 
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Chapter 2 Methods and materials 
 
In this chapter I discuss the methodology and materials used for the study.  
This was a study involving the precise pigmentary phenotyping of individuals and 
relating the clinical phenotypes to genotypes. First of all, the detailed pigmentary 
clinical phenotype of the volunteers was determined. Secondly their genetic 
phenotype was then ascertained. 
 
2.1 Recruitment of volunteers 
2.1.1 Ethics 
Ethical approval was obtained from the Lothian Regional Ethics Committee (LREC)  
(Study number: Derm/03/JLR/6/TW, LREC/2003/4/27, Project ID (Royal Infirmary of 
Edinburgh): 2003/R/DER/01) in the light of the Declaration of Helsinki 
(www.wma.net/e/ethicsunit/helsinki.htm) and subsequent amendments 
(www.wma.net/e), in so far as was possible for studies on volunteers, before 
commencement of recruitment for this study. All volunteers gave written informed 
consent (Appendix 1 and 2) prior to taking part in the study. 
 
2.1.2 Volunteers 
Volunteers aged 18-40 were randomly recruited to take part in the study. The choice 
for the age group of 18-40 was intended to reduce likelihood of the hair colour 
change with age i.e. grey. This project aimed to recruit individuals from 
Dermatology outpatient clinics, the Medical Research Council Human Genetics Unit, 
University of Edinburgh and other centres via posters, word of mouth, electronic 
mail and press coverage. A total of 161 volunteers have participated (see Figure 3.1 
flowchart). Volunteers were approached and had at least 24 hours and usually one to 
two weeks to decide whether to take part in the study. The reasons for individuals 
who declined to take part in the study were noted. Exclusion criteria include 
individuals: with photosensitivity, on drugs known to interfere with the cutaneous 
inflammatory response (such as high dose systemic steroids, ciclosporin, 
methotrexate and mycophenolate mofetil (MMF), on drugs known to act on the 
adrenergic pathways (such as Tricyclics, Monoamine oxidase inhibitors (MAOIs) 
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and beta-blockers) (substudy only), who are breast feeding (substudy only), who are 
pregnant (substudy only), attempting to get pregnant before or during the study 
(substudy only) and referred because of acute inflammatory skin disease. 
 
2.1.3 Volunteer Questionnaire 
Demographic data were obtained including volunteer name, gender, date of birth, 
age, address, phone number and their general practitioner. All volunteers completed 
a questionnaire providing the following background information: Fitzpatrick skin 
type, natural hair colour, use of hair dye, eye colour, past medical history, drug 
history, allergies, family history, (sun sensitivity) sun bed use, sunscreen, holidays 
abroad, sunny countries, (sun exposure) sunburn, freckles, freckling site, resident 
country, (genetic background) ethnic ancestry, place of birth, parents’ place of birth 
and parents’ hair colour (Appendix 3). 
Volunteers were asked to attend the outpatient appointment when the procedures 
were explained to them and demographic details and medical background 
information and characteristics collected. Volunteer information sheets (Appendix 4) 
were given and volunteers consented for the initial study: 
  1) Sample of venous blood 
  2) Sample of hair 
  3) Measuring skin, hair and eye colour 
  4) Exposure to graded doses of ultraviolet radiation affecting 10 small areas 
  of skin less than 1cm2 in each 
And if agreeable and appropriate to return for a substudy involving: 
  5) Noradrenaline iontophoresis (passage of a small electric current from a 9v 
  battery) using the drug Noradrenaline to make the skin blanch to areas that 
  have developed erythema from ultraviolet radiation exposure 
 
2.1.4 Collection of hair samples 
A locket of hair (measuring 3-4cm in length, approximately 0.3mg in weight) was 
cut with a pair of scissors and stored at room temperature in Minigrip resealable 
labelled polyethylene 40mm x 65mm bags (Fisher Scientific, UK) until required for 
the determination of melanin content. Hair was de-identified and planned to be sent 
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to Professor Ito’s laboratory in Japan for biochemical analysis. Hair melanins 
including eumelanin and phaeomelanin will be assayed using published method 
(Wakamatsu and Ito, 2002; Wakamatsu et al., 2002). A hair melanin assay (Ozeki et 
al., 1995) was also performed in an attempt to assay the total melanin content in hair. 
This made use of new methods to solubilize differentially phaeomelanins and 
eumelanins, which correlated well with the melanin content in mouse hairs. It made 
use of a Soluene 350 method to characterise melanins on the basis of eumelanin is 
insoluble in acid or alkali whereas phaeomelanin is soluble in alkali. 
 
2.2 Clinical phenotyping 
This study was divided into two parts – an initial study and a substudy. The initial 
study involved the precise clinical phenotyping and UV irradiation of the volunteers. 
The substudy involved noradrenaline iontophoresis of UV irradiated skin, this 
technique will be described in more detail later. 
 
2.2.1 Instruments used in this study 
All equipments were compliant with European Union safety standards. 
 
2.2.1.1 Spectrophotometer 
An instrument was sought to measure colour, pigmentation quantitatively and 
objectively. A Minolta spectrophotometer CM-2600d (Photo 2.2.1.1) (Minolta Co., 
Ltd, Osaka, Japan) was used to measure skin colour and hair colour quantitatively. 
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Photo 2.2.1.1. Minolta spectrophotometer CM-2600d 
 
The measure of colour using colorimetry and spectrophotometry has been utilised in 
chemistry and in industrial sectors including colour printing, paints, textiles, food, 
pharmaceuticals (Fairbrother et al., 1980) and cosmetics (Gillman, 1950). It has also 
been used for experimental purposes for a number of years in Dermatology (Harvey 
and Lord, 1978; Little and Wolff, 1981). It consisted of a measuring aperture and a 
computer for data processing. The aperture contained a polychromatic xenon lamp 
for illuminating an area, 8mm in diameter, of the surface to be studied. Six silicon 
photocells, three for measuring the source and three for reflected light, were also 
situated within the probe. The photocells converted the light they received into 
current, the voltage of which is proportional to the brightness of the spectral band. 
This current was converted into a digital signal, which the computer converted to 
tristimulus values. Prior to making measurements in an experimental session, the 
spectrophotometer was calibrated with a reference colour (white) plate supplied by 
Minolta. The measuring end aperture was placed against the skin surface to be 
measured without exerting pressure to avoid causing any ischaemia of the skin, 
which may alter the skin colour. 
A spectral reflectance graph of 31 readings taken at 10nm increments along the 
electromagnetic spectrum from 360 – 740nm was obtained. The values were 
mathematically reduced to 3 values via a calculation that integrated the standard 
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observer and the light source, resulting in 3 tristimulus values, L* a* b* that was 
represented into coordinates in the desired colour space. 
 
2.2.1.2 Colour model system 
Trichromatic colour theory (Young and Helmholtz) was proposed in the 18th century 
that colour vision was due to 3 photoreceptors and cone pigments in human retinas. 
Colour was represented using the L* a* b* system (International Commission on 
Illumination, Commission Internationale de l’Eclairage CIE 1931), CIE  
(www.cie.co.at),(Westerhoff, 1995) in which colour was represented as summary 
values in three dimensions (Figures 2.2.1.2.1-2) designed to be commensurable with 
human colour perception: L*, representing lightness, on a scale of 0-100 where 0 is 
black and 100 is white; a*, representing red-green, on a scale from +60 to –60, where 
positive values indicate increasing shades of red; and b*, representing a yellow-blue, 
on a scale from +60 to –60, with positive values representing increasing shades of 
yellow. These three values were plotted and intersected into a three dimensional 
space to give a numerical value for colour. 
  





Figure 2.2.1.2.2. L* a* b* 3-Dimensional colour space. 
 
Source: Minolta chromameter operational manual (Minolta, Osaka, Japan) 
 
This method has been previously used in the study of human hair and skin colour and 
phototype (Naysmith et al., 2004; Park et al., 2002; Takiwaki et al., 1994). 
Triplicate measurements were taken for each volunteer. L* a* b* colorimetry and 
spectrophotometric reflectance data were obtained as described above. Prior to 
measurements with each volunteer, the spectrophotometer was zero calibrated and 
white calibrated as per manufacturer’s instructions. Appropriate settings were chosen 
and set (specular component excluded, small aperture). The small aperture was 
chosen in preference because the diameter of small aperture (0.55cm) was smaller 
than that of the UVB induced pigmentation whereas the larger medium aperture 
(1.05cm) would underestimate the degree of pigmentary colour change. The specular 
component excluded (SCE) option was set in order to estimate the true reading 
without the specular or gloss component in a spherical spectrophotometer in 
providing reflectance measurements. Specular reflectance is the light that is reflected 
without penetrating the stratum corneum. This carries information about the structure 
and the state of hydration rather than about the underlying chromophores. In mode 
SCE (Specular Component Excluded), an internal light trap opens up and let the 
specular reflection of the source lamp onto the sample surface be captured and 
eliminated from the measurement. Only scattered light from the sample surface is 
measured. The Total Integrated Scatter (TIS) was measured and related to the micro-
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roughness of the surface as: In mode SCI (Specular Component Included), the light 
trap is closed, therefore the source light bounced off it and got to the sensor: the 
combination of reflected and scattered lights were measured. Specular reflected light 
will then come from the calculation of the difference SCI-SCE. 
 
2.2.1.3 Contact Laser Doppler 
A contact laser doppler (Photo 2.2.1.3) MoorLab Server Laser Doppler Perfusion 
Monitor (Moor contact Doppler velocimetry, Moor Instruments Ltd, Millwey, 
Axminster, Devon, UK) was used to measure blood flux at 24 hours and 1-week post 
UVB irradiation. 
 
Photo 2.2.1.3. MoorLab contact laser doppler 
 
The blood flux measure was chosen to quantify the amount of erythema post UVB 
irradiation. This technique has already been widely used in Dermatology 
(Mustakallio and Kolari, 1983; Oh et al., 2004) and other branches of medicine to 
measure blood flow (Rushmer, 1977). 
This technique was based on the Doppler principle. Christian Johann Andreas 
Doppler (1803-1853), an Austrian mathematician and physicist, first described the 
effect in 1842 whereby the change in frequency and wavelength of a wave that is 
perceived by an observer moving relative to the source of the waves. This was 
initially on the coloured light from refracted stars and other celestial objects. 
Hippolyte Armand Louis Fizeau (1819-1896) independently discovered the same 
phenomenon for electromagnetic waves in 1848. The same effect applies to sound 
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waves which accounts for the everyday emergency vehicle sirens which start out at a 
higher approaching pitch than its stationary pitch and then slides down as it passes 
and continues to go lower than its stationary pitch as it departs further from the 
observer. In Medicine and in particular Dermatology, Laser Doppler velocimeters 
were used to measure the Doppler shift in wavelengths of reflections from particles 
moving with the flow. A low power light from a monochromatic stable laser is 
scattered by moving erythrocytes (perpendicular to the laser light beam) and as a 
consequence its frequency broadened. The frequency-broadened light, together with 
laser light scattered from static tissue, was photodetected and the resultant 
photocurrent processed to provide a blood flow measurement. One limitation with a 
single stationary Laser Doppler probe is that these blood flow measurements are 
relative blood flow values at a particular time point. If absolute blood flow values are 
required, multiple Laser Doppler probes could be used simultaneously. Melanins in 
the skin were stationary, and therefore do not affect the Doppler shift caused by the 
movement of erythrocytes (Stern, 1975). The laser-Doppler blood perfusion monitors 
output a signal that is proportional to the red blood cell perfusion (or flux). This 
represents the transport of blood cells through microvasculature and is defined as: 
 
Red Blood Cell Flux = Number of blood cells moving in the tissue sampling volume 
× Mean velocity of these cells 
Microvascular blood perfusion (Flux) is the product of mean red blood cell velocity 
and mean red blood cell concentration in the volume of tissue under illumination 
from the probe. For cutaneous measurements, the sampling depth is likely to be in 
the range 1.0 – 1.5 mm (Holloway and Watkins, 1977). This method is consistent 
with published guidelines for laser Doppler perfusion imaging (Fullerton et al., 
2002). 
Perfusion measurements with Flux were obtained from MoorSoft software. Blood 
flux results were expressed as an increase in blood flux relative to basal cutaneous 
blood flux. All measurements were taken in triplicate. 
The reproducibility of laser doppler flowmetry measurements in a microcirculatory 
environment was previously tested (Grodzicki et al., 2003). 
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2.2.1.4 Erythema meter and melanin index measures 
Skin pigmentation and ambient lighting influences our perception of erythema 
(Diffey and Robson, 1992), thus an objective approach is required. A Diastron 
erythema meter (Diastron, Andover, Hampshire, UK; Photo 2.2.1.4) was used to 
measure erythema induced by UVB radiation. 
 
Photo 2.2.1.4. Diastron Erythema meter 
 
The basis for erythema index (EI) measurements by erythema meter was fully 
described in (Diffey et al., 1984). In brief, the principle of the instrument was based 
on a spectrophotometric technique and the fact that haemoglobin in upper dermal 
blood vessels is the chief chromophore of green light (510-568nm) in skin. When 
there is increasing erythema due to vasodilation, more green light (510nm) is 
absorbed by haemoglobin and less is reflected. However, the amount of red light 
(650-655nm) absorbed or reflected stays relatively constant. By comparing the 
quantity of reflected red (660-690nm) and green (530-560nm) light, an ‘erythema 
index’ could be obtained which is dependent on the amount of blood. The Erythema 
index for this instrument can be defined as follows: the logarithm value of the 
amount of reflected red to green light (Diffey et al., 1984). 
                                                  Intensity of red component of reflected light 
Erythema index (EI) = log 10    ______________________________________        
                                                  Intensity of green component of reflected light 
                                        
White light from a projector bulb was transmitted along one branch of a fibre optic 
cable to a conically shaped handheld applicator with an aperture of 21mm diameter, 
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which was in turn held against the skin to be measured. The aperture of the handheld 
applicator was greater than the diameter of the light guide (5.5-6mm) such that the 
instrumental readings were unaffected by changes in applied pressure within 
reasonable operational limits. Light re-emitted from the skin travels back up two 
different branches of the fibre optic cable; one to a green interference filter and 
photodiode, the other to a red interference filter and photodiode. The photocurrents 
from both diodes were amplified and formed the two inputs to a log ratio module. 
The output from this module was the erythema index. 
The erythema meter was able to record quickly, easily and precisely the degree of 
erythema at any anatomical site, with a coefficient of variation of about 3% that may 
be obtained by repeated measurements at a single site. A note of caution when using 
this instrument – care must be taken not to rest the handheld applicator against the 
skin to be measured for a prolonged period of time (>5 seconds), as the light from the 
projecting bulb could warm up the underlying skin, contributing to an artefactually 
increased erythema index. Although the instrument cannot fully discriminate 
between erythemal and pigmentary changes, a measurement of the erythema index at 
a site on the skin before and after irradiation shows that the difference between the 
two readings is essentially related to an increase in vasodilatation and is independent 
of the melanin content of the epidermis. UVR induced erythema can therefore be 
expressed as the erythema index derived from reflectance spectroscopy log10 
[672nm: 546nm] × 1000 (Diffey and Farr, 1991; Diffey et al., 1984). A baseline 
erythema reflectance reading was measured in triplicate from unirradiated skin 
adjacent laterally to the lowest UVB irradiated dose on the mid back and the buttock. 
The mean value of erythema index was calculated from the 3 measurements. The 
baseline erythema index was calculated similarly. The erythema index response was 
expressed as the change in erythema index after the subtraction of baseline values. 
 
2.2.1.5 Melanin index measurements 
Melanin index (MI) was obtained using the same reflectance instrument (Photo 
2.2.1.4) to measure pigmentation. The basis of MI is as follows. The MI 
measurement is a function of the remittance at 632nm (for melanin absorption) and 
905nm (reference signal) (Diffey et al., 1984; Feather et al., 1988). For this MI scale  
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(-150 to 0) increase in pigmentation leads to a higher MI (most Caucasian skins have 
negative MI numbers) and there is a strong inverse relationship between MI and 
erythema in response to a UV irradiation dose between individuals (Ha et al., 2003; 
Wagner et al., 2002b). Thus the MI is a useful predictor of an individual’s sensitivity 
defined as erythema to UVR (Flanagan et al., 2001; Ha et al., 2003). Melanin index 
(MI) was measured in triplicate before and after UVB irradiation at mid back and 
buttock at the same locations as the erythema recordings. 
 
2.2.2 Skin colour measurements 
Phenotype measurements of these volunteers were performed using tristimulus L* a* 
b* colorimetry (Clydesdale, 1978; Westerhof et al., 1986) and spectrophotometry by 
Minolta spectrophotometer CM-2600d (Minolta Co., Ltd, Osaka, Japan) (see Photo 
2.2.1.1) to measure their skin colour at multiple sites including forehead, cheek, 
forearm, medial arm, hand, chest, abdomen, thigh, calf, back and buttock. 
Where many previous studies only used upper inner medial arm as the body site for 
skin colour measurements (Dwyer et al., 1998; Wagner et al., 2002a; Wagner et al., 
2002b), this study included a wide range of photoexposed and photoprotected body 
sites for constitutive skin colour measurements. Before each machine start and 
experimental session and measurement, the spectrophotometer was zero calibrated 
according to manufacturing instructions. 
 
2.2.3 Assessment of freckling 
Previous methods have used freckling charts (Bastiaens et al., 2001a) as described by 
(Gallagher et al., 1990), freckling score (Duffy et al., 2004), crude freckling 
categories (Elwood et al., 1990), presence or absence (Motokawa et al., 2007; Zhang 
et al., 2004), freckling tendency by history (Naysmith et al., 2004), number of 
freckling sites by history (Flanagan et al., 2000) to measure freckling. No previous 
method involves counting the number of freckles. I have chosen to objectively assess 
the degree of freckling by recording the presence or absence of freckles at 7 freckling 
sites for ease of recording for this phenotype and due to time constraints. 
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The presence or absence of freckles at 7 freckling sites including face, shoulders, 
chest, abdomen, back, arms and legs was recorded. The number of freckling sites 
was also noted while skin colour measurements were obtained. 
 
2.2.4 Hair colour measurements 
Hair colour was measured similarly using tristimulus L* a* b* colorimetry 
(Clydesdale, 1978; Westerhof et al., 1986) and spectrophotometry by Minolta 
spectrophotometer CM-2600d (Minolta Co., Ltd, Osaka, Japan). Hair colour is not 
the same over the whole scalp from our preliminary studies. Individuals often have 
different coloured strands of hair within the same scalp. There were intrapersonal 
variations in hair colour within the same scalp. In order to minimise this, an “average 
hair colour” was obtained and used. Hair colour was measured at 6 scalp hair sites 
including: left and right frontal (8cm superiorly from supraorbital ridge), left and 
right temple (8cm laterally from supraorbital ridge), left and right occipital (5cm 
laterally from occiput). All measurements were obtained in triplicate. These sites 
were chosen in an attempt to obtain a true “average hair colour”. The sites were 
chosen from anatomical points so that it was reproducible. 
 
2.2.5 Eye colour measurements 
Previous methods have used crude classification, photography, computerised image 
analysis of photographs (Takamoto et al., 2001) and colour matching, comparison to 
standard photographs (Mitchell et al., 2003), purpose-developed chart (Semes et al., 
2006), 3-CCD video camera with computer software (Niggemann et al., 2003) to 
assess eye colours. This method has been used previously (Sparrow et al., 1988). An 
indirect method was therefore used to measure eye colour. The colour of the iris were 
noted and matched using Munsell colour atlas (X-Rite Ltd, UK), based on the 
Munsell colour system (Munsell, 1912), with over 1500 colour plates under 
standardised daylight illumination (custom-made) fitted with two (2 feet) Philips 
F20W/54 Daylight fluorescent tubes (colour temperature 6500K) (Philips, UK). A 
myopic vision technique was used such that any variation in iris colours was blended 
to one uniform iris colour due to myopic vision. The observer, having spectacles 
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removed, performed eye colour matching of the uniform iris colour to the resultant 
Munsell colour plate in the Munsell colour atlas. Colour vision of the observer was 
previously evaluated by using the Farnsworth-Munsell 100 Hue Test (Macbeth, New 
Windsor, New York). The resultant Munsell colour plate was recorded as a complete 
Munsell notation: Hue Value / Chroma i.e. H V/C. There were 5 main hues: red, 
yellow, green, blue and purple, with 5 intermediate hues midway between the main 
hues. 
 
 These 10 steps were broken into 10 substeps which resulted in 100 hues with integer 
values.  
 
Value or lightness ranges from black (value 0) to white (value 10). 
 








Munsell colour space notations (HVC) were converted to CIE L*, a* and b* colour 
space representations using Munsell Conversion Software version 8.0.1 
(WallkillColor.com, http://livingstonmanor.net/Munsell/index2.htm) for quantitative 
analysis of eye colour. 
 
2.2.6. UVR source and irradiation 
A custom made UVB radiation source (Photo 2.2.6.A) by Emeritus Professor Brian 
Diffey (Regional Medical Physics Department, Newcastle, UK) was used for the UV 
irradiation experiments. 
 
Photo 2.2.6. Custom made broadband UVB radiation source 
A              B  
 
This consisted of a broadband UVB lamp (Philips PLS 9w/12) housed within an 
enclosed unit, with 10 apertures of 9mm diameter anterior to the UVB lamp to enable 
10 doses to be delivered simultaneously. All 10 apertures were within an area of 
7cm×3cm (Photo 2.2.6.B). The maximum dose aperture consisted of no metal foil 
filter, the other 9 dose apertures were backed by perforated metal foil with hole grids 
of differing but increasing sizes to allow for the 9 increasing dose aperture ranges. 
The UVB lamp casing is made of transparent plastic that is opaque to UV. The unit 
also consisted of a digital photodiode that switched the lamp off automatically when 
the appropriate doses at the apertures were delivered.  
The relative spectral irradiance was plotted for the TL12 UVB lamp in Figure 2.2.6. 
(Medical Physics, Royal Infirmary of Edinburgh; Philips, UK): 
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Unweighted irradiance was the absolute spectral irradiance. Weighted irradiance 
referred to the erythemally-weighted irradiance weighted for biological erythemal 
effect i.e. distribution of effective radiance with standard erythemal doses (SEDs) for 
the individuals. 1 SED is equivalent to an erythemal effective radiant exposure of 
100 J/m2 (Diffey et al., 1997). 
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The mid back and buttock skin were irradiated with UVB exposure to graded doses 
0, 1, 1.3, 1.6, 2, 2.6, 3.2, 4.1, 5.2, 6.5 and 8 SEDs (Diffey et al., 1997) on one 
occasion affecting 10 small areas of skin less than 1cm2 in each (diameter 9mm). 
Volunteers’ end responses were measured after 24 hours and 1-week post irradiation 
using blood flux (Moor contact Doppler velocimetry), erythema (Diastron erythema 
meter), melanin index (degree of melanin developed facultatively), L* a* b* 
colorimetry and spectrophotometry. At 1-week post irradiation, a paper card template 
with 10 holes corresponding to the 10 apertures of the custom made UVB source was 
positioned over the site of previous irradiation. The superimposed paper card 
template holes with the resultant reaction(s) (erythema and/or tanning) also served as 
a further confirmation of the site of previous irradiation. The peripheries of the 
apertures were then ink marked. Care was taken in marking the sites of irradition as 
this is a potential pitfall. 
It is important to be able to assess and measure tanning in the absence of blood. If the 
blood flux was still elevated 1-week post UVR, noradrenaline iontophoresis (Oh et 
al., 2004) (Photo 6a) was performed to reduce the amount of blood flux back to basal 
control level before melanin index and colorimetry spectrophotometry were 
obtained. 
For the purposes of ease of description, “Dose 1” was designated as 95mJ/cm2 which 
was equivalent to 2.6 SEDs (~ 1 MED) for average Northern European. This dose 
generates just perceptible erythema in an average normal Northern European (~1 
MED). 
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 UVB dose (mJ/cm2) SEDs MEDs equivalent 
Dose 1 95 2.6 1 
Dose 2 189 5.2 2 
Dose 3 300 8.2 3-4 
 
“Dose 2” was designated as 189mJ/cm2 which was equivalent to 5.2 SEDs (~ 2-3 
MEDs). “Dose 3” was designated as 300mJ/cm2 which was equivalent to 8.2 SEDs 
(~ 3-4 MEDs). 
 
2.2.7. Noradrenaline iontophoresis 
A key problem in measuring pigmentary change after UV irradiation is the presence 
of erythema caused by the UV irradiation. This erythema in turn poses a problem in 
the measurement of induced pigment, which may inadvertently measure the 
erythema as well as the induced pigment. In order to overcome the contributory 
effect of erythema to pigment / skin colour measurements after UVB irradiation, I 
used the method of Noradrenaline iontophoresis after UVB irradiation to remove 
blood and the effect of vasodilatation as the gold standard before reflectance 
measurements. 
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Noradrenaline iontophoresis was performed using Phoresor II Auto unit model 
PM700 (Iomed, Salt Lake City, Utah, USA) (Oh et al., 2004) (Photo 2.2.7.a) which 
involved the passage of a small electric current (0.2mA) from a 9V battery for 5 
minutes using the drug Noradrenaline 1:1000 (0.1%) (Abbott Laboratories Ltd., UK) 
applied to a total area of 4cm2 via a well of 9mm diameter to make the skin blanch to 
areas that have gone red from UVR exposure (see Photo 2.2.7.c). 
Photo 2.2.7.a. Noradrenaline iontophoresis 
 
Photos 2.2.7.b, 2.2.7.c Before and after noradrenaline iontophoresis 
b) Pre noradrenaline      c) Post noradrenaline 
 
 
Skin colour was measured after iontophoresis of noradrenaline to remove blood and 
then skin pigment was measured using tristimulus L* a* b* colorimetry and 
spectrophotometer. Noradrenaline was driven by the current during iontophoresis 
and had a potent vasoconstrictor effect. The dosage used was optimized such that any 
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increase in UVB-induced flux was reduced back to basal blood flow. The method 
was further developed. 
 
2.2.8. Pressure colorimetry versus Noradrenaline iontophoresis study 
Another technique was tried to circumvent the problem posed by erythema after UV 
induced pigment change. The possibility to study pigmentary changes in the absence 
of blood flow was to use a technique that utilised pressure – if sufficient pressure was 
employed via a transparent cover, the pressure exerted onto the skin would exclude 
and expel blood from blood vessels temporarily, blanching the skin. A tailor made 
transparent cover (Minolta Co., Ltd, Osaka, Japan) (Photo 2.2.8) was obtained and 
fitted to the Minolta spectrophotometer CM-2600d (Minolta Co., Ltd, Osaka, Japan). 
 
Photo 2.2.8. Tailor made transparent cover (A) fitted to the Minolta 
spectrophotometer CM-2600d (B).  
A             B 
 
A series of preliminary experiments (n=9) were performed to study this technique. 
L* a* b* colorimetric values and reflectance spectrophotometric values were 
measured for pressure with cover and post-noradrenaline iontophoresis with cover. 
 
2.2.9. Shriver method 
A method of measuring pigmentary phenotype and melanogenic dose response was 
published - Shriver method (Wagner et al., 2002a). Wagner et al concluded that 
adjusted melanin (AM) index (slope 650:700 nm) is a more accurate measure of 
melanogenic dose–response (i.e. facultative pigmentary response) than other 
 72
traditional indices (e.g. colorimetric L* or melanin index MI), as it allows 
measurement of induced melanin without the complications of residual erythema. In 
addition, Wagner et al argued that AM is only measuring wavelengths at the red end 
of the visual spectrum, where haemoglobin does not absorb and that the only 
chromophore being measured is melanin. The method could be compared with my 
data and analysed according to this method. 
 
2.2.10. Dwyer method 
A method (Dwyer et al., 1998) was previously used to determine the density of 
cutaneous melanin from skin reflectance measured by a Minolta 508 
spectrophotometer. Cutaneous melanin was shown to be estimated by a mathematical 
difference between 2 measurements of skin reflectance at 400nm and 420nm. Dwyer 
et al argued that this mathematical difference correlated well with Masson Fontana 
stain. A comparison of this mathematical method with my experimental data 
analysed will be detailed in the results section in Chapter 5. 
 
2.3. Genetic phenotyping 
2.3.1. Collection of blood samples 
Venepuncture was performed on all volunteers to obtain a total of 18ml venous blood 
sample and placed in two 9ml Sarstedt Monovette plastic tubes containing 
ethylenediamine tetra-acetic acid (EDTA). These were frozen at -80°C and stored 
until required for DNA extraction. 
 
2.3.2. General reagents used in molecular biology procedures 
All chemicals were analytical grade and were supplied by Sigma, Promega, Gibco 
BRL, BDH, Fisher Scientific, Flowgen, and Boehringer Mannheim.  Nucleic acid 
manipulations were done in 1.5ml centrifuge tubes unless otherwise stated.  General 
solutions were prepared by Human Genetics Unit (HGU) technical staff and 
autoclaved and stored at room temperature. 
Tris.HCl 
Tris base (tris[hydroxymethyl]aminomethane) was dissolved in sterile water. HCl 
was used to adjust the pH to the required value. 
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EDTA 
EDTA (ethyldiaminetetra-acetic acid di-sodium salt) was dissolved in sterile distilled 
water.  The solution was adjusted to pH 8.0 by adding solid NaOH.  
TE buffer 
10mM Tris.HCl (pH 7.5); 1mM EDTA.  
Tris-Borate-EDTA (TBE) buffer, 20× stock 
Tris base  216g 
Boric acid  110g 
0.5M EDTA  80mM 
Distilled water was added to a final volume of 1 litre. Stock was diluted to 1× with 
distilled water. 
TAE 50× stock 
Tris base  242g 
Glacial acetic acid 57.1ml 
0.5M EDTA  100ml 
Distilled water was added to a final volume of 1 litre.  Stock was diluted to 1× with 
distilled water. 
 
2.3.3. DNA extraction 
DNA was extracted using Nucleon Genomic DNA extraction kit (Tepnel Life 
Sciences PLC, Manchester, UK). Collected whole blood were fully thawed, then 
lysed, deproteinised with sodium perchlorate, DNA extracted with chloroform, DNA 
precipitated with ethanol, washed, air-dried for 30 seconds and re-dissolved in 1ml 
Tris-EDTA and rotary mixed for 24 hours before storage at 4°C. 
 
2.3.4. Polymerase Chain Reaction (PCR) 
DNA molecules were amplified by PCR. 
dNTPs 
Deoxyribonucleotide triphosphate (dNTPs) were purchased as stocks of 100mM.  
Working stocks of 10mM were made by mixing 10ml of each of the dNTPs (dATP, 
dCTP, dGTP, dTTP) with 60ml dH2O to a final volume of 100ml.  Stocks were 
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Primers were initially designed using Primer3 
(http://fokker.wi.mit.edu/primer3/input.htm). Primers were purchased as lyophilised 
desalted compounds (Invitrogen). Stocks were made up to 1mg/ml using sterile 
distilled H2O. Working stocks were diluted to 1mg/ml and stored at 4°C. Primers 
were used in PCR reactions at a final concentration of 2ng/ml (1:50 dilution). 




The forward primer (401F) used was 5’-GAA CTA AGC AGG ACA CCT GGA 
GG-3’ and the reverse primer (1492R) used was 5’-GGA CCA GGG AGG TAA 
GGA ACT GC-3’. 
PCR conditions were 94°C 4min, then 35 cycles of 94°C 30s, 55°C 30s, 72°C 2min; 
followed by 72°C 10min. 
 
POMC primers 
Exon 1 forward primer used was 5’-CCG GGA AGG TCA AAG TCC-3’ and the 
reverse primer used was 5’-GCG CAG AAA GTT TGT C GA G-3’. 
Exon 2 forward primer used was 5’-TGT TGT TAA TGT TGG CTC AAG G-3’ and 
the reverse primer used was 5’-AGC TCC AGT CCC ATC TAA TGT C-3’. 
Exon 3 forward primer used was 5’-CTG GAG TTC AAG AGG GAG CTG-3’ and 
the reverse primer used was 5’-GAA GTG CTC CAT CCT GTA GGG-3’. 
PCR conditions were 94°C 4min, then 35 cycles of 94°C 30s, 60°C 30s, 68°C 1min; 
followed by 72°C 10min. 
 
Taq polymerase, PCR buffer, and Mg2+ 
These reagents were purchased (Applied Biosystems). AmpliTaq (5U/ml) was used 
at 0.2ml per 25ml reaction. PCR buffer was a 10× stock and therefore diluted 1:10 
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for reactions. Mg2+ was used at a final concentration of 1.5mM. Routine PCRs were 
done in a Hybaid Omnigene thermocycler using Abgene thin walled thermo tubes. 
 
PCR Recipe for a 25μl reaction: 
2.5μl buffer     0.5μl dNTP   0.5μl forward primer 
0.5μl reverse primer    0.1μl Taq polymerase 
0.5μl DNA     19.65μl water  0.75μl Mg2+ 
 
Optiprime protocol 
5μl buffer of each of 12 Optiprime buffer 
45μl reaction mix 
 
12-reaction mix Recipe: 
12.5μl 50× Mastermix  12.5μl dNTP  2.5μl forward primer 
2.5μl reverse primer    3μl Taq polymerase 30U 
6.25μl DNA     525.75μl water 
 
2.3.5. Polyacrylamide Gel Electrophoresis (PAGE) 
Agarose gel loading buffer 
Loading buffer was prepared as a 10× stock and stored at room temperature. 
    Final concentration 
Ficoll    20% 
Orange G (Sigma)  1% 
EDTA    100mM 
This was made to required volume with distilled water. 
 
For preparing gels, the required amount of agarose (High pure, BioGene) was 
dissolved in either 1× TBE or TAE by heating. Molten agarose was cooled and 
ethidium bromide added to a final concentration of 0.5μg/ml agarose. The DNA 
markers used were 100bp marker (Promega) and 1kb marker (Invitrogen) depending 
on the expected size of fragments. DNA size markers were run alongside the samples 
to estimate the size and amount of DNA in the samples. The gel was placed in a gel 
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tank with 1×TBE buffer and a current applied. After adequate migration as indicated 
by the loading buffer, the gel was placed in a UV-transilluminator. Samples were run 
in 1× loading buffer. 
 
2.3.6. Determining concentrations of DNA 
The intensity of DNA was visualized and estimated against known DNA 
concentration on agarose gel by electrophoresis, or by measuring the absorbance 
(optical density, OD) in a spectrophotometer (GeneQuant) at a wavelength of 260nm 
(A260). A260/ A280 ratio of 1.7-1.9 indicates DNA purity. 
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2.3.7 Genotyping and sequencing 
Volunteers were genotyped to identify MC1R (OMIM 155555) status. The sample of 
venous blood (10-20ml) was used for genotyping. Single Nucleotide Polymorphisms 
(SNPs) were initially identified using existing bioinformatic resources (e.g. the SNP 
Consortium (www.snp.cshl.org) and the International HapMap Project 
(www.hapmap.org). These were subsequently detected in the sample populations 
using fluorescent primer extension on ABI 310 or 3100 electrophoresis systems at 
Medical Research Council Human Genetics Unit. The primer extension assay with 
fluorescence polarization (FP) detection is an assay for SNP genotyping. 
Fluorescence polarization occurs when a fluorescent dye is excited by plane-
polarized light and is detected if the fluorescent dye is part of a large molecule. In 
assays where small fluorescent molecules are turned into large fluorescent products, 
FP provides a simple way to determine if the reaction has occurred without the need 
for separation or purification of the reaction mixture. In the primer extension assay, 
DNA polymerase incorporates the complementary, allelic nucleotide onto the SNP 
primer designed to anneal to the target DNA one base upstream of the polymorphic 
site. When a fluorescently labeled nucleotide is incorporated, high FP is observed for 
that dye and the genotype of the DNA sample is determined (Kwok, 2004). 
MC1R and 34 other genes thought to be important in skin inflammation and 
susceptibility to ultraviolet radiation and skin cancer were sequenced or genotyped 
using automated technology. 
 
2.3.8. MC1R and POMC Sequencing 
PCR primers used for gene of interest were used for DNA sequencing. Sequencing 
primers were diluted to a concentration of 50μg/μl or 20μM and submitted to the 
HGU Technical service together with the PCR products. 
 
The dye terminators used was BigDye (PerkinElmer, UK), which consisted of DNA 
polymerase, dNTPs and ddNTPs-Dye terminators. Successive cycles of amplification 
resulted in the incorporation of one of the 4 ddNTPs, each tagged with a different 
fluorescent dye in each extension product. 
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The sequencing reaction was as follows: 
Sequencing primer   5pmol 
DNA template   10ng 
Mg2+     0.4mM 
BigDye terminator   0.5ul 
DdH2O    up to 20ul 
 
The sequencing programme was as follows: [30s at 96°C, then 15s at 55°C, followed 
by 4min at 60°C] × 25 cycles. Sequencing products were ethanol precipitated and 
separated with an ABI3100 by the HGU Technical service to discriminate ssDNA 
fragments of different length. Sequencing traces were analysed using Sequencher 
software version 4.7 (Gene Codes Corporation, USA) and Mutation Surveyor 
software version 2.61 (SoftGenetics LLC, USA). 
 
The candidate gene approach and delineation and choice and the final selection of 
candidate gene loci and SNPs will be discussed in detail in Chapter 7. 
 
2.3.9. Illumina SNP genotyping 
Illumina GoldenGate microarray assay systems (Illumina Inc, San Diego, California, 
USA) (Fan et al., 2003; Steemers and Gunderson, 2005) was a novel highly 
multiplexed assay used for genotyping in this study. This was performed at the 
Wellcome Trust Clinical Research Facility Genetics Core (Edinburgh, UK). 
A total of 33 genes were haplotype tagged and genotyped in this population using 
Illumina GoldenGate SNP genotyping technology. 
The basis of Illumina GoldenGate Assay Genotyping is as follows: 
This assay utilises the BeadArray technology, where targeted regions of DNA are 
immobilized on beads randomly arranged into arrays, and the SNPs visualized 
through fluorescent tags, which differentiate among alleles. 
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Figure 2.3.9.a. The Sentrix BeadChip (left) features eight array clusters, each 
with 50,000 beads and 20-micron spacing between beads (right) 
  
 
Source: www.illumina.com  
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Figure 2.3.9.b. Illumina GoldenGate Genotyping Assay 
 
Source: www.illumina.com  
 
DNA sample used is ‘activated’ for binding to paramagnetic particles by binding to 
streptavidin and biotin. Next, assay oligonucleotides, buffer and paramagnetic 
particles are combined with the ‘activated’ DNA in the hybridization step. 3 
oligonucleotides were designed for each SNP locus. Two oligos were allele-specific 
to the SNP i.e. Allele-Specific Oligo (ASO). The third oligo hybridizes several bases 
downstream from the SNP site is the Locus-Specific Oligo (LSO). All three 
oligonucleotide sequences contain regions of genomic complementarity and 
universal PCR primer sites. The LSO also contains a unique address sequence that 
targets a particular bead type. The 384 SNPs were tested (in fact up to 1,536 SNPs 
may be tested simultaneously) using GoldenGate technology. Following 
hybridization, several wash steps are performed, reducing noise by removing excess 
and mis-hybridized oligonucleotides. Extension of the appropriate ASO and ligation 
of the extended product to the LSO joins information about the genotype present at 
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the SNP site to the address sequence on the LSO. These joined, full length products 
provide a template for PCR using universal PCR primers. The single-stranded, dye-
labeled DNAs are hybridized to their complement bead type through their unique 
address sequences. Hybridization of the GoldenGate Assay products onto the 
BeadChip allows for the separation of the assay products in solution, onto a solid 
surface for individual SNP genotype readout. After hybridization, the BeadArray 
Reader (BeadStation 500GX) was used to analyze fluorescence signal on the 
BeadChip, which is in turn analyzed using software for automated genotype 
clustering and calling. Average call rates were >99%. This translates to a particular 
allele. The genotypic data were related to phenotypic measurements to look for 
associations. 
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Figure 2.3.9.c. BeadStation 500GX Genotyping system 
 
Source: www.illumina.com 
Prior to running the custom GoldenGate Genotyping assay, Illumina Assay Design 
Tool was used to refine and eliminate cross hybridisation and improve success rate. 
The SNP selection design began from RS list, Sequence list, Regions (by 
coordinate), or Gene List. Using the tool, full annotation as part of standard results 
including design score, design rank, minor allele frequency (MAF) and validation 
status were available for screening. Information from the most up to date sources for 
both genome build and dbSNP version was used. MAF, validation status* 
(GoldenGate validation, two-hit validation status, non-validated) and SNP scores 
were obtained from Illumina. Design, failure codes were also obtained and 
considered before eliminating down to the final 384 SNPs from 33 genes. 
*GoldenGate validation status: SNP has been previously designed and successfully generated 
polymorphic results on the Illumina platform. Designed oligonucleotides have 100% sequence match 
to those previously designed. 
*Two-hit validation status: Both alleles of the SNP have been seen in two independent methods and 
populations 
*Non-validated: SNP seen in only one method or population. Even if it has a high design score, there 
is still an increased chance that it is monomorphic 
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2.3.10 Hair melanin assay 
Hair melanins in mice have previously been determined chemically (Ozeki et al., 
1995) and used in a previous study (Healy et al., 2001). An attempt to quantify the 
amount of melanins in human hair was made using an adaptation of this method. 
 
2.3.10.1 Total Melanin (TM) content 
1-1.5mg of human hair was weighed in 2ml screw top tube. 1ml of Soluene mix 
(100ul sterile water + 900ul Soluene 350) per mg of hair was added. This was then 
heated for 30 minutes in a 90°C water bath and then vortexed to sediment any 
precipitants. This released melanin into the supernatant. This was followed by a 
further 15 minutes of heating in water bath, vortexed and allowed to cool to room 
temperature. This was then centrifuged for 10 minutes at 13000rpm in microfuge. 
Absorbances were read with an Ultraspec 2000 UV Visible Spectrophotometer 
(Pharmacia Biotech, UK) at 500nm against a standard blank of 9:1 Soluene 
350:water that also went through the same heating procedure. Quartz cuvettes were 
used. The mean absorbance was equal to the total melanin (TM) content. 
 
2.3.10.2 Alkaline Soluble Melanin (ASM) content 
Alkaline soluble melanin (ASM) content was determined as follows. 2mg of hair was 
weighed in 2ml screw top tube. 1ml of 6.4M Urea/0.8M NaOH mix was added to 
every 2mg of hair. The mixture was shaken horizontally for 30 minutes in a 37°C 
incubator. After vortexing, the mixture was centrifuged for 10 minutes at 13000rpm 
in microfuge. Absorbances were read with an Ultraspec 2000 UV Visible 
Spectrophotometer (Pharmacia Biotech, UK) at 400nm against a standard blank of 
6.4M Urea/0.8M NaOH. Results were expressed as a ratio of ASM to TM. 
 
The human hair melanin assay was found to give inconsistent results and not very 
useful and it was not pursued further. The results will be presented in Appendix 5. 
 
2.4 Data analysis and statistics 
Volunteers were anonymised and deidentified by allocating a unique number so that 
their confidentiality was maintained. Data were captured and processed using 
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Microsoft Excel (version 10.6829.6830 SP3 2002, Microsoft Corporation) and pasted 
to Minitab (version 14 Minitab Ltd., Coventry, UK) and PLINK version 0.99r, Shaun 
Purcell, pngu.mgh.harvard.edu/purcell/plink (Purcell 2007). Graphs were drawn 
using Microsoft Excel and Minitab. Statistical analyses were performed on Minitab 
version 14 and PLINK and described in relevant sections in the thesis. Fisher’s Exact 
test was used for comparison of contingency tables. The Fisher-Freeman-Halton Test 
was used for the analysis of the r × c contingency tables using StatsDirect (version 
2.6.9 StatsDirect Ltd., www.statsdirect.com, Cambridge, UK). Non-parametric tests 
were used if distribution was not normal. Mann Whitney U test was used to compare 
medians. Analysis of variance was used when results were normally distributed and 
parametric. Kruskal-Wallis test was used to perform non-parametric ANOVA. A 
large number of data has to be presented and a compromise was made between 
visibility and readability of the graphs plotted in data presentation. 
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Chapter 3 Static Phenotypes 
 
3.1. Introduction 
The data set comprised 159 individuals who participated in this study (Figure 3.1). 
Demographic and background data were recorded from a volunteer questionnaire 
(Appendix 3). Phenotypic variables were measured at 22 anatomical body skin sites 
(11 on each side) using the following measures: baseline tristimulus L* a* b* 
colorimetry and baseline spectrophotometric reflectance data. Other phenotypic 
characteristics listed in section 3.1.1 were also measured and recorded. 
 
3.1.1. List of variables 
Individuals were grouped by age, sex, hair colour groups, eye colour groups, 
presence of freckling (yes or no), number of freckling sites (0-7), ethnicity, 
Fitzpatrick skin type, blonde hair group, presence of hair dye (yes or no), hair colour 




3.2.1. Completeness of data 
57 individuals (14 males and 43 females) did not wish to participate in the UVB part 
of the study (Figure 3.1). 2 individuals only returned once for day 1 erythemal 
measurements and did not attend the 1-week tanning measurements. Tanning data 
from the back was available from 2 individuals who did not wish to expose the 
buttock for tanning experiments. Erythemal data will be discussed in Chapter 4. 
Tanning data will be discussed in Chapter 5. 
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Figure 3.1. Study flowchart for volunteers 
 
3.2.2. Volunteer phenotypic characteristics 
3.2.3. Age 
Volunteers were between the ages of 18-40. The median ages for males and females 
were similar at 23 and 24 respectively. 
 
3.2.4. Sex 
The 159 volunteers were made up of 33 males (21%) and 126 females (79%). Two 
volunteers defaulted to attend the study. 
 
3.2.5. Fitzpatrick Skin types (I - VI) 
The participants comprised of 10 skin type I, 35 skin type II, 65 skin type III, 35 skin 




Drop outs (2) 
 
Day 1 only (2) 
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European Mediterranean Chinese Indian 
Recruited 136 8 10 5 
UV 81 5 9 3 
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Chinese and Indians were grouped together as Asians for subsequent analysis, on the 
basis of their Asian origin, darker skin colour and lower rate of skin cancer. 
 
3.2.7. Freckling 
Freckling was defined as small, less than 0.5cm in diameter, well defined light 
brown, golden brown to brown macules of at least 10 in number. The freckling sites 
investigated include the face, shoulder, chest, back, abdomen, arm and leg. Freckles 
were present in 80 out of 159 volunteers on 1-7 of these freckling sites. Figure 
3.2.7.1 shows the distribution of individuals with freckling. When present, the 
commonest sites of freckling were face and arms, followed by the shoulders, chest, 
back, legs and abdomen. 
freckles 80 
no freckles 79 
 














































Figure 3.2.7.2 shows the number of freckling sites individuals had. 27 out of 80 
people with freckles had the commonest number of freckling sites (one). 4 
individuals had the maximum number of freckling sites (seven). 
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3.2.8. Preliminary studies of hair, skin and eye colour 
Prior to the initiation of the research study formally, preliminary studies were 
performed with regards to skin colour, hair colour and eye colour measurements. 
 
3.2.9. Hair colour variation study 
There are 3 types of variability – of the sample, the population and the estimate 
(Grafen, 2002). First, variability of the sample i.e. how variable the sample is can be 
estimated by the sample mean and the variance by the standard deviation / spread of 
the data. Second, variability of the population i.e. how variable the population is can 
be estimated by the population variance of the sample or in other words, deviation 
from the true population mean (SEM). Accuracy of the estimate of population 
variability, quantifies the confidence for the estimate of the population mean. Third, 
variability of the estimate – obtain the mean of the estimate or, in the case of this 
experiment, measurement. This gives an idea of how accurate the estimate is. 
The objective of the hair colour variation study was to investigate whether there was 
a day-to-day variation on hair colour measurements using objective means of 
measurement (Minolta spectrophotometer CM-2600d). i.e. Do hair colour 
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measurements change from day to day (systematic variation)? What about hair at 
different sites on the scalp in the same person? 
Six scalp hair sites were measured to obtain L* a* b* tristimulus colorimetry and 
spectrophotometric reflectance data: 
  Left and right frontal (8cm superiorly from supraorbital ridge) 
  Left and right temple (8cm laterally from supraorbital ridge) 
  Left and right occipital (5cm laterally from occiput) 
Triplicate measures were obtained for each site. Data from “specular component 
included” setting were compared against “specular component excluded”. Advice 
was obtained (personal communication, Emeritus Professor B. L. Diffey, Regional 
Medical Physics Department, Newcastle, UK) and it was felt that “specular 
component excluded” was the more appropriate for measuring skin and hair colours 
as it excludes the specular reflectance from the measurement and only the diffuse 
reflectance is measured. This equates to a colour assessment that correlates to the 
way an observer sees the colour of an object. Data were acquired for three volunteers 
for three different days within an immediate two-week period (total of 72 datasets 
per person per day). 
Figure 3.2.9 shows the range of L* for 12 individuals in the preliminary hair colour 
study. 
 







0 1 2 3 4 5 6 7 8 9 10 11 12
L*
 
Y-axis shows hair colour L*. X-axis shows the volunteer number (n=12). 
 
The coefficient of variation (SD/mean) was calculated for hair colour. Hair colour 
variation was estimated using the coefficient of variation, which was <9% for 12 
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individuals measured on 3 different days within 2 weeks on the scalp (data not 
shown). Other sites showed similar coefficient of variation. One-way ANOVA for 
measured L*, a* and b* values on the scalp on 3 different days showed no significant 
difference between the means (P=0.975, 0.999, 0.996). There was no significant day-
to-day variation in the hair measurements of L*, a* and b* by reflectance. 
 
3.2.10. Hair colour reproducibility 
The variability of the estimate on hair colour measurements using a 
spectrophotometer was investigated. The reproducibility of hair colour measurements 
was estimated using coefficient of variation. 
 
Figure 3.2.10. Hair colour reproducibility (preliminary study) 























This is an individual value plot of hair colour reproducibility. Y-axis shows the coefficient of 
variation (%). X-axis shows hair colour L* a* b*. Blue marker denotes the mean value. 
 
Hair colour reproducibility was estimated using the coefficient of variation, which 
was usually <11% for 12 individuals, except 1 individual’s b* value which was very 
small in number. This meant that a small change resulted in a larger change in 
percentage of coefficient of variation. 
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3.2.11 Hair colour results – by site 
Are there significant variations in hair colour by site? Figures 3.2.11.1 showed hair 
colour L*, a* and b* by 6 scalp hair sites. Blue marker denotes the mean value. 
 




















































































One-way ANOVA for hair colour L*, a* and b* at the 6 scalp sites showed no 
significant differences (P=0.95, P=0.33, P=0.61). 
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Figure 3.2.11.2 shows hair colour L*, a* and b* variance at 6 scalp sites for 3 representative 
individuals (green triangles, red squares and blue circles).  
 
3.2.12. Hair colour results 
Measurements took place between November 2003 and April 2005. 
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There were 133 individuals with natural hair colour. 86 individuals have dark hair, 
27 individuals have fair hair, out of which 19 individuals have blonde hair and 20 
volunteers have red hair. 
 
Figure 3.2.12. shows the range of hair colour for 133 volunteers (dyed 







































26.84 0.74 13.92 53.20 4.29 0.20 0.40 12.7 8.18 0.45 0.05 20.2 
Results shown are mean ± standard error of the mean. Hair L* = 26.84 ± 0.74, a* = 4.29 ± 
0.2 and b* = 8.18 ± 0.45. Readings were averaged to provide a mean value for hair 
colorimetry values. 
 
The range of hair colour L* was 13.92 (darkest) to 53.2 (lightest). Dark hair 
volunteers had a mean L*, a*, b* of 21.92 ± 0.45, 3.13 ± 0.15, 5.05 ± 0.31 
respectively. Fair hair volunteers had a mean L*, a*, b* of 34.33 ± 2.13, 5.23 ± 0.41, 
12.47 ± 1.35 respectively. Blonde hair volunteers had a mean L*, a*, b* of 39.67 ± 
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1.66, 5.26 ± 0.17, 13.62 ± 0.63 respectively. Red hair volunteers had a mean L*, a*, 
b* of 32.83 ± 1.21, 8.00 ± 0.51, 14.76 ± 0.78 respectively. 
 
3.2.13. Hair colour groups 
Hair colour was divided into 3 groups – Dark, fair and red. Dark hair colour was 
further subdivided into black and brown. Blonde hair colour will be discussed in 
Chapter 8. 
 

















From the above 3D scatter plot, there was clear clustering of the hair colour groups. 
Dark hair colour group was further subdivided into brown and black hair colour and 


















This showed clear clustering of the 4 hair colour groups. 
 
3.2.14. Hair dye 
26 volunteers had highlighted their hair between 1 month to 2 years prior to the 
study. These have been excluded in the analysis. The remaining 133 volunteers who 
had natural hair colour were included in the analysis. 
Hair Dye  No. 
dyed 26 
no dye 133 
 
3.2.15. Hair colour spectrophotometry and reported / observed hair colour 
Next the objective quantitatively measured hair spectrophotometric reflectance was 
compared to the categorical reported / observed hair colour from volunteers. Initially 
a log reflectance graph of red versus non-red individuals was plotted. 
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This is an interval plot of log hair spectrophotometric reflectance ± SEM (95% CI for the 
mean). Y-axis shows the log spectrophotometric reflectance data. X-axis shows the 10nm 
increments of 360-740nm wavelengths. Red hair (red), non-red hair (black). 
 
There was a kink in the graph at around log(600nm) for the red haired individuals. 
Were the reds more special in terms of the reflectance? Next the reported hair colour 
of individuals were categorised into dark (brown, black), fair (fair, blonde) and red. 
The measured hair reflectance was plotted according to their reported hair colour 
groups (dark, fair and red). 
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What if dark hair colour was subdivided into brown and black categories? 
 











































































































The hair colour groups were clearly distinguishable spectrophotometrically. Principle 
component analysis technique (personal communication, Professor J. L. Rees) may 
be useful in analysing the data. 
  
3.2.16. Skin colour variation study 
The objective of this preliminary study was to investigate whether there was a day-
to-day variation on skin colour measurements at various body sites using objective 
means of measurement i.e. do skin measurements change from day to day? 
12 body sites were measured to obtain L* a* b* tristimulus colorimetry and 
spectrophotometric data: 
Left and right forehead (2cm superiorly from supraorbital ridge) 
Left and right temple (3cm laterally from supraorbital ridge) 
Left and right inner arm (10cm superiorly from medial epicondyle) 
Left and right dorsal hand (3cm proximally from 3rd proximal interphalangeal joint) 
Left and right lower back (8cm superolaterally from coccyx) 
Left and right buttock (8cm inferomedially from posterior superior iliac spine) 
Triplicate measures were obtained for each site (total of 72 datasets per person per 
day). Data were acquired for 11 volunteers for 3 different days within immediate 2 
weeks. 
 
3.2.17. Skin colour day to day variation study results 
Figure 3.2.17. Skin colour day to day variation results 













Coefficient of variation was <9% for 11 individuals measured on 3 different days 
within 2 weeks at left back. Other sites showed similar coefficient of variation. 
One-way ANOVA for measured L* value at Left back on 3 different days showed no 
significant difference between the means (P=0.93). There was no significant day-to-
day variation in the skin measurements of L*, a* and b* by reflectance 
spectrophotometry. 
 
3.2.18. Skin colour reproducibility 


















Blue marker = mean 
Random sites chosen from both photo protected and photo exposed skin sites. 
Average coefficient of variation was <4%. 
 
3.2.19. Skin colour results 
The plotting of some of the variables of particular interest, such as L* a* b* 
characteristics show that the distributions were not always normal. In particular, 
some of the distributions showed a negative skew. Attempts to correct this, using 
reflection together with adding a constant and taking logs, were not successful. 
Because the characterisation of the initial data set was meant to confirm previous 
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work, it was therefore felt more appropriate to use non-parametric methods. 
Therefore, throughout this chapter, medians were usually quoted rather than means 
(although in most cases the means and medians were very close) and comparisons 
between groups were made using the non-parametric tests such as the Kruskal-Wallis 
analysis of variance or the Wilcoxon signed rank test. 
For most of this chapter the L* score of the L* a* b* reading was used as a 
phenotypic marker of skin colour. Differences in the other measures of the L* a* b* 
score were seen but the L* score has been used commonly in previous work (Han et 
al., 2006; Oh et al., 2004; Wei et al., 2007). As expected, median L* scores varied 
between body site and this body site variation was maintained by sex and by ethnic 
group. There did not appear to be any major interactions between these variables. 
Tables of the relevant median were shown (Tables 3.2.19.1-4). 
 















Upper inner arm 69.15 
 
Table 3.2.19.3. Median skin L* score for 11 anatomical skin sites by sex 












Upper inner arm 69.04 69.46
 
Females have lighter skin colour (i.e. higher L*) than males at all 11 anatomical skin 
sites. This is consistent with previous literature (Jablonski and Chaplin, 2000; 
Robins, 1991). One possible reason for this is that females require more calcium 
during pregnancy and lactation, therefore the lighter skin colour permits more UV 
light to penetrate the skin for vitamin D synthesis (Jablonski and Chaplin, 2000). 
 
Table 3.2.19.4. Median skin L* score for 11 anatomical skin sites by ethnicity 
 Asian Mediterranean Northern 
European 
Abdomen 61.37 66.21 68.86 
Back 62.28 66.20 69.16 
Buttock 66.25 71.59 71.68 
Calf 62.88 64.94 65.59 
Cheek 59.88 62.55 63.96 
Chest 60.97 65.70 67.19 
Forearm 57.71 61.30 62.32 
Forehead 54.67 59.68 62.92 
Hand 56.40 62.22 63.56 
Thigh 61.06 64.41 66.78 
Upper 
inner arm
65.62 69.06 69.41 
 
3.2.20. Skin colour range and site 
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This is a boxplot of the skin colour L*. Median ± interquartile range and outliers. 
 



















































This is a boxplot of the skin colour a*. Median ± interquartile range and outliers. 
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This is a boxplot of the skin colour b*. Median ± interquartile range and outliers. 
 
Table 3.2.20. show the average skin colour L* (mean ± SEM) for 11 sites 
Range of skin darkness – lightest L* value of 78.7; darkest L* value of 42.8. 
The lightest skin areas by rank include buttock (L* = 70.6 ± 0.3), inner upper arm 
(L* = 68.6 ± 0.3), abdomen (L* = 67.4 ± 0.4). and back (L* = 67.3 ± 0.4). The sites 
are ranked by decreasing L* values i.e. increasing darkness: 
Site Mean L* SEM 
Buttock 70.59 0.33 
Inner arm 68.62 0.26 
Abdomen 67.41 0.44 
Back 67.34 0.42 
Chest 66.28 0.38 
Thigh 65.3 0.38 
Calf 64.55 0.38 
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Cheek 63.42 0.33 
Hand 62.27 0.35 
Forehead 61.77 0.32 
Forearm 61.5 0.37 
Colorimetric data a*, b* and spectrophotometric data from 22 skin areas were 
obtained and analysed. 
 
3.2.21. Eye colour preliminary study 
The range of eye colours was first ascertained by going through around 1000 
prosthetic eyes at the ophthalmology department. These were the prosthetic eyes 
used to match patients’ remaining eye and used as eye prosthesis. The colour of the 
iris were matched using Munsell colour atlas with over 1500 colour plates under 
standardised daylight illumination (custom-made) fitted with two (2 feet) Philips 
F20W/54 Daylight fluorescent tubes (colour temperature 6500K). The observer, 
having spectacles removed, performed eye matching such that any variation in iris 
colours were blended to one uniform colour due to myopic vision. 
 
3.2.22. Eye colour preliminary study results 
In the preliminary eye colour study, the categories of eye colour have been selected 
and narrowed down by looking at around 1000 prosthetic eyes at the ophthalmology 
department, resulting in 9 typical prosthetic eyes that resemble real eyes colour 
ranges. These are as shown in Photo 3.2.22.1. 
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Photo 3.2.22.1. Typical prosthetic eyes resembling real eye colour ranges 
 
A photo showing 9 representative eye colours from prosthetic eyes. 
 
The Munsell system of colour notation identifies colour in terms of three attributes: 
hue (H), value (V) and chroma (C). Hue notation of a colour indicates its relation to a 
visually equally spaced scale of 100 hues. Value notation indicates the lightness or 
darkness of a colour in relation to a neutral gray scale, which extends from absolute 
black to absolute white. The value symbol 0/ is used for absolute black, 10/ is 
absolute white. Chroma notation indicates the degree of saturation or degree of 
departure of a given hue from a neutral gray of the same value. The complete 
Munsell notation for a chromatic colour is represented symbolically: H V / C. Figure 
12 shows typical colour plates from the Munsell colour atlas. 
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3.2.23. Eye colour – quantitative Munsell notation 
The volunteers’ matched eye colours were detailed in Table 3.2.23. 
 
Table 3.2.23. Eye colours of volunteers by Munsell notation 
5G 7/2 10B 7/6 10YR 6/8 5B 7/6 10Y 8.5/8 10B 7/4 10YR 6/8 2.5B 8/4
10BG 8/2 2.5B 9/2 10BG 8/2 10YR 6/8 2.5Y 7/10 5YR 5/8 10B 8/4 10YR 5/4
5B 9/2 5Y 7/8 10YR 6/8 5GY 8/4 10B 7/4 10YR 6/10 5Y 7/6 10B 7/6 
10B 7/4 5BG 8/2 10B 6/4 10Y 8.5/8 10B 8/2 10B 7/4 10B 6/4 5B 8/4 
10B 7/4 10YR 7/6 7.5YR 4/4 10B 6/6 7.5YR 4/8 5YR 5/1 10YR 6/6 5GY 8/2 
10YR 6/4 5YR 5/6 5GY 8.5/2 10Y 8.5/8 10Y 8/6 10YR 7/8 10GY 7/4 5GY 8/2 
10B 7/4 10B 8/4 5B 7/4 10BG 7/4 10BG 7/2 7.5Y 8.5/8 10BG 7/4 10B 7/6 
10YR 7/4 5Y 8/4 5GY 8.5/2 10YR 7/10 7.5Y 8.5/6 5B 9/2 10YR 6/8 5B 9/2 
10YR 5/6 10YR 5/6 10YR 6/4 2.5Y 8/8 10B 9/2 5B 7/4 10B 6/6 10B 7/6 
5YR 3/2 10Y 9/6 2.5Y 7/10 5Y 8/8 10B 7/4 5B 7/4 5Y 6/6 10Y 8/4 
5Y 7/6 5B 7/4 10Y 8/8 10B 7/4 10YR 5/6 7.5B 9/2 10B 7/4 10B 6/6 
10YR 7/8 5Y 7/8 10B 6/4 10B 6/4 10Y 8.5/6 10B 6/6 10YR 5/8 10B 8/4 
5Y 7/6 10YR 5/8 10BG 7/4 5B 7/4 2.5Y 7/8 2.5Y 7/8 7.5B 7/4 5B 8/4 
10YR 6/10 10YR 5/6 10YR 6/8 10YR 6/8 5GY 8/4 10BG 7/4 10B 6/6 5Y 7/8 
5GY 8/4 10YR 5/4 5B 7/4 10YR 6/6 5GY 8.5/4 5Y 6/6 10YR 6/8 7.5YR 6/4
5B 9/2 10B 8/4 2.5Y 7/10 10YR 5/8 10BG 8/2 5B 7/4 10B 8/4 10YR 6/6
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5Y 7/6 10B 7/6 10YR 3/2 10B 8/4 10B 8/4 10B 6/6 2.5B 7/4  
2.5Y 7/12 10B 7/4 10YR 3/2 5B 7/4 10B 8/4 10BG 8/2 10B 8/4  
2.5Y 7/10 10YR 7/8 10Y 8/8 10YR 5/6 5Y 8/6 10YR 5/6 10B 7/4  
These show the matched eye colour and denoted in Munsell H V/C annotation where 
H=hue, V=value, C=chroma (n=149). 
 
Each of these annotations correspond to a colour plate with specific L* a* b* 
colorimetric values. These Munsell colour space notations (HVC) were converted to 
CIE L*, a* and b* colour space representations using Munsell Conversion Software 
version 8.0.1 (WallkillColor.com, http://livingstonmanor.net/Munsell/index2.htm) 
for quantitative analysis of eye colour. 
 
3.2.24. Eye colour – quantitative L* a* b* 









0 30 -2060 90b*
 
This is a scatterplot of the distribution of eye colours converted from Munsell HVC notation to 
L* a* and b* values (n=149). 
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3.2.25. Eye colour by eye colour groups (categorical) 


















This is a scatterplot of the distribution of eye colours converted from Munsell HVC notation to 
quantitative L* a* and b* values by eye colour groups (blue, brown, green, grey, hazel) 
(n=149). 
 
As demonstrated in the above figure, there was clear clustering for the eye colour 
groups. The Munsell colour system and the subsequent converted L* a* b* data for 
eye colour suggested that this might be a good and more appropriate method to 
consider and better way of performing comparisons in future eye colour genotype 
studies.  
 110




These are iris photos from 4 individuals showing typical examples of Munsell colour matches 
of 5Y 7/8 (top left panel), 2.5Y 7/10 (top right panel), 10BG 8/2 (bottom left panel) and 10YR 
5/8 (bottom right panel). 
 
3.3. Analysis of key phenotypic variables by co-factors such as sex, freckling 
etc. 
Because there was little evidence of interaction between body site in different 
groups, and for simplicity, the L* a* b* readings at different body sites were 
averaged and used as a summary variable in the following section. The alternative to 
this would have been to use a multi level model (e.g. split plot analysis of variance) 
which given the distribution of the data would have been difficult. 
 
3.3.1. Skin colour L* a* b* and age 
Plotting of age by L* a* b* score showed no relation. This was not surprising given 
the narrow range of ages studied and it will not be considered further. The 




A number of expected correlations between individual variables were found and the 
chief ones of these are shown in box plots. 
3.3.2. Skin colour and sex 
Is there a skin colour difference between males and females? The skin colour L* a* 
and b* were compared in males and females. 
 






















As shown in the above boxplot, females were lighter in skin colour (larger L* score) 
than males. A Kruskal-Wallis rank sum test showed significant difference between 
females and males (P=0.0002821) for skin L*. 
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3.3.3. Skin colour and ethnicity 























There was considerable overlap of skin colour between ethnic groups even for the 
same anatomical site. Skin colour trend was as expected. Asians were darkest, 
followed by Mediterraneans and Northern Europeans. Ethnicity was associated with / 
explained skin colour darkness/lightness. Kruskal-Wallis rank sum test showed 
significant difference between ethnic groups for skin colour L* (P=1.413×10-5). 
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There appeared to be clustering for ethnic groups. 
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3.3.4. Skin colour and freckling 






















As expected, individuals with freckles have lighter skin colour. Kruskal-Wallis rank 
sum test showed significant difference between those with and without freckles 
(P=7.603×x10-9). Those with freckles have a mean L* of 58.82 ± 0.24 and those 
without a mean of 56.32 ± 0.35. 
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Those with freckles were lighter. Those without freckles were darker. The number of 
freckling sites (1-7) did not affect skin colour L* beyond the presence of freckles. 
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3.3.5. Skin colour and skin type 


























Skin colour L* was associated with skin type. As expected, individuals with skin 
type 1 were lighter in skin colour. As one go from skin type 1 to 6, skin colour of 
individuals become darker. Kruskal-Wallis rank sum test showed significant 
difference between skin type and skin colour L* (P=1.685×10-14). 
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3.3.6. Skin colour and eye colour group 

























Skin colour L* a* b* were associated with eye colour. Individuals with blue and 
hazel eye colours had lighter skin L*. Kruskal-Wallis rank sum test showed 
significant difference with skin colour L* (P=0.0006244), a* (P=0.0008543) and b* 
(P=1.369×10-5) with eye colour. 
Similar relations were found with other measures of skin colour such as mean a* and 
mean b* with eye colour, and some of the other variables (data not shown). 
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3.3.7. Skin colour and presence of red hair 























Individuals with red hair have lighter skin colour. Kruskal-Wallis rank sum test 
showed significant difference in skin colour with presence of red hair 
(P=0.0003231). 
 
3.3.8. Skin colour and hair colour 
There was a subset of data (n=26) where individuals who have dyed their hair were 
excluded. There were marked correlations between skin colour L* a* b* readings 
and hair colour L* a* b* readings. A table summarising some of these correlations is 
shown (Table 3.3.8.). Lighter skin individuals have lighter hair colour also. 
 
Table 3.3.8. Correlations between skin colour and hair colour 




Mean skin L* Hair L* 0.339 7.188×10-5 
Mean skin L* Hair a* 0.370 1.15×10-5 
Mean skin L* Hair b* 0.360 2.397×10-5 
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3.3.9. Hair colour and skin type 
As could be expected, hair L* a* b* readings were also related to skin type. 



























Individuals with Skin type 1 had lighter hair L* a* b*. Kruskal-Wallis rank sum test 
showed significant difference with hair L* (P=0.00124), a* (P=0.0004855) and b* 
(P=0.0003409) with skin type. 
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This is a 3D scatter plot of hair colour L* a* and b* with skin type (1-6). 
 
3.3.10. Interactions between other phenotypic variables 
3.3.11. Freckling and sex 
Do males or females have more freckles? The number of freckling sites with sex for 
the Edinburgh population was plotted. 
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It seemed that females have more freckling sites than males. A Mann-Whitney Test 
was performed which compared the 2 medians for males and females and showed 
that females have significantly more freckling sites than males (P<0.05). 
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Table 3.3.11.b. The presence of freckling and sex 
              F       M      All 
No freckles  51      28      79 
Freckles     75       5      80 
All         126      33     159 
 
There were more females (94%) with freckles than males (6%). Is freckling and sex 
related to paler skin in females? 
 



























This showed that freckling is the major determinant of paler skin colour, rather than 
sex. It is also possible that freckling could be related to previous sun exposure and 
differences in behavioural patterns in males and females may contribute to the 
difference between sex. 
 
3.3.12. Freckling and age 
Log age was plotted with the number of freckling sites and showed no obvious trend 
and no evidence of large difference. Low sample numbers for some of the freckling 
sites may be a limitation. 
A Mann-Whitney Test was performed which compared the 2 medians for with or 
without freckles and showed no significant difference between the groups (P=0.78). 
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Individuals with or without freckles do not differ significantly with age. 
 
3.3.13. Freckling and ethnicity 




















  N. European Mediterranean Chinese Indian 
Freckles 77 3 0 0 
No 
freckles 59 5 10 5 
 
Northern Europeans tend to have more freckles than non-Northern Europeans. 
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3.3.14. Freckling and red hair colour 
Figure 3.3.14.1. Freckling and red hair 




















Non-red hair individuals have fewer or no freckles whereas red hair individuals have 
more freckles. A Mann-Whitney Test was performed which compared the 2 medians 
for reds and non-reds and showed that the number of freckling sites was significantly 
different for reds and non-reds (P<0.05). 
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The association of red hair and freckling is due to pale skin colour. Individuals with 
red hair and freckles have the lightest skin colour. 
 
 126
3.3.15. Freckling and skin type 


















The number of freckling sites was plotted against skin type. Skin type was 
categorised into skin type (IV-VI) or (I-III). 
As expected skin types I-III have more freckling sites than skin types IV-VI. A 
Mann-Whitney Test was performed which compared the 2 medians for skin types I-
III and skin types IV-VI and showed that the groups were significantly different 
(P<0.05). 
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3.3.16. Freckling and eye colour 













































Kruskal-Wallis Test was performed which compared the medians for eye colour 
groups and number of freckling sites and showed that the groups were significantly 
different (P<0.05). Blue and hazel eye colour individuals have more freckling sites. 
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3.3.17. Fitzpatrick skin type (I - VI) and sex 
Is there a sex difference in Fitzpatrick skin types? 

















One-way ANOVA of Fitzpatrick skin type versus sex showed no significant 
difference between males and females (P=0.056). 
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3.3.18. Ethnicity and skin type 































  N. European Mediterranean Chinese Indian 
I 10 0 0 0 
II 34 1 0 0 
III 56 5 4 0 
IV 27 1 4 3 
V 9 1 1 1 
VI 0 0 1 1 
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3.3.19. Hair dye and age 















Individuals who dyed their hair tend to be younger (19-30), however several 
individuals aged 36-38 and 40 also dyed their hair. 
 
3.3.20. Hair dye and Sex 
The dyed individuals consisted of 25 females and 1 male. 
 
3.3.21. Hair colour L* a* b* and hair dye 
Reflectance data was obtained for individuals who were dyed or not. 
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Hair dye appeared to lighten the colour of the hair. This may be due to the choice of 
hair dye – perhaps individuals liked to dye their hair lighter. 
 
3.3.22. Hair colour spectrophotometric reflectance and hair dye 
Spectrophotometric data by 10nm increment of visible colour spectrum wavelength 
between 360-740nm were obtained. 
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This confirmed the expected observation that individuals who dyed their hair tend to 
dye them lighter. This also confirmed that hair spectrophotometry as a valid measure. 
Human scalp hair grows at about 0.35mm (Myers and Hamilton, 1951) to 0.5mm/day 
(Robertson, 1999). Despite taking hair growth rate into account and that hair colour 
measurement of dyed hair was taken closer to the hair root when volunteers’ hair 
were dyed, this highlighted the need to exclude dyed hair in any analysis. 
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3.3.23. Hair colour and age 

















There was no relation for hair colour and age. 
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3.3.24. Hair colour spectrophotometric reflectance with age 
Hair reflectance was plotted for age<24 and age>24. 









































































































There was no relation for hair spectrophotometric reflectance and age. 
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3.3.25.1. Hair colour and sex 

















































M 24.41 1.34 13.92 45.70 3.14 0.36 0.40 10.82 5.93 0.80 0.05 19.51 
F 27.61 0.87 16.38 53.20 4.66 0.23 0.82 12.74 8.90 0.52 0.51 20.20 
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3.3.26. Hair spectrophotometric reflectance and Sex 











































































































This is an interval plot of log hair spectrophotometric reflectance ± SEM (95% CI for the 
mean) for males (red) and females (black) n=133. Y-axis shows the log hair 
spectrophotometric reflectance. X-axis shows the 10nm increments of 360-740nm 
wavelength. 
 
This showed that females have generally lighter hair colour. Two-sample t-test 
showed significant differences from log(570nm)-log(740nm) (P<0.05). 
 
3.3.27. Distribution of hair colour L* a* b* with different eye colour groups 



















This is a 3D scatter plot of hair colour L* a* b* and eye colour groups. 
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3.3.28. Distribution of hair colour L* a* b* with presence of freckling 










































3.3.29. Hair colour spectrophotometric reflectance with freckling 











































































































Next the effect of freckling on hair colour was analysed. This figure showed the log 
hair reflectance data of 133 individuals with freckling. The error bars present 95% 
confidence interval for the mean. This showed that individuals with freckles have 
generally lighter hair colour. Two sample t-test showed significant differences from 
log(570nm)-log(740nm) (P<0.05). 
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3.3.30. Hair colour spectrophotometric reflectance and eye colour 












































































































3.3.31. Hair colour spectrophotometric reflectance and skin type 














































































































3.3.32. Hair spectrophotometric reflectance with sex and freckling 











































































































Next the effect of sex and freckling on hair colour was analysed. This figure showed 
the log hair reflectance data of 133 individuals. The error bars present 95% 
confidence interval for the mean. Sex difference was lost / lessened when the effect 
of freckling was taken into account. Without freckles, females were lighter than 
males. Females with and without freckles showed reflectance at wavelength 
log(550nm) of 0.74±0.03 and 0.61±0.04 respectively. Males with or without freckles 
showed reflectance at wavelength log(550nm) of 0.82±0.09 and 0.56±0.04 
respectively. Similarly at wavelength log(740nm), females with and without freckles 
showed reflectance of 1.12±0.03 and 0.95±0.04 respectively. Males with or without 
freckles showed reflectance at wavelength log(740nm) of 1.15±0.11 and 0.83±0.05 
respectively. 
 
3.3.33. Hair spectrophotometric reflectance with reported hair colour, sex and 
freckling 
Figure 3.3.33. Hair spectrophotometric reflectance with reported hair colour, 




































































































n M non red
Sex
n M red
y F non red
HairColour
y F red
y M non red
y M red
n F non red
 
As expected, individuals with the highest hair reflectance (lightest) were not red 
females with freckles, but red males with freckles. 
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The darker individuals were non-red males without freckles, followed by non-red 
females without freckles, non-red females with freckles, non-red males with freckles, 
red females with freckles, red females without freckles, red males with freckles. 
There were no red males without freckles. 
 
3.3.34. Skin colour and sidedness 
Skin colour is assumed to be the same in an individual between the left and the right 



























There was no significant difference between left and right measured skin L*, a* or 
b* as tested by two sample t-test (P=0.79, P=0.90, P=0.62). 
 
3.3.35. Inter-relationship between skin colour, sex and site 
The effect of skin colour of various sites is different in males and females. 
The relationship between skin colour L*, sex and site were fitted to a General Linear 
Model (GLM). This showed an R-squared value of 32.31%. Skin colour a*, sex and 
site showed an R-squared value of 53.38%. Skin colour b*, sex and site showed an 
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R-squared value of 22.19%. Inclusion of left right sidedness did not result in any 
increase in R-squared value. 
 
3.3.36. Eye colour and sex 
Comparison of eye colour in males and females 




























Fisher’s Exact Test for eye colour and sex did not show any significant difference 
between males and females (P=0.40). Males and females do not differ significantly 
in eye colour. 
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3.3.37. Eye colour and age 











One-way ANOVA was performed which showed that the 5 eye colour groups did not 
differ by age (P=0.525). 
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The following were plotted for illustration purposes only. 
3.3.38. Distribution of eye colour with red hair colour 




























Figure 3.3.38.2. 3D scatter plot of quantitative Munsell L* a* b* eye colour 















Figure 3.3.38.3. 3D scatter plot of quantitative Munsell L* a* b* eye colour 

















3.3.39. Distribution of eye colour with different hair colour 











































































































This is an interval plot of the log hair Spectrophotometric reflectance ± SEM (95% CI for the 
mean) with eye colour. Y-axis shows the log spectrophotometric reflectance data. X-axis 
shows the 10nm increments of 360-740nm wavelengths. 
 
Blue eye colour individuals have lightest hair colour. Grey, green and hazel eye 
colours have the intermediate hair colour. Brown eye colour individuals have the 
darkest hair colour. 
3 wavelengths were chosen (400nm, 550nm and 740nm) based on visible light 
spectrum of violet, green and red respectively. One-way ANOVA was performed at 
each wavelength for the 5 eye colour groups which showed significant difference 
(P<0.05). 
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3.3.40. Distribution of eye colour with skin type 




















3.3.41. Distribution of eye colour with freckles 
Presence of freckling 
















Number of freckling sites 
Figure 3.3.41.2. 3D scatter plot of quantitative Munsell L* a* b* eye colour 























The static phenotypic variables of the 159 individuals in this study were presented in 
detail in this chapter. The key findings were summarised as follows. 
This study sample consisted of younger individuals (mean age 25, median age 24), 
predominantly Northern European in origin. The higher proportion of females took 
part in the study probably reflecting females were more likely to agree to participate 
in volunteer studies. This was consistent with previous studies (Wagner et al., 2002a; 
Wagner et al., 2002b). The lesser number of skin type 5 and 6 in the study were due 
to the predominantly Northern European in origin of the study population and 
sample. 
Hair and skin spectrophotometric reflectance data were new measures and did 
distinguish between groups.  
Interestingly, females’ skin colour is lighter than males. This is consistent with 
previous literature (Jablonski and Chaplin, 2000; Robins, 1991). One possible reason 
for this is that females require more calcium during pregnancy and lactation, 
therefore the lighter skin colour permits more UV light to penetrate the skin for 
vitamin D synthesis (Jablonski and Chaplin, 2000). 
Other inter-relationships with phenotypic variables were as expected. E.g. those with 
freckles have lighter skin colour. Ethnicity was related to skin colour. The higher the 
skin type e.g. 6, the darker the skin colour (smaller L*). Eye colour was associated 
with skin colour. Red heads have lighter skin colour. Skin colour and hair colour 
were related. Hair colour and skin type were associated. Lighter hair coloured 
individuals have lighter skin colour. People who dyed their hair chose to dye their 
hair lighter in colour. The results from the static phenotypes were as expected. 
I attempted to develop the methodology of quantitatively measuring eye colour 
further and showed that quantitative Munsell L* a* b* was useful and showed 
clustering of eye colour groups. This newer quantitative method could be used as a 
phenotypic measure in future studies.
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Chapter 4 Induced Phenotype - Determinants of Erythema 
 
4.1. Introduction 
In this chapter, the erythemal responses of a subset of 98 individuals who have 
undergone UVB irradiation will be discussed. The determinants of erythema will 
also be presented. Erythema was measured using 2 assays: 
i) change in erythemal index (with baseline erythemal index subtracted) and 
ii) change in erythemal flux (with baseline erythemal flux subtracted). 
The main measure of erythema data, erythemal index will be presented in section 
4.2.1. Erythemal flux data will be presented in section 4.2.2. The primary analysis of 
erythema data was performed on erythemal index. 
98 volunteers out of the initial cohort of 159 went on to have UVB irradiation. 57 
volunteers did not undergo UVB irradiation. Volunteers who did not undergo UVB 
irradiation were excluded from analysis for this part of the study. The 98 volunteers 
were made up of 19 males (19%) and 79 females (81%). Two individuals returned 
for 24 hour measurements only and then defaulted. Two individuals did not wish to 
have their buttock irradiated and only had their back irradiated with UVB. 
 
Table 4.1. Number of UVB irradiated individuals and sex  
M 19 19% 
F 79 81% 
Total 98  
M denotes males, F denotes females 
 
Erythema was chosen as an endpoint to measure experimentally induced, cutaneous 
phenotypic response to UVB irradiation.  
 
4.2. Erythemal response to UVB radiation 
4.2.1. Determinance of erythemal sensitivity measured as the erythema index 
Representative erythemal responses for volunteers to UVB were shown in Photo 
4.2.1. 
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Photo 4.2.1. Visible erythema on the back and buttock 24-hour post UVB 
irradiation 
a)                  b)               
 
Erythemal responses of a) back and b) buttock were shown. Ink markings were made on the 
skin following a cardboard template of where the 10 UVB doses were irradiated by the 
custom made UVB source.  
 
The erythemal dose responses for back and buttock are shown in Figure 4.2.1.1. 
 




































This is an interval plot of EI ± SEM (95% CI for the mean) for the back (black) and buttock 
(red). Y-axis shows the change in erythemal index (with baseline erythemal index 
subtracted). X-axis shows the UVB doses (mJ/cm2) in a logarithmic scale. 
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The back responded to UVB more by becoming more erythematous than the buttock. 
Two sample t-test comparing UVB-induced back and buttock erythemal index 
showed significant difference for all 10 doses (P<0.05). 
 
Because the data set is large, and because multiple readings were taken on the 
individual, then the problem of pseudo replication arises. Mixed effects model could 
be used to analyse these balanced and unbalanced grouped data which have arisen 
from repeated measures data by fitting these data into mixed effects model software.   
Rather than fit a complex mixed effects model, it was felt appropriate to inspect the 
curves and then choose representative doses. 
For the majority of subjects, only 4 or 5 erythemal areas were visible (see Photo 
4.2.1). Therefore, the top 5 doses were subsetted from the main data set and these 
form the basis for the following analyses. 
Separate analyses were performed on the buttock and the back. Initially, dose 
responses for these top 5 doses for each individual were inspected. In the majority of 
these instances there was no convincing evidence of plateauing of the response when 
erythema, measured as the erythemal index, was plotted against the logarithm of the 
dose. It was, therefore, decided that analysis of the top dose (300mJ/cm2) was 
appropriate to be examined. However, since the back is known to be more sensitive 
than the buttock, both doses (238mJ/cm2 and 300mJ/cm2) for both sites were looked 
at. The results are, however, similar and the results are presented for the highest 
dose. 
 
Histograms of erythema show that the data appeared normally distributed and, 
therefore, parametric statistics were used. Initially the buttock responses were 
examined, followed by the back. Broadly, the results are remarkably similar in terms 
of factors that are thought to be important. 
 
4.2.1.1. Erythema and age 
Surprisingly, correlation tests and linear regression showed a positive effect of age, 
with an increasing erythemal dose with age. However, inspection of raw data showed 
that an individual age 40 was markedly influencing the regression line. When this 
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individual was excluded there was no relation with age (P=0.1276). Age is therefore 
not considered further. 
 
4.2.1.2. Erythemal index results for buttock 
4.2.1.2.1. Erythema and sex 
There were no differences in erythemal sensitivity between the sexes with a mean of 
133 in the females and 141 in the males (P=0.5459, two sample t-test). 
 
4.2.1.2.2. Erythema and red hair 
The presence or otherwise of red hair also had no effect on mean erythema (132) in 
those without red hair, compared with 149 in those with red hair (P=0.156, two 
sample t-test). 
 
4.2.1.2.3. Erythema and blonde hair 
Similarly, blonde hair had no effect with a mean of 134 in those without blonde hair 
and 140 in those with blonde hair (P=0.5889, two sample t-test). 
 
4.2.1.2.4. Erythema and presence of freckles 
The presence or otherwise of freckles has a striking effect on presence of erythema.  
In those without freckles, mean erythema was 121 whereas in those with freckles it 
was 147 (P=0.002018, two sample t-test). 
 
4.2.1.2.5. Erythema and ethnicity 
Ethnic groups, when tested in an analysis of variance, also showed a marked effect 
(P=2.6×10-5). Tukey’s HSD test was then applied. Highly significant differences 
were noted between Northern Europeans and Asians (P=0.0004467) and Northern 
Europeans and Mediterraneans (P=0.0051447) with mean responses of 98 in the 
Asians, 93 in the Mediterraneans and 143 in the Northern Europeans. 
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4.2.1.2.6. Erythema and skin type 
Skin type was not dealt with as a factor, but treated as an equally spaced continuous 
variable. Regression showed, as expected, a marked effect of skin type with an 
adjusted R2 of 0.2066 (P=1.54×10-6). 
 








































This is an interval plot of EI ± SEM (95% CI for the mean) for the buttock by skin type 1-6. Y-
axis shows the change in erythemal index (with baseline erythemal index subtracted). X-axis 
shows the UVB doses (mJ/cm2) in a logarithmic scale. 
 
4.2.1.2.7. Erythema and constitutive skin colour 
Correlations were observed between erythema on the buttock and the L* score of the 
L* a* b* reading on the buttock. Regression of erythema on L* scale was highly 
significant (P=1.29×10-6), with an adjusted R2 of 0.209. 
Similarly, correlations were also observed between constitutive buttock skin colour 
and erythema. The P-value of 1.29×10-6 and a correlation of 0.47 between erythema 
and the L* score of buttock skin; and of P-value of 0.003168 and correlation 
coefficient of -0.30 of the a* reading of the L* a* b* score; of the b* score of buttock 
skin of P=2.039×10-5 and correlation of -0.42 were observed. 
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Figure 4.2.1.2.7. Erythema responses (erythemal index EI) and constitutive 
skin colour over buttock 
























This is a scatter plot of buttock erythema (EI) and constitutive buttock skin colour L*. Y-axis 
shows the change in erythemal index (with baseline erythemal index subtracted). X-axis 
shows the constitutive buttock skin colour in L* scale. Pearson correlation = 0.47. Adjusted 
R2 = 0.209 (P=1.29×10-6). 
 
Inspection of the raw data showed that an Asian (Indian) individual V160 with EI=8, 
L*=48 was possibly an outlier. If this individual was excluded from the analysis, 
similar correlations were still observed between constitutive buttock skin colour and 
erythema with Pearson correlation = 0.42, and adjusted R2 = 0.178 (P<0.0001). 
However there was no particular reason to exclude this Asian since this population 
sample included Asians. 
 
4.2.1.2.8. Erythema and hair colour 
Correlations were also observed between hair colour and erythema. The P-value of 
0.01714 and a correlation of 0.24 between erythema and the L* score of hair; and of 
P-value of 0.000353 and correlation coefficient of 0.35 of the a* reading of the L* a* 
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b* score; of the b* score of hair of P=0.004311 and correlation of 0.29 were 
observed. 
 
4.2.1.2.9. Model to explain erythemal sensitivity 
Linear regression was then used with multiple variables to explain erythemal 
sensitivity. Once skin colour at the particular site (buttock) was factored in, freckles 
were no longer significant. However, skin type remained significant (whichever way 
the regression was ordered) but once the skin type had been factored in, ethnic factor 
had no influence. The regression with skin with buttock L* and skin type is shown 
below. 
Formula = Erythema buttock ~ buttock L* + skin type 
 Estimate SE t value P r(>t) 
(Intercept) -51.15 80.95 -0.63 0.52901 
Buttock L* 3.16 1.04 3.05 0.00294 
Skin type -12.45 4.16 -2.99 0.00353 
F-statistic 18.93 on 2 and 95 degrees of freedom, P=1.205×10-7 
This regression explains about 27% of the variation as reflected by the adjusted R2. 
 
4.2.1.3. Erythemal index results for back 
4.2.1.3.1. Erythema and sex 
There was no difference in the erythema index between sex (P=0.5459, two sample t-
test). Female mean 133, male mean 141. 
 
4.2.1.3.2. Erythema and red hair 
There were no differences between those with or without red hair (P=0.156, two 
sample t-test), mean in those without red hair 132 and in those with red hair 149. 
 
4.2.1.3.3. Erythema and blonde hair 
There were no differences between those with or without blonde hair with respect to 
erythemal index on the back, mean in those without blonde hair 134 and in those 
with blonde hair 140 (P=0.5889, two sample t-test). 
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4.2.1.3.4. Erythema and presence of freckles 
As with the results for the buttock, freckles was highly significant (P=0.002018, two 
sample t-test) with the mean in those without freckles of 122 compared with 147 in 
those with freckles. 
 
4.2.1.3.5. Erythema and ethnicity 
An analysis of variance showed that ethnic factor was highly significant (P=2.6×10-5) 
and Tukey’s test showed highly significant differences between Northern Europeans 
and Asians (P=0.0004467) and Northern Europeans and Mediterraneans 
(P=0.0051447). The direction of the differences was as for the responses on the 
buttock. 
 
4.2.1.3.6. Erythema and skin type 
Skin type treated as a continuous variable was also highly significant, with an 
adjusted R2 of 0.21 (P=1.54×10-6). 
 








































This is an interval plot of EI ± SEM (95% CI for the mean) for the back by skin type (1-6). Y-
axis shows the change in erythemal index (with baseline erythemal index subtracted). X-axis 
shows the UVB doses (mJ/cm2) in a logarithmic scale. 
 
4.2.1.3.7. Erythema and constitutive back skin colour 
As for results on the buttock, there were highly significant correlations between 
erythema index and the L*, a* and b* scores on the L* a* b* measure on the back. 
The P-value of 1.49×10-10 and a correlation of 0.59 between erythema and the L* 
score of back skin; and of P-value of 3.42×10-8 and correlation coefficient of -0.52 of 
the a* reading of the L* a* b* score on back; of the b* score of back skin of 
P<0.0001 and correlation of -0.504 were observed. Constitutive back skin colour L* 
predicts erythema index over the back. 
 
Figure 4.2.1.3.7. Erythema responses (erythemal index EI) and constitutive 
skin colour over back 






















This is a scatter plot of back erythema (EI) and constitutive back skin colour L* (n=98). Y-
axis shows the change in erythemal index (with baseline erythemal index subtracted). X-axis 
shows the constitutive back skin colour in L* scale. Pearson correlation = 0.59. Adjusted R2 
= 0.34 (P=1.49×10-10). 
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4.2.1.3.8. Model to explain erythemal sensitivity - back 
As for the buttock, a linear model was fitted with freckles not being significant once 
back and skin colour had been taken into account. Unlike the buttock, with skin type 
included the R2 failed to achieve formal significance with a P-value of 0.161. This 
difference could be explained by the difference in body site – the back may have 
undergone acclimatisation to solar exposure and therefore have taken into account 
the effect of skin type. 
The results for the linear regression of erythemal index of the back on back L* are 
shown. 
Formula = Erythema back ~ back L* 
 
 Estimate SE t value P r(>t) 
(Intercept) -164.71 41.90 -3.93 0.00016 
Back L* 4.45 0.62 7.18 1.49×10-10 
F-statistic = 51.53 on 1 and 96 degrees of freedom, P=1.49×10-10 
This regression explains about 34% of the variation as reflected by the adjusted R2. 
 
The findings of erythema at the second highest UVB dose 238mJ/cm2 were in 
keeping with those at 300mJ/cm2. 
 
4.2.2. Erythema flux results 
Erythema flux was the second assay used to measure erythema. For ease of clarity 
and conciseness, important points will be presented and highlighted in terms of 
erythemal flux in this section. The measure of erythema flux (via the contact Doppler 
probe) is very sensitive to pressure and touch. Er ythema flux has more variability 
(coefficient of variability (SD/mean) of up to 10%) than Erthemal Index (EI) 
(coefficient of variation of up to 5%). Despite these potential limitations, broadly 
similar results were found. 
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4.2.2. Erythema dose response (flux) by site 




























This is an interval plot of erythemal flux ± SEM (95% CI for the mean) for the back (black) 
and buttock (red) by UVB doses. Y-axis shows the change in erythema flux (with baseline 
erythema flux subtracted). X-axis shows the UVB doses (mJ/cm2) in a logarithmic scale. 
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4.2.3. Does back erythema predicts buttock erythema? 
Figure 4.2.3. Back Erythema and Buttock Erythema (flux) 




























This is a scatter plot of back erythema (flux) and buttock erythema (flux). Y-axis shows the 
change in erythemal flux (with baseline erythemal flux subtracted) over back. X-axis shows 
the change in erythemal flux (with baseline erythemal flux subtracted) over butttock. Pearson 
correlation = 0.498. Adjusted R2 = 0.248 (P<0.0001). 
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4.2.4. Erythema Flux and Skin Type (Back) 






































This is an interval plot of erythemal flux ± SEM (95% CI for the mean) for the back by skin 
type 1-6. Y-axis shows the change in erythemal flux (with baseline erythemal flux 
subtracted). X-axis shows the UVB doses (mJ/cm2) in a logarithmic scale. 
 
It is clear from the above graph that the means of erythemal flux move with skin 
type. The means of erythemal flux reduce as you increase from skin type 1 to 6. 
The degree of UVB-induced erythema over back was greater than that of the buttock. 
The mean erythema flux over back for skin type I at 8.2 SEDs (300mJ/cm2) = 571 ± 
95. 
Europeans skin types 1-2 are roughly twice more sensitive than non-Europeans skin 
types 4-5 (Average flux 600:300). 
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I 571 95 399 57 7 
II 447 66 434 66 16 
III 405 31 405 32 46 
IV 308 43 257 50 22 
V 287 56 224 92 6 
VI 151 - 89 - 1 
 
Skin type and erythema flux summary – The erythemal response of the back to UVB 
irradiation was greater than that of the buttock. This trend was similar across all skin 
types. 
 
4.2.5. Erythema Flux and Skin Type (Buttock) 










































This is an interval plot of erythemal flux ± SEM (95% CI for the mean) for the buttock by skin 
type 1-6. Y-axis shows the change in erythemal flux (with baseline erythemal flux 
subtracted). X-axis shows the UVB doses (mJ/cm2) in a logarithmic scale. 
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The degree of UVB-induced erythema over buttock was less than that of the back. 
Mean erythema flux over buttock for skin type I at 8.2 SEDs (300mJ/cm2) = 399±57. 
 
4.2.6. Erythema Flux and eye colour 



































One-way ANOVA showed no significant difference between eye colour groups and 
erythema flux over the back (P=0.0559). Although this did not reach formal 
significance, individuals with blue eye colour appear to develop more erythema (than 
brown or green). This is in keeping with other studies which reported association of 
blue eye colour characteristics and skin cancers e.g. blue eye colour has a RR of 1.55 
times that of brown eye colour in developing melanoma (Bliss et al., 1995). This is 
important even if the result was not formally significant. A larger sample size may 
demonstrate a significant result. 
However, some studies did not find any association of eye colour with erythema or 
burning. Azizi et al found no effect of eye colour on minimal erythemal dose (MED) 
(Azizi et al., 1988). 
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One-way ANOVA showed no significant difference between eye colour groups and 
erythema flux over the buttock (P=0.133). 
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4.2.7. Erythema Flux and sex 





















This is an interval plot of erythemal flux ± SEM (95% CI for the mean) for the back by sex, Y-
axis shows the change in erythemal flux (with baseline erythemal flux subtracted). Females 
(black), males (red). X-axis shows the UVB doses (mJ/cm2) in a logarithmic scale. 
 
Two sample t-test comparing males and females for back erythemal flux at UVB 
Doses 1-3 showed no significant difference (P=0.86, P=0.53, P=0.81). 
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This is an interval plot of erythemal flux ± SEM (95% CI for the mean) for the buttock by sex, 
Y-axis shows the change in erythemal flux (with baseline erythemal flux subtracted). 
Females (black), males (red). X-axis shows the UVB doses (mJ/cm2) in a logarithmic scale. 
 
Two sample t-test comparing males and females for buttock erythemal flux at UVB 
doses 189mJ/cm2 (dose 2) showed significant difference (P=0.04). Other doses 95, 
150, 238, 300mJ/cm2 were not significant (P=0.50, P=0.18, P=0.12, P=0.15). 




Erythema was used as an endpoint to measure UVB-induced responses. Erythemal 
index (EI) was chosen to be the primary measure for erythemal responses. As 
mentioned, the primary analysis of erythema data was performed on erythemal index. 
Erythema flux measurements have a higher degree of variability (coefficient of 
variability of up to 10%) and also sensitive to pressure and touch. Nevertheless, 
similarly results were obtained with both assays of erythema. Erythema flux was 
used to confirm no increase in blood flow after noradrenaline iontophoresis was 
performed. 
There was a dose dependent increase in erythema with increasing UVB radiation 
over both back and the buttock at 24 hours. The back developed more erythema than 
the buttock. This is in keeping with previous findings (Rhodes and Friedmann, 1992; 
Waterston et al., 2004). 
The major determinants of erythema for this study population were constitutive 
buttock skin colour L* and skin type. Constitutive buttock skin colour does predict 
erythema index of buttock, accounting for about 21% of the variation (R2 of 0.209, 
P=1.29×10-6). 
This is in keeping with Ha et al that pigmentary differences between people are a 
major determinant of erythemal responses (Ha et al., 2003). 
It is important to note that skin type is actually just as good as constitutive skin 
colour L* in predicting erythema, accounting for about 21% of the variation (R2 of 
0.2066, P=1.54×10-6).  
Other factors e.g. freckling may already be a marker of lighter constitutive skin 
colour and the propensity to burn or go red (Bliss et al., 1995; Palmer et al., 2000; 
Valverde et al., 1995) and therefore is, as expectedly, related to erythema. 
Ethnicity and hair colour are factors that are related to constitutive skin colour. 
Different ethnic groups have different ranges of constitutive skin colours. Overlap in 
skin colour range has been taken into account when analysing the results 
quantitatively. Lighter hair colour individuals tend to be lighter skin coloured as 
well. This in turn may explain their erythemal responses. 
For the back, the inclusion of skin type in the erythema model still failed to achieve 
formal significance. This may be due to the fact that at the photoexposed back, the 
 172
ability of the constitutive back skin to develop erythema has already been “factored” 
in, and Fitzpatrick skin type did not add additional predictive value. Whereas at the 
normally photoprotected buttock, skin type does add additional predictive value, 
according to the model. 
The erythema results presented were in agreement with Wagner et al (Wagner et al., 
2002a). This study showed that buttock erythema was related to constitutive buttock 
skin colour L* and skin type and that back erythema was related to constitutive back 
skin colour L*. Wagner argued that there was a very strong inverse relationship 
between constitutive pigmentation and erythemal dose response (EDR) in their 
population i.e. people with higher constitutive pigmentation levels have lower 
burning responses. They used different assays to measure constitutive skin colour 
(adjusted melanin index AMI - which is the slope of 650: 700nm calculated from 
spectrophotometer apparent absorbance), erythema (slope of change in a*) and 
facultative pigmentation (adjusted melanin index AMI) (Wagner et al., 2002b). 
In addition their methodology did not remove erythema before using L* as a measure 
of tanning. Wagner showed that skin L* and baseline erythema were correlated (R2 = 
17.6%, P<0.001) (Wagner et al., 2002b) and a* correlated with adjusted slope of 
change in a* (not EI or flux). 
The variation explained by this study is higher than that of Wagner et al. R2 = 27% 
(buttock) to 34% (back); P=1.205×10-7 (buttock), P=1.49×10-10 (back). This 
difference in variance explainable may be due to difference in methodology and / or 
the site of UVB irradiation. Their population of study is different in terms of bigger 
sample size, broader population with more Asians. On the contrary this population of 
study consisted of a homogenous population mostly of Caucasian Northern 
Europeans and smaller number of reds and smaller sample size. This study 
methodology used direct measures of erythema (erythemal index and erythemal flux) 
whereas Wagner et al used derived equations for erythemal responses. 
One could arrive at different answers depending on what population is being studied. 
Another difference is that their constitutive skin colour choice of skin site was upper 
medial arm. 
Wagner et al found constitutive pigmentation in females was slightly lower than in 
males in all three samples, but the difference was not significant. While no 
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differences were observed in melanogenic dose response (MDR) between sexes, 
males had a higher EDR than females (i.e. steeper slope of a*) regardless of 
population or constitutive pigmentation level, and this sex difference was significant 
in European Americans and Hispanics. However in their study, the site of UV 
irradiation was on medial aspect of arms. This study used the mid back and the 
buttock. Previous literature reported sex difference (Wagner et al., 2002b). I found 
females to have a higher erythemal dose response in terms of erythemal flux (P=0.04 
at dose 2). This could have arisen by chance 4 out of 100 times. The study 
populations were different in the 2 studies, with different methodology also – these 
could all explain the different findings. The importance of differences in study 
methodology and the study population should be emphasized. 
There were no other previous reports on sex differences in cutaneous erythemal 
responses. Wagner et al suggested that perhaps hormonal or physiological causes 
may be plausible explanations e.g. Mercurio et al showed that oestrogen increases 
water holding capacity of stratum corneum (Mercurio, 1998). 
Previous studies did not find an effect of age on erythema (Cox et al., 1992; Lim et 
al., 2008). This is not surprising given this study has a limited age range of 18-40. 
Given the narrow age range, it was not surprising that no significant effect of age on 
tanning was found in my study. 
It is also worthy to note that the previous literature was confusing on minimal 
erythemal dose (MED) and skin type, with different conclusions drawn from 
different studies: 
1) no correlation (Chung et al., 1994; Tejasvi et al., 2007; Westerhof et al., 1990) 
2) poor or weak (Rampen et al., 1988; Youn et al., 1997) 
3) unreliable (Park et al., 1998) 
4) inconclusive (Stanford et al., 1996) 
5) correlate (Li and Chu, 2007; Liu et al., 2006b; Wee et al., 1997)  
MED determination is very subjective method, and dependent on the operator, skin 
colour, lighting (Diffey and Robson, 1992) and environmental temperature (Wagner 
et al., 2002a). This study’s skin type data were objective and comprised of 
quantitative measurements of erythema. This is in keeping with (Li and Chu, 2007; 
Liu et al., 2006b; Wee et al., 1997) despite the shortcomings recognised with skin 
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type. One important point to note is the way the skin type was obtained in this study 
by reading the classification criteria to the volunteers and they make their choice. It 
is important to standardise the criteria of skin type and how the questionnaires were 
administered. 
In summary, erythemal responses can be predicted simply from constitutive skin 
colour L* and/or skin type. It is interesting to note that a recent paper by Pershing et 
al (Pershing et al., 2008) argued that reflectance spectrophotometer of upper volar 
arm provides a rapid non-invasive and reliable method to objectively determine 6 
skin types using only skin colour at the upper volar arm. Pershing et al did not have 
any erythema or tanning measures though and the site of constitutive skin colour 
assessment was different to this study. 
 
The relationship between erythema and MC1R genotype will be discussed in 
Chapter 6. 
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Chapter 5 Tanning responses – Determinants of Tanning 
 
5.1. Introduction 
Individuals vary in their sensitivity to the sun. The facultative pigmentary response 
(tanning) also varies. The aim of this part of the study was to irradiate a subset of 98 
individuals with UVB radiation and objectively measure their tanning responses to 
investigate the determinants of tanning. 
The results are presented under several headings. First the results from the objective 
measure of tanning (5.2.1), then the correlation between experimentally induced 
tanning and co-factors including erythema in section 5.2.2, and finally the discussion 
is in section 5.3. 
 
5.2. Results 
5.2.1. Objective measures of tanning responses 
The facultative pigmentary (tanning) responses were measured objectively using 3 
assays: 
a) Tanning by change in L*, a* and b* values. L* was used as the chief measure of 
tanning. This will be discussed later. 
b) Tanning by change in melanin index (MI). The limitations with this assay will be 
discussed later. 
c) Tanning by change in spectrophotometry 360-740nm. An attempt to analyse the 
results from this assay proved difficult. 
3 other tanning assays were developed while undertaking this study: 
d) Tanning by pressure spectrophotometry, the methodology discussed in Chapter 2. 
e) Tanning by change in ‘Dwyer calculation method’ 420-400nm from baseline. The 
tanning data was analysed by following the Dwyer principles (Dwyer et al., 1998). 
f) Tanning by the “Shriver method” (Wagner et al., 2002a). The analysis of the data 
also proved complicated. 
It was therefore decided that noradrenaline iontophoresis was used instead and 
tanning represented by change in L* score. 
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Two anatomical sites were chosen for the tanning experiments: back (photoexposed) 
and buttock (photoprotected). UVB-induced facultative pigmentary responses 
(tanning) were recorded. The time point of maximal tanning at 7 day was previously 
determined (Oh et al., 2004) and used. All tanning assay results presented in this 
thesis referred to the same time point of 7 day to measure tanning. 
Representative tanning responses for volunteers to UVB were shown in Photo 5.2.1. 
Photo 5.2.1. Tanning responses on the back and buttock 7 days post UVB 
irradiation Post-noradrenaline iontophoresis. 
a)                                 
Back: 
 
b)               
Buttock: 
 
Tanning responses of a) back and b) buttock were shown. Ink markings were made on the 
skin following a cardboard template of where the UVB doses were irradiated by the custom 
made UVB source. 3 UVB doses (doses 1-3) i.e. 2.6, 5.2 and 8.2 SEDs were measured. 
These were post noradrenaline iontophoresis. 
 
5.2.1.a. Tanning by change in L*, a* and b* 
Quantitative measurements in terms of the change in L*, a* and b* were chosen as 
the main assay endpoint to measure tanning. 
2.6                                0         
           5.2           8.2 SEDs        
2.6                                      0     
           5.2          8.2 SEDs       
2.6                                  0       
           5.2           8.2 SEDs       
2.6                                   
           5.2         8.2 SEDs       
          0             
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Figure 5.2.1.a.1. Tanning responses in terms of change in L* to UVB doses 





























This is an interval plot of change in L* ± SEM (95% CI for the mean) for the back (black) and 
buttock (red) in 98 UVB-irradiated individuals at 7 days. Y-axis shows the change in L* (with 
baseline L* subtracted). X-axis shows the UVB doses (mJ/cm2) in a logarithmic scale. 
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Figure 5.2.1.a.2. Tanning responses in terms of change in a* to UVB doses 

























This is an interval plot of change in a* ± SEM (95% CI for the mean) for the back (black) and 
buttock (red) in 98 UVB-irradiated individuals at 7 days. Y-axis shows the change in a* (with 
baseline a* subtracted). X-axis shows the UVB doses (mJ/cm2) in a logarithmic scale. 
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Figure 5.2.1.a.3. Tanning responses in terms of change in b* to UVB doses 

























This is an interval plot of change in b* ± SEM (95% CI for the mean) for the back (black) and 
buttock (red) in 98 UVB-irradiated individuals at 7 days. Y-axis shows the change in b* (with 
baseline b* subtracted). X-axis shows the UVB doses (mJ/cm2) in a logarithmic scale. 
 
From the graphs one can see a dose dependent increase in tanning for back and 
buttock. The increase in tanning at the back appeared greater than that of the buttock. 
Two sample t test comparing tanning at back vs buttock at dose 1 (P<0.05), dose 2 
(P<0.05) and dose 3 (P<0.05) showed significant difference for change in L* score. 
Similarly significant results comparing tanning between back and buttock for a* and 
b* were shown. 
 
What about between different UVB doses? Significant differences for tanning L* 
between back dose 1 and 2, dose 2 and 3, dose 1 and 3 (P<0.05, P<0.05, P<0.05). 
Similarly significant results comparing tanning between doses of back for a* 
(P<0.05, P<0.05, P<0.05) and b* (P<0.05, P<0.05, P<0.05) were shown. As for the 
buttock, there were significant differences for L* between buttock at dose 1 and 2 
(P<0.05), dose 2 and 3 (P<0.05), dose 1 and 3 (P<0.05). Similarly significant results 
 180
comparing tanning between doses of buttock for a* (P<0.05, P<0.05, P<0.05) and b* 
(P<0.05, P<0.05, P<0.05) were shown. 
 
Table 5.2.1. Mean tanning in terms of change in L* a* b* with SEM with UVB 





















Back 1 0.82 0.21 0.37 0.14 0.61 0.13 
Buttock 1 -0.43 0.18 -0.16 0.10 -0.38 0.18 
Back 2 2.92 0.28 1.68 0.20 1.93 0.16 
Buttock 2 1.09 0.22 0.74 0.15 0.80 0.17 
Back 3 6.31 0.33 3.70 0.27 2.56 0.19 
Buttock 3 4.05 0.32 2.82 0.26 2.00 0.19 
n=98 
 
The back tans significantly more than the buttock with a mean increase of 6.3 ± 0.3 
L* units for the back and 4.1 ± 0.3 L* units for buttock (P<0.05) in response to dose 
3 (8.2 SEDs) of UVB. There was a dose-dependent increase in tanning for both the 
back and the buttock. There was a dose dependent UVB-induced increase in L*, a* 
and b*. 
The average gradient of tanning response for the back L* (0.98) was higher than that 
for the buttock L* (0.80). 
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5.2.1.b. Tanning by change in Melanin Index at 7 days – back and buttock 

























This is an interval plot of change in MI ± SEM (95% CI for the mean) for the back (black) and 
buttock (red) in 98 UVB-irradiated individuals at 7 days. Y-axis shows the change in MI (with 
baseline MI subtracted). X-axis shows the UVB doses (mJ/cm2) in a logarithmic scale. 
 
Similarly the back tans more than the buttock in terms of change in MI. Two sample 
t test showed significant difference between back and buttock at dose 1, 2 and 3 
(P<0.05, P<0.05, P<0.05). Significant difference between back dose 1 and 2 
(P<0.05), dose 1 and 3 (P<0.05). But no significant difference between back dose 2 
and 3 (P=0.29). There were no significant difference between buttock at dose 1 and 2 
(P=0.12), dose 2 and 3 (P=0.94), dose 1 and 3 (P=0.24). There was no further dose 
dependence for the 2 higher doses at the back and no dose dependence for the 
buttock. 
Tanning by MI data (Figure 5.2.1.b.) did not show an as “neat” dose response as 
compared to tanning by change in L* data (Figure 5.2.1.a.1) in the absence of blood. 
There was no obvious explanation for this. Possible explanation of this discrepancy 
could be the rationale of the measurement of MI by the erythema meter in that it 
compares blood and melanin at 632 nm and then use a reference wavelength of 
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905nm. MI measurement is a function of the remittance at 632nm (for melanin 
absorption) and 905nm, the reference signal (Diffey et al., 1984; Feather et al., 
1988). An increase in pigmentation should result in a more positive melanin index, 
but not always the case as seen in the tanning response over the buttock. Melanin 
index measurements are independent of blood flow, however even after 
noradrenaline iontophoresis, the melanin index data still did not give a neat dose 
response. As L* a* b* scores are more widely used and standardised, it would seem 
preferable that L* a* b* should be used chiefly. 
 
5.2.1.c. Tanning by reflectance spectrophotometry 360-740nm 
The third assay measure of tanning was using reflectance spectrophotometry. In a 
physiological setting, reflectance was due to blood (haemoglobin) and pigment 
(melanin) normally in the skin. The pigment melanin absorbs maximally at 335nm 
wavelength, and absorbs almost none at longer than 700nm (Kollias, 1995). Note the 
type of melanin was human melanin. Reflectance is inversely proportional to 
absorbance. 
 
Figure 5.2.1.c.1. Spectral absorption of melanins 
 
These are spectral absorption graphs for eumelanin and phaeomelanin. Y-axis, relative 
absorption. X-axis, wavelength (nm). Note these are synthetic melanins eumelanin (using 
DHI monomer) and phaeomelanin. Source: (Sarna, 1988). 
 183
 
Figure 5.2.1.c.2. Spectral absorption of melanin 
 
This is a spectral absorption graph for human melanin. Y-axis shows the apparent 
absorbance. X-axis is wavelength (nm). Source: (Kollias, 1995). 
 
Figure 5.2.1.c.3. Spectral absorption of haemoglobin 
 
These are spectral absorption graphs for oxyhaemoglobin and deoxyhaemoglobin. Y-axis, 
relative absorption. X-axis, wavelength (nm). Source: 
http://omlc.ogi.edu/spectra/hemoglobin/summary.html. Data from W. B. Gratzer, Med. Res. 


























































































































This is an interval plot of tanning by spectrophotometry ± SEM (95% CI for the mean) for the 
back (n=98). Y-axis shows the absolute spectrophotometric reflectance data (without 
baseline spectrophotometric reflectance data subtracted). X-axis shows the 10nm 
increments of 360-740nm wavelengths. 
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This is an interval plot of tanning by spectrophotometry ± SEM (95% CI for the mean) for the 
buttock (n=98). Y-axis shows the absolute spectrophotometric reflectance data (without 
baseline spectrophotometric reflectance data subtracted). X-axis shows the 10nm 
increments of 360-740nm wavelengths. 
 
The above absolute spectrophotometric reflectance graphs were used to plot the 
following spectrophotometric reflectance graphs with baseline subtracted (n=98). 
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This is an interval plot of tanning by spectrophotometry ± SEM (95% CI for the mean) for the 
back. Y-axis shows the change in spectrophotometric reflectance data (with baseline 
spectrophometric reflectance subtracted). X-axis shows the 10nm increments of 360-740nm 
wavelengths. 
 
Tanning causes a reduction in reflectance at the back. For Dose 3, there was some 
reduction in reflectance at the shorter wavelengths 360-400nm (up to -7.2±0.4 units). 
The reduction in reflectance was greatest at wavelengths 540nm (-9.53±0.5 units) 
and 580nm (-9.46±0.5 units). The change in reflectance was less at the longer 
wavelengths 690-740nm (about –3±0.2 units). 
 187




















































































































This is an interval plot of tanning by spectrophotometry ± SEM (95% CI for the mean) for the 
buttock. Y-axis shows the change in spectrophotometric reflectance data (with baseline 
spectrophometric reflectance subtracted). X-axis shows the 10nm increments of 360-740nm 
wavelengths. 
 
Similarly, tanning causes a reduction in reflectance at the buttock, to a lesser degree 
than the back. For Dose 3, there was some reduction in reflectance at the shorter 
wavelengths 360-400nm (up to -5.6±0.5 units). The reduction in reflectance was 
greatest at wavelengths 540nm (-6.9±0.6 units) and 580nm (-6.9±0.6 units). The 
change in reflectance was less at the longer wavelengths 690-740nm (about –1.5±0.2 
units). 
Absolute reflectance was lower at shorter wavelengths and higher at longer 
wavelengths. As one goes from lower to higher wavelengths (360-740nm), melanin 
absorbs maximally at 335nm i.e. lowering of reflectance and gradually with decrease 
in absorption (Figure 5.2.1.c.2.). The reduction in reflectance in the 
spectrophotometric graphs for back and the buttock are therefore likely due to 
melanin, this is as expected. At longer wavelength >700nm, absolute reflectance is 
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the highest i.e. absorption lowest because melanin absorbs closely to nil at the longer 
wavelengths. The change in reflectance is therefore less. 
I expect that there should be no contribution from haemoglobin as the noradrenaline 
iontophoresis has removed any UVB-induced increase in blood flow (confirmed by 
contact laser Doppler) and that the subtraction of baseline spectrophotometric 
reflectance should also have removed the effect of basal blood flow. 
It is possible that other chromophores e.g. bilirubin, β-carotene may have contributed 
to the change in reflectance, although the assumption is that these are negligible in 
physiologically normal healthy volunteers. 
The skin tanning spectrophotometry data can be difficult to analyse, similar to hair 
colour spectrophotometry data, despite obvious striking difference between groups. 
Principle component analysis technique (personal communication, Professor J. L. 
Rees) may be useful in analysing the data. The analysis is beyond the remit of this 
thesis. Future work aims to address this. 
 
5.2.1.c.8. Comparison between pre and post noradrenaline iontophoresis 
absolute spectrophotometric reflectance graphs 
Although we confirmed the absence of increased blood flow with a contact Doppler 
probe, it would be useful to confirm this with our spectrophotometric reflectance 
measurements. How much difference in reflectance did noradrenaline iontophoresis 
contribute at each wavelength? 
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This is an interval plot of the difference in spectrophotometric reflectance ± SEM (95% CI for 
the mean). Y-axis shows the difference (post-pre noradrenaline iontophoresis) in 
spectrophotometric reflectance data. X-axis shows the 10nm increments of 360-740nm 
wavelengths (representative from 264 data points). 
 
From the graph, post noradrenaline iontophoresis resulted in greater reflectance. 
Maximal differences in reflectance occur at 2 peaks: 400-450nm and 520-590nm. 
These corresponded to the haemoglobin absorption peaks (see Figure 5.2.1.c.3) and 
is in keeping with blood as expected. 
The above spectral reflectance data, together with laser contact Doppler flux data, 
confirmed that noradrenaline iontophoresis could rid the increase in blood flow post 
UVB irradiation at 7 days. 
The next 3 assays to measure tanning were investigated and developed further in an 
attempt to measure tanning in the absence of blood after UV irradiation.  
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5.2.1.d. Pressure colorimetry against Noradrenaline iontophoresis study 
results 
I wondered if pressure exerted on the skin could physically remove the increased 
blood flow temporarily by using the newly described Pressure colorimetry method in 
Chapter 2. 
 






















NA = Noradrenaline iontophoresis
P = Pressure
 
This is an interval plot of the absolute value of L* a* b* ± SEM (95% CI for the mean) for the 
noradrenaline iontophoresis (NA) (red) and pressure colorimetry (P) (black), n=9. Y-axis 
shows the absolute L* a* b* values. X-axis shows the effect of noradrenaline iontophoresis 
(red) and pressure colorimetry (black). The panels show data from the back (left) and buttock 
(right). 
 
Paired t-test comparison between Noradrenaline iontophoresis versus Pressure 
showed no significant difference for L* (two sided P=0.1827), but significant 
difference for a* score (two sided P=0.0063) and b* score (two sided P=0.0168). 
This suggests that pressure has a similar effect on L*, whereas the measurements of 
a* and b* scores were still different significantly between noradrenaline 
iontophoresis and Pressure. 
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It is possible that Pressure exerted could have removed any increased blood flow 
post-UVB irradiation, however it is not possible at present to confirm whether all the 
increased blood flux was removed by pressure – a technical limitation means that a 
contact laser Doppler probe could not be physically fitted onto the spectrophotometer 
cover. 
 
5.2.1.e. Results from the comparison with Dwyer method 
An alternative assay method of analysing the day 7 tanning spectrophotometric 
reflectance data was performed. As was discussed in Methods section in Chapter 2, 
Dwyer et al argued that the difference between reflectance at 420nm and 400nm on 
skin measurements can be calculated and this difference has been shown to correlate 
(r=0.68) with cutaneous melanin density as measured by Masson Fontana staining 
histologically (Dwyer et al., 1998). The difference has been assumed to be void of 
contribution by blood / haemoglobin since the absorption at these 2 wavelengths 
should cancel out each other, according to the authors. Hypothetically the difference 
in the presence and absence of blood should be the same, if blood at 420-400nm is 
negligible, unless there are contributions from other things. 
The facultative pigmentary response to UV radiation in man remains poorly 
characterised. It is important to measure facultative pigmentation in the absence of 
changes in blood flow, but this is made difficult because of the spectral overlap of 
haemoglobin and melanin. The aim is to compare a calculation method of measuring 
skin colour (‘Dwyer method’) with a more invasive method that we have recently 
published (Oh et al., 2004). We use the latter as the gold standard. 
Melanin absorbs more light at 400nm>420nm. But haemoglobin absorption is high 
and similar at both wavelengths. Differences in absorption at 400 and 420nm are 
therefore said to be due to pigment and not blood according to the Dwyer method. 
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Figure 5.2.1.e. Dwyer model versus Pre Post NAdr iontophoresis at different 























Student’s t test was performed to compare the pre and post noradrenaline 420-
400nm reflectance data for 0 SEDs (-1.24±0.19, -1.07±0.20) (P=0.55), 2.6 SEDs (-
1.31±0.20, -0.67±0.62) (P=0.32), 5.2 SEDs (-0.91±0.19, -0.84±0.18) (P=0.80) and 
8.2 SEDs (-0.79±0.15, -0.86±0.17) (P=0.74). 
Our data showed no statistically significant difference between the pre and post 
noradrenaline iontophoresis results, in keeping with the predictions of the Dwyer 
model. This confirmed that it was uninfluenced by blood (independent of blood flow 
/ flux). The Dwyer model deserves more attention. 
 
5.2.1.f. Results of facultative pigmentation using Dwyer method 
Next my results were compared with Dwyer method (Dwyer et al., 1998). If my 
tanning data (spectrophotometry) was analysed using Dwyer method by subtracting 




Figure 5.2.1.f. Tanning by ‘Dwyer’ calculation (420-400nm) for n=98 plotted 
for UVB doses 1-3 on back and buttock (with baseline subtracted i.e. 















































This is an interval plot of tanning by ‘Dwyer’ ± SEM (95% CI for the mean) for the back 
(black) and buttock (red). Y-axis shows the tanning by ‘Dwyer’ calculation (420-400nm) for 
98 individuals. X-axis shows the UVB doses (mJ/cm2) in a logarithmic scale for the back 
(black) and buttock (red). 
 
There was a better dose response for the buttock than the back with ‘Dwyer’ 
calculation method. There was a good dose response for the buttock although not as 
marked as the tanning measure of ‘change in L*’. 
 
In theory, Dwyer argued that 420-400nm should correlate well with the amount of 
pigment i.e. melanin. In practice this assay was not useable, in theory ok. Even 
though subtracting 420-400nm did get rid of blood, there may be other unknown 
contributory factors. It is possible that for instance other chromophores in skin which 
may account for this difference (bilirubin, β-carotene). SEM bars overlap. There 
were 2 different trends between back and buttock. 
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Therefore the ‘Dwyer’ calculation method could also rid the increase in blood flow, 
but did not give a good tanning assay response for the back. 
 
5.2.2. Correlation between experimentally induced tanning and co-factors 
including erythema 
The principle aim of this section was to relate changes in tanning with independent 
variables that might explain the changes in tanning. Tanning was measured at 3 
doses of UVB radiation on the back and on the buttock. Two factors must be kept in 
mind. A large number of variables were recorded and, second, some of these 
variables could not be considered independent. For instance, L*, a* and b* values 
were recorded as a measure of change in skin colour after tanning. Although the 
analyses could be repeated with all 3 variables, the results presented here are for L* 
only. The justification for this is simplicity and previous published work from our 
group showed that L* lends itself to dose dependent measures of tanning and 
distinguishes between different patient groups (Oh et al., 2004). 
The second issue is that because tanning responses were sought at 3 different doses 
within any one individual, therefore the results to the UVB challenge cannot be 
considered statistically independent. The most appropriate analytical method would 
be the use of either a split plot design or a mixed effects model. The split plot design 
is useful when a particular type of restricted randomization has occurred during the 
experiment. The split plot design involves two experimental factors A and B. Levels 
of A are randomly assigned to whole plots i.e. main plots, and levels of B are 
randomly assigned to split plots i.e. subplots within each whole plot. The subplots 
are assumed to be nested within the whole plots so that a whole plot consists of a 
cluster of subplots and a level of A is applied to the entire cluster. The design 
provides more precise information about B than about A. Mixed effects model could 
be used to analyse these balanced and unbalanced grouped data which have arisen 
from repeated measures data by fitting these data into mixed effects model software. 
These are complex. Inspection of the raw data showed that, for most individuals, 
evidence of a dose effect was present between tanning and UV dose. For simplicity, 
and for ease of modelling, results at the highest dose (dose 3 i.e. 300mJ/cm2) were 
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used for the analysis. The approach was to look at univariate measures initially 
before moving on to more complicated analyses. 
5.2.3. Tanning Results 
The score for tanning on back and buttock appeared reasonably normally distributed 
at the 300mJ/cm2 dose. Parametric statistics were therefore used where appropriate. 
 
5.2.3.1. Tanning and sex 
Simple t-tests show that there was no relation between tanning on the back or the 
buttock and sex. 
 
5.2.3.2. Tanning and freckles 
There was no relation between tanning on the back and freckles, but conversely there 
was a highly significant relation between the presence, or otherwise, of freckles and 
tanning on the buttock (P=0.01) with the mean increase in tanning of 4.75 in those 
who freckled, compared with 3.27 in those who did not freckle. 
 
5.2.3.3. Tanning and red hair 
No difference was seen between those with red and those without red hair in back 
tanning, but again differences between the red and non-red group were almost 
significant for buttock tanning (P=0.06, two sample t-test) with the tanning mean of 
5.61 in those with red hair and 3.74 in those without red hair. 
 
5.2.3.4. Tanning and blonde hair 
Similarly, there was no relation between tanning on the back and the presence of 
blonde hair or otherwise, but tanning on the buttock was greatest at 4.33 in those 
without blonde hair, compared with 1.99 in those with blonde hair (P=0.02, two 
sample t-test). 
 
5.2.3.5. Tanning and ethnicity 
A simple analysis of variance (ANOVA) failed to show any significant relation 
between back or buttock tanning and ethnic group. Small numbers in some groups 
may have limited the power of this test. 
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5.2.3.6. Tanning and skin type 
Whereas simple analysis of variance failed to reveal any relation between skin type 
treated as a factor and back tanning (P=0.27), there was a highly significant relation 
(P=0.0001) for skin type and tanning on the buttock. 
 





























Inspection of an individual value plot with skin type on the x-axis and buttock 
tanning L* on the y-axis, shows that clear differences between skin type groups 2, 3, 
4 and 5 appeared obvious. Comparison of the individual skin types using the Tukey 
method reveals the following differences: Skin type 1 versus skin type 2 (P=0.016); 
skin type 3 versus skin type 2, (P=0.01); skin type 4 versus skin type 2, (P=0.00008); 
skin type 5 versus skin type 2, (P=0.02). The significances of these differences 
shown on buttock skin, but not back skin, will be returned to later. 
 
5.2.3.7. Tanning and constitutive skin colour 
If skin colour was treated as a continuous variable, then there were significant 
correlations between constitutive skin colour (at a particular site) and the change in 
L* following UV radiation. Note that the change in L* refers to, in fact, a darkening 
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(because small values on the L* scale reflect darker skin) whereas with the basal 
measure, the more positive it is, the lighter the skin. 
 
Figure 5.2.3.7.1. Tanning responses (change in L*) over back and 
constitutive back skin colour L* 





















This is a scatter plot of back tanning (change in L*) and constitutive back skin colour L* at 
UVB dose 3 (300mJ/cm2) for 98 individuals. Y-axis shows the back tanning change in L* 
(with baseline L* subtracted). X-axis shows the constitutive back skin colour in L* scale. 
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Figure 5.2.3.7.2. Tanning responses (change in L*) over buttock and 
constitutive buttock skin colour L* 




























This is a scatter plot of buttock tanning (change in L*) and constitutive buttock skin colour L* 
at UVB dose 3 (300mJ/cm2) for 98 individuals. Y-axis shows the buttock tanning change in 
L* (with baseline L* subtracted). X-axis shows the constitutive buttock skin colour in L* scale. 
 
These results show that the greatest increase in tanning was in those with the lightest 
skin. i.e. individuals who have a lighter constitutive skin colour tend to tan more. 
The relation between back L* and tanning on the back for L* was P=0.03748 with a 
correlation coefficient of 0.21; between buttock L* and buttock tanning L*, the P-
value was equal to 0.0004602 and the correlation coefficient was 0.347. Therefore 
back constitutive skin colour could explain 4% of the tanning response (R2 of ~4%). 
Buttock constitutive skin colour could explain 12% of the tanning response (R2 
~12%). The diminished amount of tanning in individuals with darker skin could be 
explained by either i) a limited amount of further tanning in individuals with darker 
skin or ii) a smaller amount of UVB dose received biologically. 
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5.2.3.8. Tanning and erythema 
It is known from previous work that tanning is related to UV-induced erythema 
(Parrish et al., 1982). Simple correlations for back skin showed a P value of 0.07 
with a correlation coefficient of 0.18 between erythema measured as the erythemal 
index at 300mJ/cm2 and the change in L* on the back. For the buttock, the 
comparable figures were P=1.473×10-6 and with a correlation coefficient of 0.46. 
Again, it is noted that the results between the buttock and the back differ with a 
clearer relation been seen on the buttock than on the back. 
 
Table 5.2.3.8. Summary of ANOVA 










5.2.3.9. Multivariate Analysis 
A simple linear model was fitted with erythema at 300mJ/cm2 and constitutive 
buttock skin colour L*. There was no evidence of interaction between erythema and 
constitutive skin colour and this term was removed. 
 
Linear model formula 
= Buttock Tan L* ~ buttock erythemal index 300 * Buttock constitutive L* 
 
Table 5.2.3.9. Summary of Linear Model for tanning 
 Estimate SE t value P r(>t) 
(Intercept) -8.10 5.29 -1.53 0.128998 
Buttock EI 300 0.03 0.01 3.80 0.000254 
Buttock L* 0.13 0.08 1.62 0.108098 
F-statistic 11 on 2 and 95 degrees of freedom, P=2.687×10-6 
This regression explains about 24% of the variation as reflected by the adjusted R2. 
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A summary analysis of variance table is shown and it can be seen that the erythemal 
index (EI) of 300mJ/cm2 is highly significant of tanning ability at the buttock, but 
that the constitutive buttock colour is no longer significant (P=0.108098), as seen in 
the univariate analysis. The R2 for this model is 0.24 (P=2.687×10-6). 
The corresponding model for back skin attempting to relate erythema at 300mJ/cm2 
to constitutive colour does not reveal any significant results (P=0.14). With regards 
to buttock skin, the addition of neither skin type, nor ethnic group nor the presence, 
or otherwise, of red hair, nor the presence, or otherwise, of freckles, was significant 
beyond that accounted for by erythema. 
 
As could be expected, UVB-induced tanning on the back and buttock were correlated 
(P=0.04, correlation coefficient = 0.28). 
 
5.2.10. Tanning (change in Melanin Index) correlation back and buttock 




















back MI*buttock MI (95mJ/cm2) back  MI*buttock MI (189mJ/cm2)
back   MI*buttock MI (300mJ/cm2)
 
This is a scatter plot of back tanning (change in melanin index (MI) and buttock tanning 
(change in melanin index (MI) at 3 UVB doses (95, 189 and 300mJ/cm2) for 98 individuals. 
Y-axis shows the back tanning (change in melanin index (MI) (with baseline MI subtracted). 
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X-axis shows the buttock tanning (change in melanin index (MI) (with baseline MI 
subtracted). 
 
Table 5.2.10. Correlation between back tanning by melanin index (MI) and 






Dose 1 0.026 0.797 0.1% 
Dose 2 0.455 <0.05 19.9% 
Dose 3 0.633 <0.05 39.4% 
 
Similarly for melanin index (MI), UVB-induced tanning on the back and buttock 
were correlated (P<0.05, correlation coefficient = 0.63) for dose 3. 
The relationship between tanning and MC1R genotype will be discussed in Chapter 
6. 
5.3. Discussion 
There were 6 different assays used to quantitatively measure tanning. Tanning by 
change in L* in the absence of increased blood flow (by performing noradrenaline 
iontophoresis) was found to be the optimal measure of tanning in this study. Melanin 
index also presented some limitations due to the way MI was estimated by the 
erythema meter. Tanning by change in spectrophotometric reflectance presented 
some difficulty in analysing the data. The Dwyer calculation method appears to be 
effective in measuring tanning also, although the dose response curves were less 
defined. Shriver method was also difficult to analyse. 
The aim of this section was to summarise what the determinants of tanning are. 
Firstly, tanning is dependent on UVB dose. As the UVB dose increases, there is more 
tanning. Secondly, tanning is also site dependent. The back tans much more than the 
buttock. Thirdly, the phenotypes freckling and skin type are correlated with tanning 
(over the buttock P=0.01, P=0.0001). Buttock tanning correlates with freckles and 
skin type. Skin type is a factor for buttock tanning, not back tanning. Freckle and 
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back tanning were not significant. It is possible that individuals who tan well, may 
expose their back more. Fourthly, constitutive skin colour. Back constitutive skin 
colour correlated with back tanning with a correlation coefficient of 0.21 – R2 of 
~4% i.e. importantly only explained 4% of variation. Buttock constitutive skin colour 
correlated with buttock tanning R2 ~12% i.e accounting for 12% of the variation. 
Finally, erythema is the most important determinant which we will return to disuss. 
Ethnicity does not seem to have a large effect on tanning in this population sample. 
This may be due to the small numbers in some of the ethnic groups which in turn is 
reflective of this Scottish population. 
Red hair status was almost significant (P=0.06) towards tanning when compared to 
non-reds. Blonde hair status does seem to have less of a tanning effect (P=0.02). 
Do people with darker constitutive skin colour tan more? No. In fact, lightest skin 
tanned the most due to becoming the reddest in response to UVB over the buttock 
and effectively received a larger effective biological UVB dose. In other words, the 
individuals with darker constitutive skin colour cannot be compared equivalently to 
those with lighter skin colour because although they were irradiated with the same 
mJ/cm2 of UVB, these were not equal erythemogenic doses of UVB to those 
individuals with different skin colours. 
Different kinetics of tanning to UVB could explain some of the tanning responses. 
Individuals who have the lowest starting point i.e. lightest skin colour could in theory 
generate the most magnitude of tanning. These paler individuals could increase blood 
flow (i.e. erythema) the most, in response to UVB irradiation and therefore produce 
more melanin. For those individuals who showed an increased in erythema (blood 
flow) at 7 days, it is possibe that they may have the capacity to tan further and this 
could not be excluded. 
Erythema matters most and explains much of the variation in tanning. Buttock 
erythema correlates with buttock tanning (r=0.46). One goes brown proportional to 
redness. Buttock tanning correlates with buttock constitutive skin colour. 
Constitutive skin colour is also important in explaining some of the variation in 
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tanning. When erythema is put into a simple linear model, all these other factors are 
taken into account by erythema. Although other co-factors like skin type (P=0.0001), 
freckles (P=0.01) were associated with buttock tanning – all these other factors 
ultimately determine an individual’s propensity to go red with UVB. Once erythema 
was put into the equation, all other factors are out. Since erythema is ultimately 
dependent on all these factors. How red you go is a reflection of these other factors. 
In explaining the determinants of tanning, erythema (with EI chosen as the assay 
measure) is the most important. Adding ethnicity has no effect, probably because 
ethnicity tells you how red you go and reflect the degree of redness you go after UV 
exposure. Skin type explains tanning. This is in keeping with (Pershing et al., 2008). 
Some skin type e.g. type 2 matters and develops redness with UV exposure. There is 
no additional information beyond what could be explained by erythema, beyond skin 
type. Thus Fitzpatrick skin type, as a continuous variable, provided no further 
information beyond what erythema did. 
Buttock is a better site to measure for tanning responses since it is photoprotected 
and naïve to UV. One limitation encountered in this study was that some individuals 
(2) did not want to expose their buttocks to be irradiated. 
Erythema is a useful and good phenotypic measure. The best correlation found was 
between buttock erythema and buttock tanning (r=0.46). 
To date, no previous study has ever measured tanning in this detail and 
quantitatively. This is the first study of tanning in this detail, despite a large 
quantitative dataset; it was disappointing that these other factors did not contribute 
much towards the determination of tanning responses. 
Tanning data was normally distributed. Parametric methods were used. The analysis 
of tanning data was focussed on change in L* score as the measure of tanning (in the 
absence of increased blood flow). Perhaps other alternative measures e.g. a* score or 
b* score could be used too. Indeed, L* score correlates with a* too. Alaluf et al 
suggested that melanin contributes to b* score in lighter skin but as melanin 
increases in darker skin, b* reaches a maximum and then decreases, possibly due to 
the optical masking of yellow light by high concentrations of melanin (Alaluf et al., 
2002). 
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However, we have previously established a valid, proven and reproducible method 
using L* score (Oh et al., 2004). 
The tanning data analysis was performed for dose 3, the maximum UVB dose, as I 
was expecting the largest effect and that any effect would be easiest to spot. In order 
to ensure that the effects found were not supraphysiological, I also looked at tanning 
at another dose (dose 2, 189mJ/cm2). As expected, at dose 189mJ/cm2, EI buttock 
correlated with buttock tanning 0.31 (P=0.0018) also. Erythema is still the only real 
predictor; other factors were not very strong. At 189mJ/cm2, comparisons not as 
impressive i.e. when corrected for multiple testing. 
In summary, the chief determinant of tanning is erythema, which in turn is dependent 
on the dose of UV irradiated and received by the skin biologically. Constitutive skin 
colour comes into play and determines how much UV is received into the skin, 
together with other co-factors e.g. ethnicity, hair colour, which in turn determines the 
propensity to develop erythema. It is these factors that make up a person and 
determines whether that person burns or not. 
Hence the model of tanning: 
Linear model formula = Buttock Tan L* ~ buttock erythemal index 300 * 
Buttock constitutive L* 
 
The key finding is that the only real predictor of tanning using photoprotected 
buttock is erythema (R2=0.24, P=2.96×10-6). My tanning results are in keeping with 
Wagner (Wagner et al., 2002b) – positive correlation between tanning and burning 
response in European Americans i.e. Tanning correlates with Erythema, despite 
difference between the 2 studies with regards to the irradiation sites. Wagner et al 
used medial arm whereas I used mid back and buttock. 
Erythema accounts for 24% of variation in tanning response over the buttock. What 
is left? Tanning is not a perfect assay. There is noise in the system. Other unknown 
and not yet identified factors may be accountable for the rest of the variation. Non-
pigmentary photoadaptation may account for the difference in facultative pigmentary 
response e.g. skin hyperplasia or thickening. 
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Further experiments 
The findings from this study raised the point that erythema is the key determinant for 
tanning. What if normalised for erythema? What if normalised for skin colour? 
Asians received lower erythemogenic UV dose. If they are normalised for erythema, 
do they tan more? A dose response could be performed to investigate this. 
Another additional experiment to perform is to compare ‘matched colour’ individuals 
between different ethnicity, and to see if they tan to the same extent or to a different 
extent? Is it possible to measure redistribution in skin if there is no great change in 
the overall melanin amount? Are Asians not very different to Europeans when skin 
colour has been accounted for? If we recruit a sample of Asians, Japanese and 
Europeans and measure their tanning responses if normalised for skin colour, would 
there be any difference? Do Italians and Asians with the same skin colour tan the 
same degree? 
Another further experiment is to look at population difference using the assays 
performed in this study and perform in a different population. It is often difficult to 
compare results between different studies as other studies use different study criteria, 
different assays, different UV lamps and that factors are not constant. This can be 
exemplified by the Wagner study (Wagner et al., 2002b) and my study. 
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Chapter 6 MC1R genotype 
6.1 Introduction 
In this chapter I discuss the findings of MC1R genotype in this study. Next the 
relationship between MC1R and various phenotypic characteristics will be presented. 
 
6.2. Results 
The results will be discussed as follows: 1) MC1R genotype. 2) Relationship between 
MC1R sequence variants and phenotypic characteristics including red hair 
 
6.2.1 Summary of MC1R sequence variants detected 
Position Sequence variant Nucleotide MC1R Status Volunteer 
29 29insA 29insA c.86_87insA 
 
R  
51* Val51Ala V51A c.152T>C 
GTG-GCG 
Novel V157 
60 Val60Leu V60L c.178G>T 
GTG-TTG 
r  
63* Ile63Met I63M c.189C>G 
ATC-ATG 
Novel V40 
84 Asp84Glu D84E c.252C>A 
GAC-GAA 
R  
92 Val92Met V92M c.274G>A 
GTG-ATG 
r  
111 Ala111Val A111V c.332C>T 
GCG-GTG 
  
131* Ser131Asn S131N c.392G>A 
AGC-AAC 
Novel V120 
142 Arg142His R142H c.425G>A, 
CGC-CAC 
  
151 Arg151Cys R151C c.451C>T, 
CGC-TGC 
R  
155 Ile155Thr I155T c.464T>C 
ATC-ACC 
  
160 Arg160Trp R160W c.478C>T 
CGG-TGG 
R  
163 Arg163Gln R163Q c.488G>A 
CGA-CAA 
r  
212* Ala212Ser A212S c.634G>T 
GCC-TCC 
Novel V101,V129 
213 Arg213Trp R213W c.637C>T 
CGG-TGG 
  
230 Pro230Leu P230L c.689C>T 
CCG-CTG 
  
233 Gln233Gln Q233Q c.699G>A, 
CAG-CAA 
  




294 Asp294His D294H c.880G>C 
GAC-CAC 
R  
314 Thr314Thr T314T c.942A>G 
ACA-ACG 
  
This is a table summarizing the MC1R sequence variants detected in this study. The MC1R 
sequence was based on GenBank NM_002386.2 and nucleotide+1 is defined as the A of the 
ATG translation initiation codon. (*) means ‘new’ variants. MC1R status according to Duffy 
(Duffy et al., 2004). R = high penetrance , r = low penetrance. 
 
MC1R was sequenced successfully from 156 individuals. The DNA from 3 
individuals (V35, V71 and V85) failed MC1R sequencing Of the remaining 156, a 
total of 20 MC1R variants were detected. 17 MC1R sequence variants were found in 




























Therefore in the UVB subset of individuals, MC1R sequence variants A111V, 
R213W, Q233Q were not included. 
4 novel MC1R sequence variants were found in this population – V51A, I63M, 


























This table shows the allelic frequencies of MC1R allelic variants detected. 
 
V60L was the commonest sequence variant detected in this population with a 
frequency of 12%. The red hair allelic variants detected (D84E, R142H, R151C, 
R160W, D294H, 29insA) were at a frequency of 1.0, 0.6, 8.3, 8.0, 3.2 and 0.6% 
respectively. 
Focusing on the major MC1R allelic variants: 
 1 allele 2 alleles
V60L 35 3 
D84E 3 0 
V92M+T314T 28 0 
V92M 3 0 
R142H 2 0 
R151C 25 1 
R160W 24 1 
R163Q 20 3 
D294H 10 0 
29insA 2 0 
This table shows the number of MC1R allelic variants detected: 1 allele or 2 alleles. 
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6.2.2 Allelic frequency comparison of MC1R studies 
A comparison with the Flanagan study (Flanagan et al., 2000) of the MC1R allelic 
frequencies was performed. This was done in order to confirm that the allelic 
frequencies in both studies were similar. 
 





















































































































Frequency in current study
Frequency in Flanagan study
 
On inspection of the above figure, the frequencies appeared remarkably similar 
between the studies. 
One important point to make is that MC1R is so polymorphic, what is referred to as 
wildtype (“WT”) is the consensus sequence from Africa (Harding et al., 2000). I will 
refer to and quote the consensus sequence as wildtype (WT) (Appendix 7). 
 
MC1R allelic variants were ranked and coded according to Duffy (Duffy et al., 2004) 
into homozygous (R/R) or heterozygous (R/r or R/-) for high penetrance 29insA, 
D84E, R142H, R151C, R160W and D294H. Low penetrance alleles 60 and 92 were 
classed as r. Other variants e.g. 51, 60, 63, 92, 111, 131, 155, 163, 212, 213, 230, 
233, 279 and 314 were classed as wildtype (WT). 
Of the 156 successfully sequenced, 13 were homozygous (Hm), 41 heterozygous 
(Ht) and 102 wildtype (WT)/pseudo-WT. 
An alternate way of classifying MC1R genotype R r status into 5 groups was also 
performed. RR, Rr, rr, r/-, -/-. V60L was classed as r. 
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MC1R R r status Category 
R R 1 
R r 2 
R – or r r 3 
r – 4 
– – 5 
 
6.2.3. Relationship between MC1R genotype and phenotypic characteristics 
6.2.3.1. MC1R and age 
Firstly, age was looked at to see whether there was any association with MC1R 
genotype. There was no effect of age on MC1R genotype as tested by Kruskal-Wallis 
test (P=0.275). 
 
6.2.3.2. MC1R genotype and sex 
Next, sex was looked at to see whether there was any association with MC1R 
genotype. Females are referred as F. Males are referred as M. 
 211



















Table 6.2.3.2.a. MC1R genotype (Hm/Ht/WT) and sex  
       Hm  Ht   WT  Missing  All 
F      12  36   76        2  126 
M       1   5   26        1   33 
All    13  41  102        3  159 
 
There was no effect of sex on MC1R genotype Hm/Ht/WT (P=0.124). 
  
Table 6.2.3.2.b. MC1R genotype (Rr 1-5) and sex  
MC1R Rr 1  2   3   4   5  Missing  All 
 
F      12  5  34  21  52        2  126 
M       1  0   6   6  19        1   33 
All    13  5  40  27  71        3  159 
 
There was no effect of sex on MC1R genotype Rr1-5 (P=0.3671). 
 
6.2.3.3. MC1R and hair colour L* a* b* 






















The relationship between MC1R genotype and hair L* score. Higher L* values indicate 




Individuals homozygous for MC1R genotype have lighter hair colour i.e. greater L* 
score (P=0.0172). Pairwise comparison Hm vs WT (P=0.0183). Hm vs Ht was not 
significant (P=0.1915). Ht vs WT was not significant (P=0.3586). 
There was no dosage effect for this normal population. Failure to demonstrate a 
dosage effect does not necessary mean a lack of such dosage effect. Small numbers 
and thus inadequate power may explain this. Previous study showed a dosage effect 
from a non-random population selected for red hair (Naysmith et al., 2004). If my 
study sample was larger from the normal population, such a dosage effect may be 
demonstrable. In the normal population, heterozygous MC1R status does not appear 
to make a difference to hair colour L*. Homozygous for MC1R does contribute to 
lighter hair colour L*. 
 

























The relationship between MC1R genotype and the mean of hair a* score. Higher a* values 
indicate greater shades of red in hair colour. Hm, homozygous for MC1R; Ht, heterozygous 
for MC1R; WT, wildtype or pseudo-WT. 
 
Individuals homozygous for MC1R genotype has higher hair a* value i.e. redder 
(P<0.0001). Pairwise comparison Hm vs WT (P<0.0001), Hm vs Ht (P<0.0001). Ht 
vs WT not significant (P=0.0877). 
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The hair a* scale seems to be a good measure of red hair colour but may not be as 
good a measure for other colour characteristics of hair, if investigating for future 
studies. Similarly, heterozygous effect is small; there was no dosage effect. However 
the proportion of reds in this study was smaller than in the previous study. Ht 
appeared to act as a recessive model with WT. 
 






















The relationship between MC1R genotype and hair b* score. Higher b* values indicate 
greater shades of yellow in hair colour. Hm, homozygous for MC1R; Ht, heterozygous for 
MC1R; WT, wildtype or pseudo-WT. 
 
Individuals who are homozygous for MC1R genotype has higher hair b* value i.e. 
more yellow (P<0.0001). Pairwise comparison Hm vs WT (P<0.0001), Hm vs Ht 
(P=0.0001). Ht vs WT not significant (P=0.2987). 
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Table 6.2.3.3. ANOVA comparisons for relationship between MC1R genotype 
and hair colour L* a* b* 
 Hair L* 
Mean       SEM 
Hair a* 
Mean       SEM 
Hair b* 
Mean       SEM 
Hm (n=13) 33.15 1.26 8.60 0.61 15.47 0.88 
Ht (n=41) 28.40 1.53 4.51 0.36 8.83 0.87 
WT (n=102) 26.23 0.83 3.76 0.17 7.48 0.47 
 P value P value P value 
Hm-WT 0.0183 <0.0001 <0.0001 
Hm-Ht 0.1915 <0.0001 0.0001 
Ht-WT 0.3586 0.0877 0.2987 
Summary of ANOVA comparisons for MC1R genotype and hair colour L* a* b* values in 156 
individuals. Pairwise estimates, SEM, and P values are shown for Hm-WT, Hm-Ht and Ht-
WT comparisons for hair colour L* a* b* readings. 
 
6.2.3.3.4. MC1R genotype (Hm/Ht/WT) and hair spectrophotometric 
reflectance 
Does MC1R have any effect on hair colour? 
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This is an interval plot of hair spectrophotometric reflectance ± SEM (95% CI for the mean) 
by MC1R genotype Hm/Ht/WT Hm (black), Ht (red), WT (green) (n=130). Y-axis shows the 
log spectrophotometric reflectance data. X-axis shows the 10nm increments of 360-740nm 
wavelengths. 
 
There was a clear heterozygote effect of MC1R on hair reflectance by 
spectrophotometry. One-way ANOVA at log (740nm) showed significant difference 
for hair spectrophotometry at 740nm (P=0.0009). Tukey-Kramer multiple 
comparisons showed pairwise comparison Hm vs WT (P=0.0027), Ht vs WT 
(P=0.0452). Hm vs Ht was not significant (P=0.2987). The results from the figure 
suggest a dosage effect although Hm vs Ht was not significant. With larger sample 
size, this might have showed significant changes. While there were variations in the 
results, overall this is compatible with a dosage effect. 
The spectrophotometry method may be a more powerful means to demonstrate 
dosage effect. The spectrophotometry data can be difficult to analyse, despite 
obvious striking difference between groups. Other groups (Australia, France) are 
beginning to try using principle component analysis technique (personal 
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communication, Professor J. L. Rees) to analyse. The analysis is beyond the remit of 
this thesis. Future work would aim to address this. 
 
6.2.3.3.5. Hair reflectance with MC1R genotype (R r 1-5) 
This classification separated the heterozygous for MC1R group into 3 groups (R r; R-
/rr; r-) i.e. 2, 3, 4 of the classification. Homozygous for MC1R was classified as 
group 1. Wildtype was classified the same as group 5. 
The division of hair reflectance spectrophotometry data into 5 MC1R R r 1-5 groups 
meant very few people in many subgroups. This in turn meant a loss of power and 
was therefore not performed. 
 
6.2.3.4. Hair colour group with MC1R genotype (Hm/Ht/WT) 




















Table 6.2.3.4. Relationship between MC1R genotype and hair colour 
(categorical) 
 
         Hm  Ht   WT  Missing  All 
black     0   4   23        1   28 
brown     0  20   51        1   72 
fair      1   9   24        0   34 
red      12   8    4        1   25 
All      13  41  102        3  159 
Hair colour was classified categorically. 
 
There was a significant association of hair colour with MC1R genotype (P<0.0001). 
Red hair individuals were more likely to be homozygous or heterozygous for MC1R. 
There was an obvious overrepresentation of Hm with red hair and also more Ht with 
red hair, therefore suggesting a heterozygous effect. 
 
6.2.3.4.2. Hair colour with MC1R genotype (R r 1-5) 






















This figure is for illustration only. Homozygosity for MC1R accounted for a large 
proportion of red hair. 
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6.2.3.5. Skin colour reflectance with MC1R genotype (Hm, Ht, WT) 
Does MC1R have any effect on skin colour? 
























The relationship between MC1R genotype and the mean of skin L* score. Higher L* values 
indicate lighter skin colour. Hm, homozygous for MC1R; Ht, heterozygous for MC1R; WT, 
wildtype or pseudo-WT. n=156 
 
Individuals homozygous or heterozygous for MC1R genotype has lighter skin colour 
i.e. greater L* score (P<0.0001). Pairwise comparison Hm vs WT (P=0.001). Ht vs 
WT significantly different (P=0.0019). Hm vs Ht not significant (P=0.3609). 
This is compatible with a dominant effect rather than a dosage effect. 
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The relationship between MC1R genotype and the mean of skin a* score. Higher a* values 
indicate greater redness in skin colour. Hm, homozygous for MC1R; Ht, heterozygous for 
MC1R; WT, wildtype or pseudo-WT. 
 
There was no significantly association with skin a* value with MC1R genotype status 
(P=0.6562). Skin a* appears not to be as useful a scale to use. Colorimetric a* scale 
may not be as informative. This is in keeping with the findings of Wagner et al 
(Wagner et al., 2002a). 
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The relationship between MC1R genotype and the mean of skin b* score. Higher b* values 
indicate greater shades of yellow in skin colour. Hm, homozygous for MC1R; Ht, 
heterozygous for MC1R; WT, wildtype or pseudo-WT. 
 
Individuals who are wildtype for the MC1R genotype have higher skin b* values i.e. 
more yellow (P=0.0016). Pairwise comparison Hm vs WT (P=0.0075), Ht vs WT 
(P=0.0313). Hm vs Ht not significant (P=0.3738). 
There is an effect, but what this effect represents in terms of actual clinical difference 
is not known. Colour is subjective and dependent on illumination. Nevertheless this 
is compatible with a recessive model. 
 
Table 6.2.3.5. ANOVA comparisons for relationship between MC1R genotype 
and skin colour L* a* b* 






Hm (n=13) 59.88 0.51 14.20 0.25 12.38 0.44 
Ht (n=41) 58.67 0.38 14.08 0.14 13.33 0.36 
WT (n=102) 56.89 0.30 14.22 0.08 14.38 0.23 
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 P value P value P value 
Hm-WT 0.001 0.9971 0.0075 
Hm-Ht 0.3609 0.8883 0.3738 
Ht-WT 0.0019 0.632 0.0313 
Summary of ANOVA comparisons for MC1R genotype and average skin colour L* a* b* 
values in 156 individuals. Pairwise estimates, SEM, and P values are shown for Hm-WT, 
Hm-Ht and Ht-WT comparisons for averaged skin colour L* a* b* readings. 
 
6.2.3.5.4. Skin colour reflectance with MC1R genotype (R r 1-5) 
As discussed before, the division into 5 groups meant a loss of power in testing and 
was not performed. 
 
6.2.3.6. MC1R genotype (Hm/Ht/WT) and eye colour groups 



















Table 6.2.3.6. Relationship between MC1R genotype and eye colour groups 
 
         Hm  Ht   WT  Missing  All 
blue      4  15   32        1   52 
brown     2  12   39        2   55 
green     4   9   14        0   27 
grey      1   2   12        0   15 
hazel     2   3    5        0   10 
All      13  41  102        3  159 
A contingency table of relationship between MC1R genotype and eye colour classified 
categorically into 5 different groups. 
 
There was no significant association with a particular eye colour with MC1R 
genotype (P=0.315) in this population sample, even with Hm and Ht combined 
(P=0.1751). The numbers presented and tested were small. Nevertheless blue eye 
colour accounted for the highest percentage of eye colour - 19 (35%) out of 54 
MC1R genotypes (homozygous and heterozygous combined). Eye colour was not 
significantly associated with MC1R SNP ‘R’ or ‘r’ when analysed together with 
other SNPs of candidate genes. The effect of MC1R on eye colour was not big. This 
may be due to the way of classification could be subjective. 
 
6.2.3.7. MC1R genotype (Hm RR, Hetero (Ht), WT) and skin type 
Does MC1R have any effect on skin type? 
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Table 6.2.3.7. Relationship between MC1R genotype and Fitzpatrick skin 
type 
       Hm  Ht   WT  Missing  All 
1       2   5    3        0   10 
2       6  13   15        1   35 
3       5  17   43        0   65 
4       0   5   29        1   35 
5       0   1   11        1   13 
6       0   0    1        0    1 
All    13  41  102        3  159 
A contingency table of relationship between MC1R genotype and skin type in terms of 
Fitzpatrick classification. 
 
MC1R genotype has a significant effect on skin type (P=0.002203), P=0.0002 with 
homozygous and heterozygous combined. 
 
Testing skin type 1-3 vs skin type 4-6: 
 Hm Ht WT 
Skin type 1-3 13 35 61 
Skin type 4-6 0 6 41 
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MC1R genotype has a significant effect on skin type 1-3 and 4-6 (P=0.0002). 
6.2.3.7.2. MC1R genotype (R r 1-5) and skin type 






















For illustrative purpose only. n=156. 
 
Skin type 1-3 comprises of individuals with MC1R group 1 (RR) genotypes. 
 
6.2.3.8. MC1R genotype (Hm/Ht/WT) and freckles 
Does MC1R have any effect on freckles (yes / no)? 
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Table 6.2.3.8. Relationship between MC1R genotype and freckles 
 
           Hm  Ht   WT  Missing  All 
No freckles   1  10   66        2   79 
Freckles     12  31   36        1   80 
All          13  41  102        3  159 
The presence of freckles was classified categorically. 
 
There was a significant association of MC1R genotype and the presence of freckles 
(P<0.0001). There was an obvious overrepresentation of Hm with freckles and also 
more Ht with freckles. MC1R appeared to have a dosage effect on freckling. Only 
35% WT had freckles, as compared to 76% Ht had freckles and 92% Hm had 
freckles. Freckling is a remarkably good measure of phenotype. 
 
6.2.3.8.2. MC1R genotype (R r 1-5) and freckles 
Does MC1R have any effect on freckles? 
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6.2.3.8.3. MC1R genotype (Hm/Ht/WT) and number of freckling sites 
Does MC1R have any effect on freckling sites? 
MC1R and number of freckling sites 
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Table 6.2.3.8.3. Relationship between MC1R genotype and number of 
freckling sites 
 
       Hm  Ht   WT  Missing  All 
0       1  10   66        2   79 
1       2   8   17        0   27 
2       3   7   10        1   21 
3       4  10    4        0   18 
4       2   3    3        0    8 
5       0   1    1        0    2 
7       1   2    1        0    4 
All    13  41  102        3  159 
The number of freckling sites was presented in absolute numbers. 
 
There was a significant association between MC1R genotype and number of 
freckling sites (P=9.598x10-7), P<0.0001 with homozygous and heterozygous 
combined. Homozygous and heterozygous for MC1R accounts for higher number of 
freckling sites. Wildtype for MC1R tends to have no freckling sites. 
 
6.2.3.8.4. MC1R genotype (R r 1-5) and number of freckling sites 
Does MC1R has any effect on freckling sites? 
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For illustrative purpose only. n=156. 
 
6.2.3.9. MC1R genotype (Hm/Ht/WT) and ethnicity 

















Table 6.2.3.9. Relationship between MC1R genotype and ethnicity 
 
                 Hm  Ht   WT  Missing  All 
Asian             0   0   15        0   15 
Mediterranean     0   3    3        2    8 
NEuropean        13  38   84        1  136 
All              13  41  102        3  159 
Ethnicity was classified categorically. Data was presented in numbers. 
 
There was a significant association between MC1R genotype and ethnicity (P=0.02). 
Individuals from Northern European descent were more likely to be Hm or Ht for 
MC1R genotype than Mediterranean or Asian. 
 
6.2.3.10. Red hair and MC1R sequence variants 
Table 6.2.3.10 Red hair and MC1R genotype Hm/Ht/WT 
 
       Hm  Ht   WT  Missing  All 
n       1  33   98        2  134 
y      12   8    4        1   25 
All    13  41  102        3  159 
 
There was a significant association between red hair status and MC1R genotype Hm 
Ht (P<0.0001). 
 Hm Ht WT 
Red hair 12 8 4 
Non-red hair 1 33 98 
ORs for red hair Hm vs WT = 245.74 (95%CI 27.1-12665.3) P<0.0001 
ORs for red hair Ht vs WT = 5.85 (95%CI 1.46-28.32) P=0.005 
 
D84E Hm Ht WT 
Red hair 0 1 4 
Non-red hair 0 2 98 
ORs for red hair Ht vs WT (D84E) = 12.25 (95%CI 0.2-268.4) P=0.1374 
 
R151C Hm Ht WT 
Red hair 1 13 4 
Non-red hair 0 11 98 
ORs for red hair Hm vs WT (R151C) = infinity (95%CI 0.5-infinity) P=0.0485 
ORs for red hair Ht vs WT (R151C) = 28.95 (95%CI 7.03-136.81) P<0.0001 
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R160W Hm Ht WT 
Red hair 1 10 4 
Non-red hair 0 13 98 
ORs for red hair Hm vs WT (R160W) = infinity (95%CI 0.5-infinity) P=0.0485 
ORs for red hair Ht vs WT (R160W) = 18.85 (95%CI 4.45-90.91) P<0.0001 
 
D294H Hm Ht WT 
Red hair 0 3 4 
Non-red hair 0 7 98 
ORs for red hair Ht vs WT (D294H) = 10.5 (95%CI 1.23-73.88) P=0.0151 
 
29insA Hm Ht WT 
Red hair 0 1 4 
Non-red hair 0 1 98 
ORs for red hair Ht vs WT (29insA) = 24.5 (95%CI 0.25-1940.25) P=0.0943 
One would expect this to be loss of function allele to be significant, but due to small 
number (1 out of 2 individuals who has red hair) there is little chance to expect this 
to be significant. 
 
V60L Hm Ht WT 
Red hair 0 2 4 
Non-red hair 3 33 98 
ORs for red hair Hm vs WT (V60L) = 0 (95%CI 0-74.37) P=0.889 
ORs for red hair Ht vs WT (V60L) = 1.48 (95%CI 0.13-10.88) P=0.4814 
 
V92M Hm Ht WT 
Red hair 0 1 4 
Non-red hair 1 30 98 
ORs for red hair Hm vs WT (V92M) = 0 (95%CI 0-965.25) P=0.9612 
ORs for red hair Ht vs WT (V92M) = 0.82 (95%CI 0.016-8.69) P=0.669 
 
R163Q Hm Ht WT 
Red hair 0 0 4 
Non-red hair 3 20 98 
ORs for red hair Hm vs WT (R163Q) = 0 (95%CI 0-74.37) P=0.889 
ORs for red hair Ht vs WT (R163Q) = 0 (95%CI 0-7.93) P=0.4838 
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R142H Hm Ht WT 
Red hair 0 1 4 
Non-red hair 0 1 98 
ORs for red hair Ht vs WT (R142H) = 24.5 (95%CI 0.25-1940.25) P=0.0943 
 
6.2.3.10. Summary of results presented in tables 
V60L variant was the commonest MC1R sequence variant found in this population, 
occurring in 38/156 (24%) (allelic frequency 12%). 1 individual heterozygous for 
V60L with a wildtype allele had red hair. The other individual was a compound 
heterozygous R151C with V60L (151/60). 
V92M variant was also quite frequent in this population, occurring in 31/156 (20%) 
(allelic frequency 9%). There was no significant association between V92M and red 
hair.  
ORs for red hair V92M = 0.1 (95%CI 0.0-1.0) P=0.0483. Only 1 individual with 
V92M had red hair, coupled with a wildtype allele (92/WT). 
None of the individuals heterozygous for R163Q variant had red hair. The 20 
individuals comprised 12 black, 5 brown and 3 fair hair. 
1 individual compound heterozygous for D84E and R151C (84/151) had red hair. 
The other 2 individuals were brown (84/WT) and fair hair (84/WT). 
Only 2 individuals had R142H variant. One was compound heterozygous for R151C 
(142/151) and had red hair. The other had brown hair and was heterozygous for 
R142H (142/WT). 
14 out of 24 red hair individuals sequenced were compound heterozygous (8 with 
other red hair alleles: 5 with R151C, 1 with D84E, 1 with R142H, 1 with D294H) or 
heterozygous for R151C (1 with V60L, 1 with 131, 1 with 279, 2 WT). 1 individual 
was homozygous for R151C. 11 other individuals heterozygous for R151C were 
non-reds. 5 were fair hair and 6 had brown hair. 1 fair hair individual was compound 
heterozygous for R160W (151/160). 4 other fair hair were heterozygous for R151C 
(1 with V60L, 1 with V92M, 2 WT). The brown hair individuals were heterozygous 
for R151C (1 with 60, 2 with 92, 3 WT). 
11 out of 24 red hair individuals sequenced were compound heterozygous (7 with 
other red hair alleles: 5 with R151C, 2 with D294H) or heterozygous for R160W 
(3WT). 1 individual was homozygous for R160W. 13 other individuals heterozygous 
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for R160W were non-reds. 3 were fair hair, 9 were brown and 1 had black hair. 1 of 
the 3 fair hair individuals was compound heterozygous for R160W with R151C. The 
other 2 were with V60L or WT. The 9 brown hair individuals were heterozygous for 
R160W (2 with V92M, 1 with R163Q, 1 with 212,230 and 5 WT). The black hair 
individual was heterozygous for R160W with WT. 
10 individuals were heterozygous for D294H. 3 had red hair were compound 
heterozygous for D294H with R151C (1 individual) or R160W (2 individuals). 3 
other individuals had brown hair. 3 had black hair and 1 had fair hair. 6 of these 
individuals were heterozygous for D294H (294/WT) except 1 brown hair individual 
who was heterozygous for V60L (294/60). 
Only 2 individuals had 29insA variant. One had red hair and the other fair hair. 
 
Table 6.2.3.10.2. Red hair and MC1R genotype R r 1-5 
 
        1  2   3   4   5  Missing  All 
n       1  4  32  26  69        2  134 
y      12  1   8   1   2        1   25 
All    13  5  40  27  71        3  159 
 
There was a significant association between red hair status and MC1R genotype 
classified by Rr status (P<0.0001). 
 
To assess the penetrance of MC1R red hair allelic variants (84, 142, 151,160, 294 
and 29insA) in this study, the proportion of individuals with 2 variants that have red 
hair were looked at. 
24 individuals out of 156 sequenced have red hair. 13 individuals were homozygous 
or compound heterozygous for 2 of these variants. 12 out of 13 of these had red hair. 
The individual that did not have red hair had MC1R variant of 151/160 (V81) and 
blonde hair. 5 out of 24 were heterozygous for 1 of the MC1R variants and only 1 out 
of 5 had red hair. Only 8 out of 40 had red hair with R– or rr alleles. 3 out of 98 who 
were wildtype for MC1R variants had red hair. 
Most instances when 84, 142, 151 and 160 are present, individuals have red hair. 294 
appeared to be a weaker red allele, giving strawberry blonde. This was in keeping 
with findings from previous studies. 160 and 294 together also gave a less red shade 
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i.e. auburn, suggesting perhaps 160 appeared to be weaker in exerting its red hair 
effect than 151. Although number of individuals involved was small. 
Volunteer 
number Red hair shade MC1R genotype 
MC1R classification 
(R r) 
V6 strawberry blonde 160/294 RR 
V25 strawberry blonde 151/294 RR 
V32 red 151/160 RR 
V66 red 151/160 RR 
V73 red 151/160 RR 
V87 red 84/151 RR 
V96 red 151/151 RR 
V106 red 151/160 RR 
V121 red 142/151 RR 
V30 auburn 160/294 RR 
V43 auburn 151/160 RR 
V108 auburn 160/160 RR 
V50 red 151/60 R- 
V33 strawberry blonde 29insA/314 R- 
V72 strawberry blonde 151/WT R- 
V136 red 160/WT R- 
V126 auburn strawberry blonde 151/WT R- 
V110 auburn 160/155+314 R- 
V120 auburn 151/131 R- 
V133 auburn 151/279 R- 
V143 auburn 160/WT R- 
V31 auburn 60/WT r- 
V47 red 92+314/WT -- 
V154 auburn WT/WT -- 
V35 red ? ? 
 
All individuals, except one, harbouring two RR allelic variants have red hair (12). 
This 1 individual (V81) was Hm for RR or a compound heterozygote (151/160) 
without red hair – with natural undyed blonde fair hair, blue grey eyes and of skin 
type 2. This was contrary to Smith et al, where no individuals harbouring two RR 
allelic variants did not have red hair (Smith et al., 1998). 
The reason for this is unclear – unless there was incorrect classification of hair 
colour. This individual definitely had blonde fair hair colour and not red hair. I 
looked back through my experimental records and confirmed that there were no 
mistakes in the classification of the hair colour. Similarly, I went back to the MC1R 
sequencing data and confirmed that there was no mix up of samples. 
The possibility of interaction of MC1R with other genes e.g. ASIP could be possible, 
contributing to the less red hair colour. 
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Was there any Ht without red hair? Yes, 33 individuals had R/r or R/WT – among 
these 4 had black hair, 20 had brown and 9 had fair hair. MC1R could possibly 
interact with ASIP. ASIP blocked the binding of α-MSH to the MC1R and inhibited 
the effects of α-MSH on human melanocytes (Suzuki et al., 1997). There is evidence 
that agouti signaling protein (ASIP) gene (8818G allele) is associated with darker 
skin color in African Americans (Bonilla et al., 2005). 
8 red haired individuals have one allelic variant R only. 4 red hair individuals had 
60r/WT, 92r/WT, 151R/60r or WT/WT. For the WT/WT individual, could it be due 
to a mutation outside the MC1R gene e.g. a promoter? 
 
6.2.3.11. MC1R genotype and blonde hair 
Table 6.2.3.11. Blonde hair and MC1R 
       Hm  Ht   WT  Missing  All 
n      12  36   89        3  140 
y       1   5   13        0   19 
All    13  41  102        3  159 
 
There was no significant association between blonde hair status and MC1R genotype 
(P>0.9999). 
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6.2.3.12. Erythemal flux and MC1R genotype Hm/Ht/WT 




























This shows back erythema flux and MC1R genotype (Hm/Ht/WT). Y-axis shows back 
erythema flux ± SEM (95% CI for the mean). X-axis shows the UVB doses (mJ/cm2). 
 
MC1R status did not make much difference to the erythemal flux for back. 
Do genes affect blood flow phenotype? No, MC1R did not contribute to back 
erythemal flux. One-way ANOVA for back erythema flux at dose 3 (300mJ/cm2) 
showed no significant difference (P=0.613). 
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6.2.3.12.2. Back erythemal flux and MC1R genotype Rr1-5 


































This shows back erythema flux and MC1R genotype (Rr1-5). Y-axis shows back erythema 
flux ± SEM (95% CI for the mean). X-axis shows the UVB doses (mJ/cm2). 
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This shows buttock erythema flux and MC1R genotype (Hm/Ht/WT). Y-axis shows buttock 
erythema flux ± SEM (95% CI for the mean). X-axis shows the UVB doses (mJ/cm2). 
 
MC1R homozygosity status contributed to the erythemal flux for buttock. One-way 
ANOVA for buttock erythema flux at dose 3 (300mJ/cm2) showed no significant 
difference (P=0.071). Do genes affect blood flow phenotype? No, MC1R did not 
contribute significantly to buttock erythemal flux. 
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6.2.3.12.4. Buttock erythemal flux and MC1R genotype Rr1-5 






































This shows buttock erythema flux and MC1R genotype (Rr1-5). Y-axis shows buttock 
erythema flux ± SEM (95% CI for the mean). X-axis shows the UVB doses (mJ/cm2). 
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6.2.3.12.5. Erythemal Index (EI) and MC1R genotype Hm/Ht/WT (back) 


























This shows back erythema index and MC1R genotype (Hm/Ht/WT). Y-axis shows back 















One-way ANOVA for back erythema EI at dose 3 vs MC1R Genotype Hm/Ht/WT 
showed no significant difference (P=0.169). 
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6.2.3.12.6. Back Erythema Index and MC1R genotype Rr1-5 





























This shows back erythema index and MC1R genotype (Rr1-5). Y-axis shows back erythema 
index ± SEM (95% CI for the mean). X-axis shows the UVB doses (mJ/cm2). 
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6.2.3.12.7. Buttock Erythema Index and MC1R genotype Hm/Ht/WT 
































This shows buttock erythema index and MC1R genotype Hm/Ht/WT. Y-axis shows buttock 
















One-way ANOVA for buttock erythema EI at dose 3 vs MC1R genotype Hm/Ht/WT 
showed no significant difference (P=0.091). 
 































This shows buttock erythema index and MC1R genotype (Rr1-5). Y-axis shows buttock 















One-way ANOVA for back erythema EI at dose 3 vs MC1R genotype R r 1-5 

















One-way ANOVA for buttock erythema EI at dose 3 vs MC1R genotype R r 1-5 
showed just significant difference (P=0.0408). Tukey-Kramer multiple pairwise 
comparisons between Hm, Ht or WT showed no significant differences. 
 
Table 6.2.3.12. ANOVA comparisons for relationship between MC1R 
genotype and erythema 
 Back Erythema EI 
Mean SEM 
Buttock Erythema EI 
Mean SEM 
Hm (n=8) 155 14 142 9 
Ht (n=33) 141 7 127 7 
WT (n=57) 129 5 107 6 
 P value P value 
Hm-WT 0.2328 0.109 
Hm-Ht 0.6673 0.6676 
Ht-WT 0.4052 0.1255 
Summary of ANOVA comparisons for MC1R genotype and erythema in terms of change in 
erythemal index (EI) 24 hours after UVB irradiation (dose 3) in 98 individuals. Pairwise 
estimates, SEM, and P values are shown for Hm-WT, Hm-Ht and Ht-WT comparisons for 
averaged change in EI readings. 
 
6.2.3.13. MC1R genotype and tanning 
Does MC1R have an effect on tanning? 
This initial figure was plotted: 
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Figure 6.2.3.13.1. MC1R genotype (Hm/Ht/WT) and tanning by change in L* 

































This shows tanning on back and buttock and MC1R genotype (Hm/Ht/WT). Y-axis shows 
back or buttock tanning (change in L*) ± SEM (95% CI for the mean). X-axis shows the 3 
UVB doses (mJ/cm2): 95 (dose 1), 189 (dose 2) and 300 (dose 3). 
 
Then dose 3 and L* were looked at more closely: 
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One-way ANOVA for back tanning L* at dose 3 vs MC1R genotype Hm/Ht/WT 
showed no significant difference (P=0.1627). Individuals who were homozygous for 
MC1R appear to tan less over their back than those who were heterozygous or 
wildtype (see Table 6.2.3.13). The difference was not statistically significant. 
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MC1R genotype has no significant effect of tanning / facultative pigmentation on 
buttock as measured by the change in L* (P=0.57). One-way ANOVA for buttock 
tanning L* at dose 3 vs MC1R Genotype Hm/Ht/WT showed no significant 
difference (P=0.5699). 
 
Table 6.2.3.13. ANOVA comparisons for relationship between MC1R 
genotype and tanning 
 Back Tanning L* 
Mean SEM 
Buttock Tanning L* 
Mean SEM 
Hm (n=8) 4.42 0.48 4.81 0.85 
Ht (n=33) 6.11 0.49 4.33 0.62 
WT (n=57) 6.70 0.48 3.78 0.40 
 P value P value 
Hm-WT 0.1526 0.665 
Hm-Ht 0.3822 0.9206 
Ht-WT 0.683 0.7094 
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Summary of ANOVA comparisons for MC1R genotype and tanning in terms of change in 
skin colour L* values 7 days after UVB irradiation (dose 3) in 98 individuals. Pairwise 
estimates, SEM, and P values are shown for Hm-WT, Hm-Ht and Ht-WT comparisons for 
averaged change in L* readings. 
 
Similar results were found with MC1R genotype (R r 1-5) and also with MI. 
The following graphs were plotted as illustration. 
 
Figure 6.2.3.13.4. MC1R genotype (R r 1-5) and tanning by change in L* a* 





























back, a* back, b* back, L*









This shows tanning on back and buttock and MC1R genotype (R r 1-5). Y-axis shows back 
or buttock tanning (change in L*, a* or b*) ± SEM (95% CI for the mean). X-axis shows the 3 

































This shows tanning on back and buttock and MC1R genotype (R r 1-5). Y-axis shows back 
or buttock tanning (change in L*) ± SEM (95% CI for the mean). X-axis shows the 3 UVB 



















One-way ANOVA for back tanning L* at dose 3 vs MC1R genotype R r 1-5 showed 


























One-way ANOVA for buttock tanning L* at dose 3 vs MC1R genotype R r 1-5 
showed no significant difference (P=0.57). 
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6.2.3.14. MC1R genotype (Hm/Ht/WT) and tanning by MI (back and buttock) 





























This boxplot shows tanning on back and buttock and MC1R genotype (Hm/Ht/WT). Y-axis 
shows back or buttock tanning (change in MI) ± SEM (95% CI for the mean). X-axis shows 
the 3 UVB doses (mJ/cm2): 95, 189 and 300; and MC1R genotype (Hm/Ht/WT). Centre bar = 
median. 
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This shows tanning on back and buttock and MC1R genotype (R r 1-5). Y-axis shows back 
or buttock tanning (change in MI) ± SEM (95% CI for the mean). X-axis shows the 3 UVB 
doses (mJ/cm2): 95, 189 and 300; and MC1R genotype (R r 1-5). Centre bar = median. 
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6.2.4. Correlation of MC1R genotype with phenotypic characteristics 
6.2.4.1. MC1R sequence variants and hair colour 
In the irradiated group, 16 individuals (16 out of 98, 16%) had red hair. One 
individual had no known MC1R sequence variant associated with her red hair. 
Volunteer 
number Hair colour MC1R genotype R r classification   
V32  red  151/160  RR Hm   
V96  red  151/151  RR Hm   
V106  red  151/160  RR Hm   
V121  red  142/151  RR Hm  
V6  strawberry blonde  160/294  RR Hm  
V25  strawberry blonde  151/294  RR Hm   
V143   auburn   160/160  RR Hm   
V30  auburn  160/294  RR Hm   
V33  strawberry blonde  29insA/WT  R- Ht   
V110  auburn  160/WT  R- Ht   
V120  auburn  151/WT  R- Ht  
V126  auburn 151/WT  R- Ht   
V133  auburn   151/WT  R- Ht   
V136   red  160/WT  R- Ht   
V31  auburn  60/WT  r- Ht   
V154   auburn   WT/WT  -- WT  
 
6.2.4.2. Penetrance of MC1R sequence variants for red hair 
It appeared that the R160W sequence variant might be less potent for red hair. 2 
individuals with 60/WT and WT/WT alleles have auburn hair.  
 
6.3. Discussion 
The MC1R sequence variants found in the 159 individuals in the population were in 
keeping with previous studies. Four novel MC1R sequence variants V51A, I63M, 
S131N and A212S were found. The MC1R allelic frequency of this study was 
comparable to a previous study (Flanagan et al., 2000). MC1R homozygosity was 
associated with lighter hair colour (higher L* value), also higher a* and b* values. 
MC1R on hair spectrophotometric reflectance revealed a dominant effect for Hm and 
Ht on WT. However, the results from the figure suggest a dosage effect although Hm 
vs Ht was not significant. With larger sample size, this might have showed 
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significant changes. While there were variations in the results, overall this is 
compatible with a dosage effect. This spectrophotometric method may be more 
powerful to demonstrate dosage effect than L* a* b*. The effect of MC1R genotype 
on red hair colour group was consistent with a dosage or heterozygous effect. 
MC1R homozygosity and heterozygosity was associated with lighter skin colour 
(higher L* value) and was compatible with a dominant effect. 
There were some inconsistencies with the above MC1R results when compared with 
previous work (Flanagan et al., 2001; Naysmith et al., 2004). Some findings e.g. hair 
spectrophotometry, skin L* are compatible with a dominant effect (i.e. Ht with Hm 
vs WT). In other findings e.g. hair a* were compatible with a recessive effect (i.e. Ht 
with WT vs Hm). In other word, Ht was either like Hm or WT, dependent on a 
particular trait. 
The most likely explanation for this is due to the power of testing and that this was 
an unselected group rather than a population that had been enriched for MC1R 
variants (Naysmith et al., 2004). Sample size, different population of study and 
variability may play a role. A larger sample size may answer any future questions. 
The effect of MC1R on eye colour was small. However MC1R has an effect on skin 
type (P=0.0002). One cautionary point to highlight was that the way I administered 
the questionnaire to obtain skin type data, as this is subjective measure, and different 
to others. Rampen et al argued that skin type was not reproducible (Rampen et al., 
1988).  
MC1R homozygosity and heterozygosity were significantly associated with the 
presence of freckling (P<0.0001) and the number of freckling sites (P<0.0001). 
There appeared to be a dosage effect on freckling. This was expected, as MC1R is 
associated with individuals with red hair (P<0.0001) and fairer skin (P<0.0001). 
These results were similar with the findings from previous studies (Bastiaens et al., 
2001a; Duffy et al., 2004; Flanagan et al., 2000; Smith et al., 1998). 
 
I confirmed the high ORs of having red hair if an individual was Hm for MC1R vs 
WT = 245.74 (95%CI 27.1-12665.3) P<0.0001 and the ORs of having red hair if the 
individual was Ht for MC1R vs WT = 5.85 (95%CI 1.46-28.32) P=0.005. I also 
showed the ORs for red hair for having different red hair MC1R sequence variants. 
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These were consistent with previous findings from Sturm et al that D84E, R151C, 
R160W, and D294H, are strongly associated with red hair and fair skin with 
multinomial regression analysis showing odds ratios of 63, 118, 50, and 94, 
respectively. An additional three low-penetrance alleles V60L, V92M, and R163Q 
have odds ratios 6, 5, and 2 relative to the wild-type allele (Sturm et al., 2003). D84E 
and D294H have previously been shown to have lower cAMP response and slightly 
impaired binding ability (Ringholm et al., 2004). R142H has also been shown to not 
signal very well functionally (Schioth et al., 1999). The number of individuals with 
this MC1R variant was small. Despite this, the results were in keeping with what was 
expected. 
The effect of MC1R on hair colour was larger than on skin colour. MC1R has no 
effect on back or buttock erythema index, but buttock EI was approaching 
significance Hm/Ht/WT (P=0.091), Rr1-5 (P=0.041). Similarly, the effect of MC1R 
on erythema flux was not significant for the back (P=0.613, ANOVA). However it 
was approaching significance for the buttock (P=0.071, ANOVA). Individuals with 
paler skin do develop more erythema (Chapter 4.2.1.2.7, P=1.29×10-6). Although the 
effect of MC1R on erythema was not statistically significant, the findings are in 
keeping with Flanagan et al (Flanagan et al., 2001) that the gradient of the dose 
response curve was steeper for reds, but a subtler effect. 
MC1R has no significant effect for back or buttock tanning (P>0.05). MC1R did not 
have a large effect on single UVB dose-induced tanning. MC1R does not have an 
effect/less effect on single dose erythema, but determines repeated UVB-induced 
tanning (Healy et al., 2000). Repeated UVB doses could be used in further 
experiments to investigate the effect, but there may be more confounding variables. 
 
When this study was first designed, the belief was that objective scoring of 
phenotypes may be better in elucidating the relationship between genotypes e.g. 
MC1R and erythema and facultative pigmentary responses. The results presented 
here showed that the effect of MC1R on skin phenotype is small. There was a trend 
but it was not formally significant. I confirmed that hair colour is associated with 
MC1R, in keeping with previous studies (Duffy et al., 2004; Naysmith et al., 2004). 
Skin colour measurements are not as informative as hair with respect to MC1R. 
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Noise in the system, measurement errors were possible explanation for the different 
results. 
In fact skin type or freckling alone or in combination is better than other quantitative 
measures. 
However, previous studies compared extremes of population with particular 
characteristics e.g. reds vs non-reds to demonstrate difference by using quantitative 
assays. In a relatively homogenous unselected population, these assays did show a 
trend quantitatively, yet not statistically significant. 
There was no strong effect of MC1R on skin on its own. Although technically 
possible yet unlikely given the weakness of effect of MC1R on skin, this was not 
added into a linear regression equation as this is unlikely to add to phenotype. This is 
in keeping with other studies (Dwyer et al., 2004) that genotype information did not 
add to phenotype. 
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Chapter 7 Other Genotypes 
 
7.1. Introduction 
In this chapter I will present genotype data from 34 other candidate loci other than 
MC1R from this study. I will discuss the rationale of candidate gene approach and 
the selection of relevant SNPs in the candidate genes. Genotype results will be 
presented in section 7.2 and discussed in section 7.3. 
 
7.1.1. Candidate gene approach 
MC1R has been shown to be a key determinant of pigmentary phenotype (Box et al., 
1997; Flanagan et al., 2000; Healy et al., 2000; Schioth et al., 1999). Recently a 
number of other genes have been implicated in human pigmentation (Lamason et al., 
2005; Norton et al., 2007; Sulem et al., 2007). A candidate gene approach that can 
test the effects of these genetic variants of potentially implicated loci in human 
pigmentation would be useful. The genotype information obtained could be 
correlated with phenotypic traits. 
 
7.1.2. Candidate gene selection 
The choice of suitable candidate genes relied upon a detailed literature search of 
genes implicated in human pigmentation. Genes encoding different enzymes 
involved in the MC1R signalling pathway and downstream of MC1R were also 
chosen. This resulted in 34 other candidate loci selected. 
It was not possible to sequence all the 35 genes, due to time and financial constraints. 
Two of the genes MC1R and POMC were sequenced whole. For the other 33 
candidate genes, suitable polymorphisms needed to be selected for testing which 
would represent the whole gene of interest (i.e. tagging SNPs). The validity of this 
approach using tagging SNPs has been evaluated previously (Montpetit et al., 2006; 
Tenesa and Dunlop, 2006). 
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7.1.3. List of candidate genes 
There were a total of 34 other candidate genes chosen on the basis of genes that were 
reported to play a role in pigmentation and from the melanin biosynthesis and 
metabolism pathway. 
 
The candidate genes were ASIP, BLOC1S3, CYP1A2, CYP2C8, CYP4B1, 
DCT/TYRP2, DTNBP1, ERCC1, ERCC2, ERCC3, ERCC4, ERCC5, ERCC6, 
ERCC8, GNAS, GPR143, HPS1, HPS3, HPS4, HPS5, HPS6, KIT, KITLG, MATP, 
MITF, MYO5A, OCA2, PRKAR1A, SLC24A5, SOX10, TP53, TYR, TYRP1 and 
POMC (Table 7.1.3.). 
 
Table 7.1.3. List of 34 Candidate Genes 
Gene Name OMIM Chromosome 
ASIP Agouti Signaling Protein 600201 20q11.2 
BLOC1S3 Biogenesis of Lysosome-
related Organelles Complex 
1, Subunit 3 
609762 19q13 
CYP1A2 Cytochrome P450, 
Subfamily I, Polypeptide 2 
124060 15q22-qter 
CYP2C8 Cytochrome P450, 
Subfamily IIC, Polypeptide 
8 
601129 10q23.3 
CYP4B1 Cytochrome P450, 
Subfamily IVB, Member 1 
124075 1p34-p12 





Protein 1 / Hermansky-
Pudlak Syndrome 7 
607145 6p22.3 
ERCC1 Excision Repair Cross-
Complementing rodent 
repair deficiency 
complementation group 1 
126380 19q13.2-q13.3 
ERCC2 Excision Repair Cross-
Complementing rodent 
repair deficiency 
complementation group 2 / 
XPD 
126340 19q13.2-q13.3 





complementation group 3 
/XPB 
ERCC4 Excision Repair Cross-
Complementing rodent 
repair deficiency 
complementation group 4 
133520 16p13.3-p13.13 
ERCC5 Excision Repair Cross-
Complementing rodent 
repair deficiency 
complementation group 5 / 
XPG 
133530 13q33 
ERCC6 Excision Repair Cross-
Complementing rodent 
repair deficiency 
complementation group 6 
609413 10q11 
ERCC8 Excision Repair Cross-
Complementing rodent 
repair deficiency 
complementation group 8 
609412 5q12 
GNAS Guanine Nucleotide-binding 
protein, Alpha-Stimulating 
139330 20q13.2 
















KIT KIT Oncogene 164920 4q12 




Transporter Protein /  
Solute Carrier Family 45, 







MYO5A Myosin VA 160777 15q21 
OCA2 Oculocutaneous Albinism, 
Type II / P gene 
611409 15q11.2-q12 




Type I, Alpha 
SLC24A5 Solute Carrier Family 24 
(Sodium/Potassium/Calcium 
Exchanger), Member 5 /  
NCKX5 
609802 15q21.1 
SOX10 SRY-Box 10 
 
602229 22q13 
TP53 Tumour Protein p53 191170 17p13.1 
TYR Tyrosinase 606933 11q14-q21 
TYRP1 Tyrosinase-Related Protein 
1 / Oculocutaneous 
Albinism, Type III 
115501 9p23 
POMC Proopiomelanocortin 176830 2p23.3 
Source: OMIM (www.ncbi.nlm.nih.gov/sites/entrez?db=omim) 
 
7.1.4. Selection of SNPs in candidate gene loci 
SNPs from the 33 candidate genes were screened using data from the International 
HapMap project (www.hapmap.org) (2003; 2005; Couzin, 2002) for tagging SNPs to 
represent the whole candidate gene, which are in linkage disequilibrium with other 
tagging SNPs for the candidate gene. 
HapMap provides linkage disequilibrium (LD) information on SNPs that can be used 
for tagging SNP selection. Tagging SNPs are SNPs that are representative of a gene 
that is in high linkage disequilibrium. By using tagging SNPs, it is therefore not 
necessary to genotype all the SNPs present in candidate loci of interest. 
A haplotype is a haploid genotype. It represents a combination of alleles at multiple 
linked loci that are transmitted together on the same chromosome or set of SNPs that 
are statistically associated. These associations and alleles of a haplotype block can 
identify all polymorphic sites in the region. The programme Haploview was used 
within HapMap. Other database consulted include NCBI dbSNP database 
(www.ncbi.nlm.nih.gov/projects/SNP). 
 
The initial number of SNPs from all the 33 candidate loci was around 10000. Due to 
time and financial contraints, not all SNPs could be typed. A maximum of 384 SNPs 
could be included and genotyped using the Illumina platform. The process of fine-
tuning involved setting screening criteria by frequency in Caucasian population, 
published SNPs and using the Illumina screening tool to see whether the chosen SNP 
was suitable for the final microarray chip or interfere with another SNP. A 
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GoldenGate score was obtained for each SNP from Illumina. This is a validation 
status score for a SNP that has previously been successfully generated genotype 
results on the Illumina platform. 
 
A total of 384 haplotype tagging-SNPs were selected from introns and exons in 33 
genes from the HapMap database together with those reported in the literature were 
included. The 384 SNPs were chosen finally to run on Illumina bead array. The 
Scottish population was genotyped with all 384 SNPs using Illumina technology. 
The final 384 SNPs selected were submitted to Wellcome Trust Clinical Research 
Facility Technical Service. The 384 SNPs selected from 33 candidate gene loci for 
Illumina genotyping are detailed in Appendix 6. The rationale of Illumina 
genotyping was discussed in Chapter 2. 
  
7.1.5. Genotype analysis software - PLINK 
A whole genome association analysis toolset PLINK [version 0.99r, 
pngu.mgh.harvard.edu/purcell/plink (Purcell et al., 2007) was used to analyse the 
genotype data obtained from Illumina. PLINK is a user friendly, free, open-source 
whole genome association analysis toolset that allows for large-scale analyses in a 
computationally efficient manner and was developed at the Center for Human 
Genetic Research, Massachusetts General Hospital and the Broad Institute of 
Harvard and Massachusetts Institute of Technology. 
In brief, genotype and phenotype data were coded to form the following files: 
--pheno Phenotype 
--ped   PED Pedigree 
--map   MAP 
--snps   SNP list 
--hardy   Hardy-Weinberg disequilibrium tests (exact)  
Exact test was performed within the programme PLINK to estimate any departure 
from Hardy-Weinberg equilibrium (HWE) proportions (Wigginton et al., 2005). 
Eye colour was analysed categorically. The phenotypes hair colour L* a* b*, skin 
colour L* a* b*, Tanning L* at dose 3, Erythema at dose 3 were analysed using 
quantitative trait association analysis option: 
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--assoc --perm 
which generates results under headings: CHR (Chromosome), SNP (SNP ID), 
CHISQ (Association chi-square), P (Asymptotic P-value), EMP1 (Empirical P-value 
adaptive) and NP (Number of permutations performed for this SNP). 
--adjust  Adjustment for multiple testing: Bonferroni correction, False Discovery 
Rate (FDR) and Sidk. 
7 SNPs failed frequency test (MAF < 0.01), there are 343 SNPs after frequency and 
genotyping pruning. Corrected significance values (FDR, Sidak etc) were computed. 
Multiple-test corrected significance values were shown. Adaptive permutation was 
performed. 
 
7.2. Genotyping results 
7.2.1. POMC sequence results 
Sequencing results were unavailable for 1 individual. 1 published SNP (rs8192605 
C-T) within POMC exon 2 was found. No other sequence variations or 
polymorphisms were identified for POMC (exons 1-3) genotypes. 
 
7.2.2. Genotypes and hair colour 
Table 7.2.2. Genotype associations between SNPs and quantitative 
measures of hair colour L* and a* 
Gene Chromosome Position SNP Minor Allele MAF HWE 
P-value 




int 5 rs2254913 A 0.37 0.08 0.007 0.04 
int 8 rs6785780 T 0.41 0.86 0.03 0.0003 
int 13 rs7636389 A 0.07 0.43  0.03 
HPS3 3 
int 15 rs2681092 T 0.38 0.85 0.03 0.02 
int 1.1 rs2237034 A 0.11 1  0.04 KIT 4 
int 1.2 rs2237032 G 0.19 0.57  0.04 
MATP 5 int 2 rs3756464 T 0.41 0.27 0.03  
int 1 rs1474605 G 0.17 0.51 0.03  
int 4 rs2619545 C 0.16 0.51 0.03  
int 6 rs6909929 A 0.43 0.72 0.046  
DTNBP1 6 
exon 10 (S272P) rs17470454 A 0.05 0.24 0.03  
int 5 rs1934980 C 0.16 0.74  0.02 CYP2C8 10 
int 8 rs11572177 G 0.30 0.41  0.04 
HPS1 10 int 10 rs1061135 T 0.49 0.05  0.04 
HPS6 10 exon 1 rs3737243 A 0.07 1 0.04  
Tyr 11 int 3 rs12421746 T 0.01 1 0.02 0.048 
int 1.1 rs1492354 A 0.07 1  0.0005 
int 1.2 rs1907702 G 0.20 0.40  0.04 
KITLG 12 
int 1.3 rs10777129 A 0.08 1 0.03 0.004 
int 1.1 rs7495174 G 0.05 0.24 0.01  OCA2 15 
int 1.2 rs7174027 A 0.06 0.35 0.004  
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int 2.1 rs7179994 G 0.14 1  0.03 
int 2.2 rs1597196 T 0.15 0.74  0.03 
int 2.3 rs12442147 C 0.11 1 0.01 0.04 
int 2.4 rs12324648 A 0.07 1 0.04 0.04 
int 2.5 rs4778232 T 0.19 0.78  0.04 
int 3 rs13329466   0.41  0.02 
int 23.1 rs2311470 C 0.50 1  0.045 
int 23.2 rs6497235 A 0.50 0.30  0.007 
int 23.3 rs6497233 T 0.41 0.47  0.01 
int 23.4 rs17674017 G 0.42 0.28  0.006 
int 23.5 rs1498509 C 0.49 0.86  0.03 
int 23.6 rs11631195 A 0.37 0.85 0.03 0.006 
int 23.7 rs3947367 G 0.29 0.28 0.03  
int 23.8 rs11637518 G 0.35 1  0.03 
int 23.9 rs989869 C 0.38 0.06 0.04  
  
int 23.10 rs1603784 A 0.23 0.13 0.01  
 R C-fitive 0.21 0.19  0.000001 
 Mc1r C-fitive 0.48 0.62  0.003 
MC1R 16 
 rlit C-fitive 0.23 1   
3' UTR rs6958 C 0.32 0.31  0.047 
int 2 rs2952275 T 0.36 0.24 0.02  
PRKAR1A 17 
5' UTR rs8080306 C 0.27 0.65 0.02  
int 3 rs2295583 T 0.28 0.37 0.02  
int 5 rs3730168 A 0.41 0.14 0.03  
Gnas 20 
int 6 rs919197 T 0.43 0.77 0.03  
HPS4 22 int 5 rs17401652 T 0.10 1  0.046 
This table shows the gene, chromosome, position, SNP, minor allele frequency (MAF), 
Hardy-Weinberg Equilibrium (HWE), hair L* and Hair a* P-values. Intron (int). Untranslated 
region (UTR). Reference SNP (rs). Only quantitative hair data is shown, categorical hair data 
not shown. Associations shown were from Northern European individuals only. 
 
HPS3 
5 SNPs (rs2254913, rs6785780, rs7636389, rs2681092 and rs2689230) were 
associated with hair colour (lighter) in HPS3 gene. The most significant association 
is at intron 8 (rs6785780) of HPS3 with hair L* (P=0.03), with hair a* (P=0.0003). 
This is still significant after Bonferroni correction. HPS3 SNP rs6785780 is also 
significantly associated with red hair (P=0.008101). Intron 5 (rs2254913) of HPS3 
was significantly associated with hair L* (P=0.007) and hair a* (P=0.04). Intron 13 
(rs7636389) of HPS3 was significantly associated with hair a* (P=0.03). Intron 15 
(rs2681092) of HPS3 was significantly associated with hair L* (P=0.03) and hair a* 
(P=0.02). High linkage disquilibrium (LD) was observed between the 5 tagging 
SNPs. HPS3 SNPs rs2254913, rs2681092 and rs2689230 were associated with fair 




3 SNPs (rs1492354, rs1907702 and rs10777129) in intron 1 of KITLG gene were 
associated with hair colour (lighter). The significant associations were between 
rs1492354 with hair a* (P=0.0005). This is still significant after Bonferroni 
correction. Intron 1.2 (rs1907702) of KITLG was associated with hair a* (P=0.04). 
Intron 1.3 (rs10777129) of KITLG was associated with hair L* (P=0.03) and hair a* 
(P=0.004). The LD is high between these markers. MAF were low (7-20%). 
 
OCA2 
OCA2 intron 1: both SNPs (rs7495174, rs7174027) in intron 1 were associated with 
hair colour L* (P=0.01, P=0.004). 
3 SNPs (rs7179994, rs1597196 and rs12324648) in intron 2 were associated with 
hair colour L* (P=0.01-0.04) and hair a* (P=0.03-0.04). 
1 SNP (rs13329466) in intron 3 were associated with hair colour a* (P=0.02). 
5 SNPs (rs17674017, rs1498509, rs11631195, rs989869 and rs1603784) in intron 23 
were associated with hair colour L* (P=0.01-0.04) and hair a* (P=0.006-0.01). 
 
TYR 
1 SNP (rs12421746) in intron 3 of TYR gene was associated with hair colour L* 
(P=0.02) and hair a* (P=0.048). TYR SNP rs16913107 was associated with dark hair 
(P=0.02686, OR=7.7) or dark vs fair hair (P=0.03916, OR=9.0). 
 
MATP 
1 SNP (rs3756464) in intron 2 of MATP gene was associated with hair colour L* 
(P=0.03). MATP SNP (rs16891982) was associated with dark vs fair hair 
(P=0.008574, OR=27.7). This is in keeping with a known population marker. 
 
KIT 
2 SNPs (rs2237034 and rs2237032) in intron 1.1 and 1.2 of KIT gene were associated 




4 SNPs (rs1474605, rs2619545, rs6909929 and rs17470454) in intron 1, 4, 6, exon10 




2 SNPs (rs1934980 and rs11572177) in intron 5 and 8 of CYP2C8 gene were 
associated with hair colour a* (P=0.02, P=0.04). 
 
HPS1 












MC1R SNP “R” was associated with hair colour a* (P=0.000001). This is still 
significant after Bonferroni correction. MC1R SNP “Mc1r” i.e. WT was associated 
with hair colour a* (P=0.003). 
 
PRKAR1A 
3 SNPs (rs6958, rs2952275 and rs8080306) in 3’ UTR, intron 2, 5’ UTR of 
PRKAR1A gene were associated with hair colour. 3’ UTR (rs6958) of PRKAR1A was 
associated with hair a* (P=0.047). Intron 2 (rs2952275) and 5’ UTR (rs8080306) of 




3 SNPs (rs2295583, rs3730168 and rs919197) in intron 3, 5, 6 of GNAS gene were 
associated with hair colour L* (P=0.02, P=0.03, P=0.03). 
 
7.2.3. Genotypes and eye colour 





light vs dark Brown vs blue Brown vs otherGene Chr SNP Positon Min A MAF HWE 
P-values P-values OR P-values OR P-values OR 
rs7643410 int 1 G 0.08 0.55      0.04 2.9 
rs2254913 int 5 A 0.37 0.08 0.006 0.03 1.7 0.003 2.6 0.01 1.9 
rs2689229 int 5 A 0.46 1 0.01 0.02 1.8 0.004 2.5   
rs2689230 int 5 G 0.23 1 0.04 0.046 2.2 0.02 2.6 0.04 2.1 
rs2689234 int 6 G 0.49 0.72 0.03   0.009 2.3   
rs6785780 int 8 T 0.41 0.86 0.03   0.02 2.3   
HPS3 3 
rs2681092 int 15 T 0.38 0.85 0.02   0.01 2.3 0.04 0.5 
KIT 4 rs17084733 3' UTR A 0.11 1    0.02 4.3 0.04 3.6 
DTNBP1 6 rs9476886 int 1 T 0.28 0.12    0.04 2.4   
rs4647128 int 10 G 0.03 1 0.04 0.02 6.1     
ERCC8 5 
rs4235483 int 9 A 0.44 0.59  0.04 1.7     
ERCC6 10 rs4253231 3'UTR C 0.09 1 0.007 0.003 3.6 0.08 2.8 0.01 3.0 
CYP2C8 10 rs11572177 int 8 G 0.30 0.41      0.04 1.9 
DCT 13 rs9584233 int 6 T 0.11 1    0.03 3.4 0.03 2.4 
rs7495174(a) int 1.1 G 0.05 0.24 0.001* 0.006 6.3 0.003 NA 0.009 5.9 
rs7174027 int 1.2 A 0.06 0.35 0.009  3.1 0.003 NA 0.03 3.3 
rs7179994(a) int 2.1 G 0.14 1 0.03   0.03 3.1 0.04 2.3 
rs1597196(a) int 2.2 T 0.15 0.74 0.008 0.03 2.0 0.008 3.6 0.02 2.4 
rs1470608 int 2.3 A 0.10 1      0.046 2.3 
rs12324648 int 2.4 A 0.07 1 0.006 0.04 2.9 0.009 5.2 0.004 4.1 
rs3794604(a) int 4 A 0.08 0.55 0.03  2.5 0.04 3.8 0.006 3.7 
rs746861 int 6 C 0.45 0.37  0.02 1.8     
rs7176632 int 16 T 0.18 0.76 0.0003 0.0008 2.9 0.0008 5.0 0.01 2.3 
rs7173419 int 18.1 T 0.27 0.37 0.01 0.02 2.1 0.046 2.2   
rs2594938 int 18.2 C 0.26 0.50 0.01 0.02 2.0 0.02 2.3   
rs1562592 int 18.3 T 0.17 0.36 5.21E-05* 4.12E-05* 3.7 0.0009 4.2 0.0009 2.9 
rs1448490 int 18.4 A 0.16 0.09 0.03 0.02 2.8 0.009 7.0 0.002 8.6 
rs17674017 int 23.1 G 0.42 0.28 0.008 0.04 1.9 0.03 2.2   
rs1498509 int 23.2 C 0.49 0.86 0.03   0.04 2.0   
rs11631195 int 23.3 A 0.37 0.85 0.04   0.04 2.0   
rs989869 int 23.4 C 0.38 0.06 0.02       
rs1603784 int 23.5 A 0.23 0.13 0.01   0.03 2.6   
rs11074304 int 23.6 A 0.42 0.006 0.04   0.04 2.2   
OCA2 15 
rs11074317 int ? A 0.17 0.76    0.02 3.5 0.002 0.2 
GNAS 20 rs4810147 int 1 A 0.49 0.86 0.02   0.004 2.6 0.04 1.8 
This table shows the gene, chromosome (Chr), position, SNP, minor allele (Min A), minor 
allele frequency (MAF), Hardy-Weinberg Equilibrium (HWE), eye colour groups. Intron (int). 
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Untranslated region (UTR), reference SNP (rs), odds ratio (OR). Eye colour was classified 
according to Frudakis et al (Frudakis et al., 2003) into 1) colours (quantitative) - all four 
colours blue/green/hazel/brown 2) shades light (blue/green) vs dark (hazel/brown) 3) brown 




7 SNPs of HPS3 are associated with eye colour. SNPs (rs2254913, rs2689229, 
rs2689230, rs2689234, rs6785780, rs2681092) were significantly associated with 
quantitative eye colours (P=0.006-0.04), brown vs blue (P=0.003-0.02, OR=2.3-2.6) 
and brown vs other (P=0.01-0.04, OR=1.9-2.1). HPS3 SNP rs7643410 was 
significantly associated with brown vs other (P=0.04, OR=2.9). 
 
OCA2 
OCA2 was associated with eye colour. Several tagging SNPs in OCA2 (introns 1, 2, 
4, 6, 16, 18, 23) were associated strongly with eye colour. OCA2 SNP rs1448490 
showed a strong association for brown vs blue (P=0.009, OR=7.0), brown vs other 
(P=0.002, OR=8.6). The association of hair colour in OCA2 and eye colour ORs in 
intron 1 have been previously reported (Duffy et al., 2007). These significant 
associations are in agreement with others, with the same markers found and 
associated with eye colour and also hair colours. 
 
GNAS 
Intron 1 (rs4810147) was associated with quantitative (P=0.01732), brown vs blue 
(P=0.004438) and brown vs other (P=0.04221).  
 
7.2.4. Genotypes and skin colour 
22 SNPs from 13 candidate genes were associated with skin colour. 
 
HPS3 





HPS5 SNP rs2049129 was associated with constitutive back skin colour L* 
(P=2.3×10-5, R2=0.2481) and constitutive buttock skin colour L* (P=0.0007761, 
R2=0.2519). HPS5 SNP rs4757637 was also associated with constitutive back skin 








TYR SNP rs11018542 was associated with constitutive back skin colour L* 
(P=0.00889, R2=0.0874) and constitutive buttock skin colour L* (P=0.01989, 
R2=0.0563). TYR SNP rs16913107 was also associated with constitutive back skin 
colour L* (P=0.0499, R2=0.0308). 
 
TYRP1 
TYRP1 SNP rs17346161 was associated with constitutive back skin colour L* 




TP53 SNP rs12951053 was associated with constitutive back skin colour L* 
(P=0.00398, R2=0.1077) and constitutive buttock skin colour L* (P=0.004667, 
R2=0.0942). TP53 SNP rs2078486 was also associated with constitutive back skin 
colour L* (P=0.0107) and constitutive buttock skin colour L* (P=0.004304). TP53 





GNAS SNP rs6092704 was associated with constitutive back skin colour L* 
(P=0.01948) and constitutive buttock skin colour L* (P=0.0155). 
 
CYP4B1 
CYP4B1 SNP rs3766209 was associated with constitutive buttock skin colour L* 
(P=0.00951, R2=0.0694). CYP4B1 SNP rs837401 was associated with constitutive 




ERCC3 SNP rs4150506 was associated with constitutive back skin colour L* 
(P=0.01046, R2=0.0692) and constitutive buttock skin colour L* (P=0.02892).  
 
MATP 




DTNBP1 SNPs rs9476886, rs875462, rs9396593 were associated with constitutive 
back skin colour L* (P=0.02388, P=0.02723, P=0.02995). 
 
MYO5A 
MY05A SNP rs752865 was associated with constitutive back skin colour L* 
(P=0.04341). MY05A SNPs rs11853114, rs17614119 were associated with 
constitutive buttock skin colour L* (P=0.03055, P=0.04298). 
  
MC1R 
MC1R SNP “R” was associated with constitutive back skin colour L* (P=0.04134). 




7.2.5. Genotypes and erythema 
24 SNPs from 12 candidate genes were associated with UVB-induced erythema. 
KIT 
KIT SNPs rs2237029 and rs13135792 were associated with buttock erythema 
(P=0.03542, P=0.0499). 
ERCC8 
ERCC8 SNPs rs7726671 and rs976631 were associated with buttock erythema 
(P=0.04962, P=0.04262). 
TYRP1 
TYRP1 SNP rs10809828 was associated with buttock erythema (P=0.02008). 
CYP2C8 
CYP2C8 SNP rs3752988 was associated with back erythema (P=0.004701). CYP2C8 
SNP rs1891071 was associated with back (P=0.04075) and buttock erythema 
(P=0.04444). 
ERCC6 
ERCC6 SNP rs2228528 was associated with buttock erythema (P=0.0234). 
HPS5 
HPS5 SNP rs10766469 was associated with buttock erythema (P=0.04483). 
TYR 
TYR SNP rs11018542 was associated with buttock erythema (P=0.01872). 
KITLG 
KITLG SNP rs1492354 was associated with back erythema (P=0.01899). 
DCT 
DCT SNPs rs9584233 and rs7990565 were associated with back erythema (P=0.014, 
P=0.03194). 
OCA2 
OCA2 SNP rs746861 was associated with back (P=0.007241) and buttock erythema 
(P=0.01083). OCA2 SNPs rs2055291, rs1800404, rs2871875, rs2122005 were 
associated with buttock erythema (P=0.03683, P=0.007465, P=0.01777, P=0.02948).  
ERCC2 
ERCC2 SNP rs238415 was associated with back erythema (P=0.02982). 
HPS4 
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HPS4 SNPs rs739289, rs722997, rs1894706, rs4822721, rs877593 were associated 
with back erythema (P=0.01899, P=0.02692, P=0.03377, P=0.03547, P=0.04577). 
 
7.2.6. Genotypes and tanning 
24 SNPs from 14 candidate genes were associated with UVB-induced tanning. 
HPS3 
HPS3 SNP rs2131025 was associated with buttock tanning L* (P=0.04255). 
CYP4B1 
CYP4B1 SNP rs3766209 was associated with back (P=0.04643, R2=0.0425) and 
buttock tanning L* (P=0.03346, R2=0.0417). 
ERCC8 
ERCC8 SNPs rs7726671 and rs976631 were associated with back tanning L* 
(P=0.006213, P=0.02507). 
DTNBP1 
DTNBP1 SNP rs17470454 was associated with back tanning L* (P=0.01552). 
TYRP1 
TYRP1 SNP rs17346161 was associated with buttock tanning L* (P=0.04362). 
CYP2C8 
CYP2C8 SNPs rs11572177, rs11572093 and rs1341164 were associated with back 
tanning L* (P=0.01122, P=0.03523, P=0.03523). 
HPS1 
HPS1 SNP rs11592273 was associated with back tanning L* (P=0.04771). 
ERCC6 
ERCC6 SNP rs4253211 was associated with back tanning L* (P=0.04952). 
KITLG 
KITLG SNP rs1907702 was associated with buttock tanning L* (P=0.01645). 
OCA2 
OCA2 SNPs rs2055291, rs1448490, rs11074317, rs17566952, rs1448489 were 
associated with back tanning (P=0.008855, P=0.01136, P=0.02493, P=0.02512, 
P=0.04056). 
MYO5A 
MYO5A SNP rs11853114 was associated with buttock tanning L* (P=0.03725). 
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MC1R 
MC1R SNP “R” was associated with back tanning L* (P=0.03095). 
TP53 
TP53 SNPs rs12951053 and rs2078486 was associated with back (P=0.001211, 
P=0.008341) and buttock tanning L* (P=0.03533, P=0.01334). TP53 SNPs 
rs8064946 and rs1042522 were associated with back tanning L* (P=0.01363, 
P=0.04248). 
ERCC2 




This study utilized a candidate gene approach to select for SNPs to investigate the 
genotypic association with phenotypes. The findings that HPS3, KITLG and OCA2 
were significantly associated with aspects of phenotypic variation have plausible 
explanations. 
HPS3 
The association of hair colour, eye colour and skin colour to HPS3 is a novel 
observation. There are no mis-sense candidate SNPs in HPS3 at chromosome 3q24. 
Let us look at possible putative mechanisms for this. HPS3 is involved in lysosome 
organelle formation and biogenesis in melanosomes, lysosomes and platelet dense 
granules (Anikster et al., 2001). Mutations in HPS3 may cause a resultant change in 
shape and density of melanosomes secreted from the cell (Suzuki et al., 2001). 
Clinically, HPS3 defects could result in patients with hypopigmentation and platelet 
storage pool deficiency (Huizing et al., 2001). One can postulate that although full 
clinical manifestation of HPS3 defect may give rise to tyrosinase positive 
oculocutaneous albinism associated with a bleeding defect, a storage pool deficiency 
due to an absence of platelet dense bodies, pigmented reticuloendothelial cells 
(lysosomal) and ceroid-lipofuscinosis, milder subclinical forms may exist or even 
physiological variation in HPS3. The association of HPS3 SNPs rs6785780 and 
rs16861552 with hair colour L* and a* (red-green scale), HPS3 SNP rs2689230 with 
eye and constitutive skin colour may suggest that HPS3 protein has a role in normal 
hair colour, eye colour and skin colour variation. HPS3 SNP rs6785780 may 
contribute to red hair status (P=0.008101). There were no previous reports of HPS3 
association with red hair. HPS3 SNPs rs2254913, rs2681092 and rs2689230 may 
contribute to fair / blonde hair status (P=0.02168, P=0.03155, P=0.02867). 
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HPS3 gene contains 17 exons and spans 3,921 basepairs (Anikster et al., 2001). 
Animal model ‘cocoa’ (coa) mouse has a HPS-like mutant phenotype and is 
homologous to the human HPS3 gene (Suzuki et al., 2001). 
HPS4 
The HPS4 SNP rs9613187 was also significantly associated with constitutive back 
skin colour L* (P=0.01953). 
HPS5 
The strong association of HPS5 to skin colour is a novel observation. HPS5 was 
however not associated with tanning, nor hair, nor eye colour. The HPS5 SNP 
rs2049129 was associated with constitutive back skin colour L* (P=2.3×10-5, 
R2=0.2481) and buttock skin colour (P=0.0007761, R2=0.2519) and explains about 
25% of the variation. The other HPS5 SNP rs4757637 explains between 5-14% of 
the skin colour variation over back (P=0.0008896, R2=0.1381) and buttock 
(P=0.02748, R2=0.0539). 
Perhaps in Northern European population, HPS3, HPS4 and HPS5 may be novel 
candidates for pigmentation and may explain a significant proportion of pigmentary 
characteristics. 
 
Genotype association to hair colour: 
Most significant association is found in HPS3, KITLG, OCA2 to both hair colour L* 
and a*. The most significant associations are located in: 
1) HPS3 intron 6 and 8 
2) KITLG intron 1 
3) OCA2 intron 1 for hair L* 
4) OCA2 intron 23 for hair a* 
Sulem et al recently reported associations for 6 regions: SLC24A4, KITLG with hair 
colour, 2 coding variants in TYR with eye colour and freckles, variant on 6p25.3 with 
freckles, OCA2 refinement and previous MC1R variant (Sulem et al., 2007). 
KITLG association is in agreement with Sulem et al (Sulem et al., 2007), their 
candidate SNP is located 350kb upstream of kitlg, but show a 400kb haploblock that 
is centered on the gene. KITLG (mast cell growth factor, stem cell factor or steel 
factor) is a ligand for KIT tyrosine kinase receptor and is involved in the 
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development and maintenance of the melanocyte lineage in adult skin (Wehrle-
Haller, 2003). KITLG exerts migratory, proliferative and survival functions in 
melanocytes expressing KIT receptor. 
The association in OCA2 intron 1 (rs7495174) is in agreement with (Duffy et al., 
2007) and Sulem et al (Sulem et al., 2007). Sulem et al found the most significant 
SNP in HERC2 200kb upstream from OCA2. 
HPS1 
The association of HPS1 SNP (rs10611135) with hair colour (P=0.04) may suggest 
its role in normal pigmentary variation. The recent report by Nguyen et al suggests 
that HPS1 may act to regulate melanocytes differentially at follicular and 
interfollicular sites in mice and may have implications on physiological pigmentary 
variation in humans (Nguyen and Wei, 2007). 
 
MATP (SLC45A2) 
The very significant association of MATP SNP (rs16891982) with hair colour 
(P=0.008574, OR=27.7) is noteworthy. This advanced our understanding and 
showed that MATP is associated with hair colour also, not just skin colour. 
(Stokowski et al., 2007) showed an association between the same SNP rs16891982 
(F374L) with skin pigmentation variation in individuals of South Asian descent only. 
There is a difference in population and hair colour was not investigated in their 
study. 
A different MATP SNP (rs3756464) was significantly associated with skin colour 
(P=0.003246). This may be explained by its transporter function. MATP (SLC45A2) 
(OMIM 606202) is a pigmentation gene that is transcriptionally modulated by the 
melanocyte-specific transcription factor MITF (Du and Fisher, 2002; Newton et al., 
2001) and encodes a transporter. Graf et al found 2 SNPs (G272K and F374L) 
associated with normal variation in human pigmentation in different ethnic groups 
(Caucasians, Asians, African Americans and Australian Aborigines) (Graf et al., 
2005) and showed that 2 of the promoter SNPs (rs13289 and  rs6867641) out of the 3 
were associated with olive skin colour in Caucasians (Graf et al., 2007). The third 
which was a 3-base pair duplication (1174dupAAT) was not associated. There was 
evidence of functional significance in an assay. 
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Genotype association to eye colour: 
Eye colour association was performed as categorical data. Most significant 
association was OCA2 intron 1 which is in agreement with previously published 
studies (Duffy et al., 2007) and (Sulem et al., 2007).  
The other more significant association was HPS3 which was found to be associated 
to eye colour and discussed earlier. 
There are possible putative explanations with other significant associations found. 
The DTNBP1 / HPS7 belonged to the HPS group of family and could be involved 
together in the putative mechanisms with HPS3 or HPS5. 
The significant association with KIT cannot be easily explained. KIT somatic 
mutations (substituting valine in position 816) are characteristic of sporadic adult 
mastocytosis (Longley et al., 1999), a mast cell disorder exemplified by 
hyperpigmented red brown macules, papules and plaques that urticate on rubbing. 
There is proliferation of melanocytes and melanin production. 
One could postulate that the associations of eye colour with ERCC6, ERCC8 could 
be due to individuals with a certain eye colour have better DNA repair mechanisms 
than people with other eye colours. 
The cytochrome P450 pathway may have a role in the determination of eye colour 
through CYP2C8. 
DCT/TYRP2 is involved in melanin pigment biosynthesis (Jackson et al., 1992) and 
may act through this to affect eye colour. Kayser et al and Sturm et al found introns 
of HERC2 gene that predicts blue eye colour (Kayser et al., 2008; Sturm et al., 
2008). Sturm found that OCA2 (R419Q) could modify the penetrance of HERC2 
(rs12913832). This study did not include this new candidate. Future studies should 
include the new candidate loci. 
The GNAS SNP (rs4810147) that is associated with eye colour is different to the ones 
associated with hair colour (rs2295583, rs3730168, rs919197). It is possible that 
GNAS has a role in eye and hair colours via its effector Gs cAMP pathway. 
It is possible that some associations are spurious. 
 279
Genotype association to skin colour: 
HPS3, HPS4 and HPS5 were discussed already. Different DTNBP1 SNPs were 
associated with constitutive (rs9476886, rs875462, rs9396593) and facultative 
(rs17470454) pigmentation. The plausible explanation will be discussed later. 
Two additional MYO5A SNPs (rs17614119, rs752865) are associated with skin 
colour and will be discussed later.  
For OCA2, in contrast to the significant associations found with eye colour, no 
significant associations were found with skin colour. 
The TYR SNPs (rs11018542, rs16913107) were significantly associated with skin 
colour. Although these are significant, they are new and different to the SNPs 
reported previously. Stokowski et al (Stokowski et al., 2007) and Sulem et al (Sulem 
et al., 2007) showed TYR SNP rs1042602 (S192Y) to be associated with skin colour. 
However Shriver et al (Shriver et al., 2003) and Frudakis et al (Frudakis et al., 2003) 
found no such association with skin or eye colour. These may be explained by 
difference in population. 
TYRP1 mutation is known to be the cause of Oculocutaneous Albinism type III 
(Boissy et al., 1996; Manga et al., 1997). 
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TP53 is both significantly associated with constitutive and facultative pigmentation. 
It may play a normal physiological role. TP53 is normally found in benign skin 
lesions (Soini et al., 1994). Alternatively it may be via its transcriptional effect on 
POMC to lesser degree or indirect effect via tanning and constitutive skin colour. 
One could postulate whether p53 has a protective role by contributing to skin colour 
and subsequently less burning. 
GNAS is significantly associated with skin colour. This could play a physiological 
role in normal pigmentary variation via its Gs-alpha and cAMP pathway. It is known 
that G-protein mutations (Gnaq and Gna11) can be associated with dark skin (Dsk) 
in mice (Van Raamsdonk et al., 2004). 
CYP4B1 is significantly associated with both constitutive and facultative 
pigmentation. The cytochrome P450 system may be important candidates for 
pigmentation. 
The association of ERCC3 with skin colour may suggest that ERCC3 could exert its 
protective effect via skin colour or via DNA repair. 
 
Genotype association to erythema: 
12 genes are significantly associated with erythema in this study. Both KIT and 
KITLG SNPs are significantly associated with erythema. The KITLG finding is in 
keeping with Sulem et al (Sulem et al., 2007), although the KITLG SNP found was 
different (rs1492354). 
Sulem et al found TYR to be associated with freckling (Sulem et al., 2007). Since I 
found freckling to be highly associated with erythema (P=0.002018, discussed in 
Chapter 4), my finding that TYR SNP rs11018542 is associated with erythema is 
consistent with existing literature and explainable. 
As ERCC genes are involved in DNA nucleotide excision repair (Troelstra et al., 
1992), it is not surprising that ERCC2, ERCC6 and ERCC8 SNPs are significantly 
associated with erythema. Individuals with mutations from ERCC or having variants 
of xeroderma pigmentosum may have delayed or prolonged erythemal response 
(Cripps et al., 1971; Norris et al., 1991). 
It is possible to postulate that CYP2C8 SNP (rs3752988), acting on the cytochrome 
P450 enzyme system, may affect indirectly the generation of erythemal response. 
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The 5 OCA2 SNPs found to be significantly associated with erythema may act via 
other variables e.g. eye colour, hair colour. 
The association of 5 HPS4 SNPs (rs739289, rs722997, rs1894706, rs4822721, 
rs877593) and a different HPS5 SNP (rs10766469) were found to be associated with 
erythema as compared with 2 other HPS5 SNPs associated with skin colour. For KIT, 
HPS5, TYRP1, DCT (TYRP2), one could postulate that the function of these genes 
may affect the erythemal responses indirectly, via other genes or pathways e.g. 
prostaglandins (Sondergaard et al., 1985), nitric oxide (Deliconstantinos et al., 1996; 
Deliconstantinos et al., 1995).  
Alternatively it is possible that some of the associations could have arisen by chance. 
 
Genotype association to tanning: 
The results showed that 14 genes were associated with tanning and therefore are 
plausible candidate loci for tanning. What does this mean? 
The novel group of genes, which are found to be significantly associated with 
tanning in this study, is the Hermansky Pudlak Syndrome (HPS) genes. The 
significant associations of SNPs in DTNBP1 (rs17470454, P=0.01552), HPS1 
(rs11592273, P=0.04771) and HPS3 (rs2131025, P=0.04255) with tanning may be 
explained by the HPS proteins. Human DTNBP1 gene mutations are found in 
individuals with HPS (Li et al., 2003). Dysbindin is a protein that binds to alpha- and 
beta-dystrobrevins, which are components of the dystrophin-associated protein 
complex (DPC) (Benson et al., 2001). Dysbindin is also a component of the 
biogenesis of lysosome-related organelles complex-1 (BLOC1), which regulates 
trafficking to lysosome-related organelles (Li et al., 2003). Li et al showed that 
BLOC1 is important in producing the HPS phenotype in humans and that dysbindin 
has a role in the biogenesis of lysosome-related organelles, and highlighted the 
interactions between components of DPC and BLOC1. This in turn may have effects 
on melanosome production and ultimately tanning. 
 
Since erythema and tanning are interrelated, as shown and discussed in Chapter 5 
and in keeping with Wagner et al (Wagner et al., 2002b), some of the candidate 
genes found significantly associated with erythema may also be relevant to tanning. 
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Indeed this was the case for 7 genes. SNPs in KITLG, ERCC2, ERCC6, ERCC8, 
OCA2, CYP2C8 and TYRP1 were similarly associated with both erythema and 
tanning. 
 
KITLG SNP rs1907702 was associated with buttock tanning L* (P=0.01645). 
The significant association of KITLG SNP rs1907702 with tanning adds to the 
findings of Sulem et al. KITLG exerts migratory, proliferative and survival functions 
in melanocytes expressing Kit receptor (Wehrle-Haller, 2003). Another indirect piece 
of evidence is that KIT somatic mutations (substituting valine in position 816) are 
characteristic of sporadic adult mastocytosis (Longley et al., 1999), a disorder of 
mast cells exemplified by hyperpigmented red brown macules, papules and plaques 
that urticate on rubbing. There is proliferation of melanocytes and melanin 
production. 
 
4 TP53 SNPs (rs12951053, rs2078486, rs8064946 and rs1042522) were significantly 
associated with tanning (P=0.001211-0.04248). Recently Cui et al showed that p53 
mediates the upregulation of POMC and that POMC is a transcriptional target for 
p53 and therefore tanning (Cui et al., 2007). My findings are in keeping with this. It 
also highlights the common notion that facultative pigmentation is protective against 
skin cancer. “Guardian of the genome” p53 plays a central role. 
 
The association of MYO5A SNP (rs11853114) with tanning and skin colour raises the 
possibility that class V myosins may be involved in organelle transport (El-Husseini 
and Vincent, 1999) and pigment granule transport (Fukuda et al., 2002) as possible 
explanations for the association. 
The association findings of OCA2 with tanning may be explained by the relationship 
of the oculocutaneous albinism type 2 (OCA2) with skin colour or indirectly via its 
association with erythema. 
CYP4B1 may play a role in facultative pigmentation via its effect on cytochrome 
P450 pathway.  
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The association of TYRP1 SNP (rs17346161) with both tanning and skin colour 
suggests that oculocutaneous albinism type III (Rufous) may have a role in both 
constitutive and facultative pigmentation. 
The association of ERCC2, ERCC6 and ERCC8 SNPs may possibly be explained by 
their action via DNA repair or indirectly via its relation with erythema. 
MC1R.SNP “R” shows a significant association with tanning (P=0.03095). This is to 
be expected. There was a tendency for individuals who are homozygous for MC1R to 
tan less (4.4 L* units) as compared with WT (6.7 L* units) (discussed in Chapter 6). 
However the results did not reach significance (P=0.15). 
 
One could postulate that the function of these candidate genes may affect the 
facultative pigmentary responses direct or indirectly, via other genes or pathways or 
through non-pigmentary adaptation e.g. hyperplasia or thickening. As mentioned, an 
alternative explanation is possibly that some of the associations could have arisen by 
chance. 
 
One of the limitations of this genetic association study could be false positives from 
multiple testing. The associations found could be spurious or just by chance. The 
problem of false positives has been extensively published (Benjamini, 1995; 
Dudbridge and Koeleman, 2004; Gao et al., 2008; Reiner et al., 2003). Bonferroni’s 
correction for multiple testing was used and a P value of less than 0.05 was chosen as 
significant. 
We are in the process of confirming these positive significant findings in 
collaboration with another laboratory in Denmark and in that population. Significant 
findings were also clearly showing up positive with the SNPs tested in this study in 
the Danish population (unpublished observations, manuscript to be submitted). In 
conclusion, we found significant associations with SNPs in novel gene HPS3 and 
confirmed other associations in KITLG and OCA2. Further experiments have been 
planned to confirm other associations and phenotypes. 
This European population variation was not explained by SLC24A5 – there were no 
significant associations with any pigmentary phenotypes, except hair colour cluster 
for rs2675347 (P=7.32×10-6, MAF of only 0.00769231). The different finding is due 
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to a difference in the population under study. Lamason et al found the association in 
African Americans, the proportion of skin colour explained by SLC24A5 is much 
larger than MC1R (Lamason et al., 2005). 
Similarly ASIP did not seem to have any effect in this population, probably due to 
the low frequency in this population and a homogeneous European population, 
without e.g. African Americans. ASIP was not found to be associated with hair, skin 
or eye colours in this population. It is known that ASIP frequency is different in 
different population (Meziani et al., 2005; Norton et al., 2007). The frequency in this 
population is too low to detect an association despite the involvement in the 
production of darker eumelanin and lighter phaeomelanin together with MC1R. 
 
Since the completion of this study with the current approach of SNP genotyping 
using Illumina, a comprehensive approach covering the whole genome (genome wide 
scan) has been performed by Sulem and others (Gudbjartsson et al., 2008; Han et al., 
2008; Stokowski et al., 2007; Sulem et al., 2008; Sulem et al., 2007) and found 
variants in genes with significant associations with phenotypic traits e.g. SLC24A4, 
KITLG, TYR, 6p25.3, OCA2, MC1R, TPCN2, ASIP. 
Further experiments could include the newly found candidate loci in pigmentation. 
Using a candidate gene approach I have identified several novel SNPs for hair, eye 
and skin colour. The findings may suggest physiological roles in normal pigmentary 
variation and remains to be confirmed in further studies.
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Chapter 8 Blondes 
 
8.1. Introduction 
The aim of this chapter is to focus on blondes. What is the phenotypic definition of 
blonde? What is the blonde genotype? 
 
8.2. Results 
There were 133 individuals with natural hair colour. 86 individuals have dark hair, 
27 individuals have fair hair, out of which 19 individuals have blonde hair and 20 
volunteers have red hair. The classification of hair colour was according to careful 
visual inspection of the natural hair colour of individuals. 
 
8.2.1. Summary of Phenotype 
8.2.1.1. Hair colour 
Do blonde hair individuals differ from fair hair individuals? The blonde / fair hair 
individuals were subdivided into 2 groups: blonde (n=19) and fair (n=8) after careful 
visual inspection of the hair colour of individuals. Individuals with obvious blonde 
hair colour were classified into blonde hair colour group (n=19). Others with lighter 
hair colour were classified into fair hair colour group (n=8). 
Blonde hair volunteers had a mean L*, a*, b* of 39.67 ± 1.66, 5.26 ± 0.17, 13.62 ± 
0.63 respectively. 
Fair hair volunteers had a mean L*, a*, b* of 34.33 ± 2.13, 5.23 ± 0.41, 12.47 ± 1.35 
respectively. 
One-way ANOVA for hair colour L*, a* and b* comparing blonde and fair showed 
no significant differences (P=0.079, 0.94, 0.385). 
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8.2.1.2. Hair colour spectrophotometric reflectance 









































































































This is an interval plot of log hair spectrophotometric reflectance ± SEM (95% CI for the 
mean) for blonde and fair hair individuals. Y-axis shows the log hair spectrophotometric 
reflectance. X-axis shows the 10nm increments of 360-740nm wavelengths. 
 
Two-sample t-test showed significant differences from log(360)nm-log(470)nm 
(P<0.05). 
Interestingly, blondes appeared to be distinguishable from fair hair individuals using 
hair spectrophotometric reflectance data. 
 
8.2.1.3. Skin colour 
Blonde hair volunteers had a mean skin L*, a*, b* of 57.16 ± 0.79, 14.60 ± 0.20, 
14.37 ± 0.56 respectively. 
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8.2.1.4. Blonde and eye colour 
Table 8.2.1.4. Blonde and eye colour 
           N   Y  All 
 
Blue      39  13   52 
Brown     55   0   55 
Green     24   3   27 
Grey      12   3   15 
Hazel     10   0   10 
All      140  19  159 
 
The majority of individuals have blue eye colour (13), 3 had green eye colour and 3 
had grey eye colour. 
 
8.2.1.5. Erythema and blonde hair 
Blonde hair had no effect with a mean erythemal index of 134 in those without 
blonde hair and 140 in those with blonde hair (P=0.5889, two sample t-test). 
 
8.2.1.6. Tanning and blonde hair 
There was no relation between tanning on the back and the presence of blonde hair or 
otherwise, but tanning on the buttock was greatest at 4.33 in those without blonde 
hair, compared with 1.99 in those with blonde hair (P=0.02, two sample t-test). 
 
8.2.2. Summary of genotype 
Please note that “fair hair” in this section is a general term which includes fair and 
blonde hair individuals. 
MC1R 
There was no significant association between blonde hair status and MC1R genotype 
(P>0.9999). 
HPS3 
HPS3 SNPs rs2254913, rs2681092 and rs2689230 were associated with fair hair 
(P=0.02168, P=0.03155, P=0.02867). 
DTNBP1 
DTNBP1 SNPs rs6909929, rs9396592, rs17470454 were associated with fair hair 
(P=0.01388, P=0.03081, P=0.03801). 
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OCA2 
OCA2 SNPs rs7173419 and rs4778137 were associated with fair hair (P=0.01115, 
P=0.02965). 
MYO5A 
MY05A SNP rs752864 was associated with fair hair (P=0.04506). 
GNAS 
GNAS SNPs rs234630, rs3730168 and rs6026561 were associated with fair hair 
(P=0.01552, P=0.04248, P=0.04283). 
 
8.3. Discussion 
The category blonde / fair can be sometimes difficult to distinguish and subjective. 
There were 8 fair hair individuals, and 19 pure blonde hair individuals in this study. 
The phenotypic data for blondes as a group was not remarkable. 
Blonde hair status does seem to contribute to a lesser tanning effect (P=0.02). 
The genotype data suggest that several loci (HPS3, DTNBP1, OCA2, MYO5A and 
GNAS) may be candidate genes for blonde / fair hair. 
The number of individuals with blonde phenotype was small. Nevertheless, the 
phenotype and genotype definitions of blondes merit further investigation. Further 
experiments have been planned in collaboration with a group in Denmark to test a 
number of my chosen SNPs which were found to be associated with blonde / fair hair 
to test this in the Danish population. 
These also raised further questions to be answered in future studies: 
1) Is it possible to map out blonde families in an admixture and attempt to track 
blonde through generations? Family trees could be constructed from famliy 
history, siblings’ hair colour and kindreds with blonde. 
2) What is the mode of inheritance with blonde? 
3) Do any blondes have a homozygous MC1R mutation? Yes, in my study there 
was 1 individual (V81). This was discussed in Chapter 6 and was an 
interesting finding. 
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Chapter 9 Discussion and Concluding Remarks 
 
9.1. Discussion 
This was the first detailed quantitative phenotype-genotype study on erythema and 
tanning in relation to MC1R genotype. The aim of this study is to objectively and 
quantitatively define pigmentary phenotype of individuals (hair colour, eye colour, 
skin colour, erythema and tanning) and co-factors (age, sex, ethnicity, freckling and 
Fitzpatrick skin type) as comprehensively as possible. My study demonstrated the 
possibility of using quantitative methodology to define phenotypes. 
 
In Chapter 3, I gave a detailed description of the key phenotypic variables. I 
confirmed previous findings and demonstrated more quantitative results e.g. hair 
spectral reflectance, skin colour L* with skin type, skin colour L* and hair colour L* 
a* b*. I showed that the effect of skin colour of various sites is different in males and 
females. 
 
In Chapters 4 and 5, I presented a full description of the induced phenotype (with 
UVB), namely erythema and tanning. I confirmed the difference in erythemal 
sensitivity with site (the back is more sensitive than the buttock), which is in keeping 
with previous findings (Rhodes and Friedmann, 1992; Waterston et al., 2004).  
I showed that the major determinants of erythema for this study population were 
constitutive buttock skin colour L* and skin type. I used a linear regression model to 
explain erythemal sensitivity (4.2.1.2.9) and showed that erythema is dependent on 
constitutive skin colour and skin type. This model explained 27% of the variation in 
erythema (P=1.205×10-7) for the buttock. In fact, my findings showed that skin type 
is just as good as constitutive skin colour L* in predicting erythema. Erythema is also 
associated with other factors e.g. freckling, ethnicity and hair colour. These factors 
may be the markers of constitutive skin colour already and therefore related to 
erythema as one might expect. I confirmed that both measures of erythema 
(erythemal index and erythemal flux) gave similar results. 
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What are the determinants of tanning? In Chapter 5, I gave a detailed account of 
using 6 different quantitative measures of tanning. The main determinant of tanning 
in this study population is erythema. A model which explained tanning (5.2.11) 
showed that tanning is dependent on erythema and it also explained 24% of the 
variation in tanning responses (P=2.687×10-6) for the buttock. In fact, constitutive 
skin colour, skin type, ethnic group, red hair status and freckling were not significant 
beyond that was accounted for by erythema. Therefore erythema is the key predictor 
of facultative pigmentation. 
 
What are the genetic determinants that underpin the static phenotype and induced 
phenotype (erythema and tanning)? 
In Chapter 6, I showed that MC1R explains the variation in hair colour but the effect 
of MC1R on skin colour is small. This is in keeping with previous publication 
(Naysmith et al., 2004). MC1R is also associated with freckles. My results support 
previous findings (Flanagan et al., 2000). However, MC1R in my study did not 
significantly account for the differences in erythemal and tanning responses. This is 
in contrast to the findings of Flanagan et al (Flanagan et al., 2001). The reason for 
this could be due to differences in the selection of study individuals. Flanagan et al 
selectively studied red hair individuals to look for an effect of MC1R, whilst my 
study population consisted of a homogenous unselected population, predominantly 
Northern Europeans with a small proportion of red hair individuals. 
 
What about other genotypes? 
In Chapter 7, I demonstrated the significant genotypic associations with various 
phenotypes. I presented novel SNPs in HPS3 (rs2254913, rs6785780, rs7636389, 
rs2681092 and rs2689230) and KITLG (rs1492354, rs1907702 and rs10777129) that 
were significantly associated with hair colour. Sulem et al found a SNP (rs12821256) 
which is nearest to the gene KITLG. My finding of KITLG is in accordance with 
Sulem et al (Sulem et al., 2007). Additionally, I found 3 different novel SNPs in 
KITLG. 
I also found novel SNPs in HPS3 (rs2254913, rs2689229, rs2689230, rs2689234, 
rs6785780, rs2681092, rs7643410) and GNAS (rs4810147) that were significantly 
 291
associated with eye colour. My findings of OCA2 confirmed previous findings of its 
association with eye colour (Duffy et al., 2007). 
Skin colour was associated with SNPs of HPS3, HPS4, HPS5, HPS7, TP53, TYR, 
MATP and MC1R. The SNPs of HPS3 (rs2689230), HPS4 (rs9613187), HPS5 
(rs2049129 and rs4757637), DTNBP1 / HPS7 (rs9476886, rs875462 and rs9396593) 
were novel findings and of special interest as some of these were also significantly 
associated with hair and eye colour. The novel HPS5 SNP (rs2049129) accounted for 
~25% of the variation in skin colour. 
Putative explanation for the HPS findings is that HPS is involved in lysosome 
organelle formation. Mutations of HPS genes may cause changes in shape and 
density of melanosomes. This suggests that HPS may play a role in hair, eye and skin 
colour variation. 
In terms of erythemal sensitivity, KITLG, TYR, ERCC2, ERCC6, ERCC8, OCA2, 
TYR SNPs showed significant associations with erythema. Novel SNPs were found. 
Potential explanations include ERCC genes affecting erythema via their DNA 
nucleotide excision repair function, the effect of TYR on erythema through freckling, 
or through other pathways that affects prostaglandin or nitric oxide production. 
Tanning was associated with DTNBP1 / HPS7, TP53, ERCC2, ERCC8 and OCA2. 
The genotypic association of TP53 to tanning could be explained by p53 mediated 
upregulation of POMC and that POMC is a transcriptional target for p53 and 
therefore tanning. This is consistent with the findings of Cui et al (Cui et al., 2007). 
 
9.2. Limitations 
I have encountered a number of potential shortcomings during this study. First, 
during my attempt to further develop quantitative measures of eye colour, I used an 
adapted method of colour matching to measure eye colour and then converting the 
Munsell colour into L* a* b* values. However there could be an element of 
subjectivity of the initial colour matching. 
Second, there were limitations with some tanning assays in that they did not provide 
a good dose response of tanning e.g. Melanin index or “Dwyer method”.  
Third, it is possible that there are limitations with HapMap. The tagging SNPs may 
not fully represent the whole candidate gene locus. Another potential problem with 
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genetic association studies is false positive results from multiple testing. Although a 
Bonferroni correction was used to correct for this, associations could still have arisen 
by chance, and “real” associations may have been missed. 
Fourth, the sequencing and SNP genotyping experiments failed to provide genotypic 
data for some individuals. As a result, this reduced the power of this study. 
Fifth, while performing statistical analysis, some of the numbers within 
subcategories were too small or zero which limited the amount of testing that could 
be done. This may in turn reduce the statistical power. If the number of volunteers 
taking part in this study was larger, some of the findings may reach statistical 
significance. 
 
9.3. Development of novel assays to meaure phenotype  
During this study I have further developed quantitative methodology for future 
pigmentary studies (noradrenaline iontophoresis), pressure spectrophotometry, 
measures of tanning (Dwyer calculation method, pressure spectrophotometry) and 
indirect quantitative measure of eye phenotype (Munsell L* a* b*). 
 
Recently published studies have not used objective quantitative methodology and 
still used methods based on self assessment (Han et al., 2008; Sulem et al., 2008). 
The potential limitations in these studies could be due to problems of 
misclassification and recall bias. Further use of and development in quantitative 
methods will allow more precise measurement and definition of phenotypes to be 
made. This could subsequently lead to a better understanding of the relationship 
between genotypes, phenotypes and the cutaneous response to UVR in the genes. 
The differences in methodology also make comparisions of results between different 
studies difficult. 
 
9.4. Further experiments 
This section summarises the further experiments that are planned or could be 
performed in light of the findings from my quantitative phenotype-genotype study. 
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First, I have demonstrated freckling, skin type and hair colour L* a* b* as important 
definitive phenotypic measures for MC1R. Therefore in any future study design 
involving MC1R, the inclusion of these phenotypic measures will be sufficient. 
Second, for the study of other genotypes, the novel SNPs found in this study could be 
repeated and tested in another population. A joint study will be undertaken to verify 
our findings in the Danish population in collaboration with Jonas Mengel-Jorgensen 
and Niels Morling in Denmark. The following list of SNPs (Table 9.4) has been 
selected for repeating in the joint study: 
 
Table 9.4. List of SNPs selected to repeat in joint study 




hair L* a* b* Eye 
HPS3 3 rs678580 - √ √ √ √ √ 
HPS3 3 rs2254913 √ - √ √ √ √ 
DTNBP1 6 rs6909929 √ - √ - - - 
DTNBP1 6 rs17470454 √ - √ - - - 
CYP2C8 10 rs11572177 - √ - - √ √ 
TYR 11 rs12421746 - √ √ √ √ - 
KITLG 12 rs1492354 - √ - √ √ - 
KITLG 12 rs10777129 - √ √ √ √ - 
GNAS 20 rs919197 √ - √ √ √ - 
GNAS 20 rs234630 √ - - - - - 
GNAS  20 rs4810147 - - - - - √ 
ERCC6 10 rs4253231 - - - - - √ 
DCT 13 rs9584233 -  √ - - - √ 
Key: (√) selected to repeat, (-) not selected to repeat. 
 
Third, the findings in this study could be repeated by using buccal swab smear in 100 
newly recruited individuals. Any new candidate genes should be included in the new 
study. 
Fourth, the erythemal and tanning dose responses of individuals could be 
investigated in different people with more varied skin colour. 
Fifth, this study could be undertaken in a different population e.g. Asian or other 
European population to investigate for population differences. 
Sixth, as the range of skin colour of individuals is varied even within a population, an 
experiment could be performed to study the tanning response of individuals of 
similarly matched degree of skin colour to see whether they respond differently to 
each other. Other contributory factors could be investigated too. 
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Seventh, since the completion of this study, new whole genome genotyping 
technologies have become available: e.g. Infinium® whole-genome genotyping 
(Illumina), HumanHap300-Duo Genotyping BeadChip. These would allow large 
scale screening of variation in the human genome. These technologies could be 
incorporated into the methodology of future studies. 
What is the future with genotyping? The ideal study would be to include SNPs from 
the whole genome as Sulem et al and others have performed, using more individuals 
and carrying out more detailed analysis. The potential limitation with large numbers 
of individuals involved may mean that only basic phenotypic measures could be 
analysed. Subsequently, a more detailed quantitative study precisely defining the 
phenotypes might be necessary to define the contribution or functional significance. 
Human pigmentary phenotypes are complex traits. Further experiments in 
collaboration with other laboratories may help to advance our understanding.  
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9.5. Concluding remarks 
Phenotype-genotype correlations are very dependent on the precise definition of a 
phenotypic assay. An objective reproducible repeatable phenotypic measure used to 
define a phenotype may be most advantageous. Sometimes there are several 
phenotypic measures and assays for a particular phenotype e.g. tanning. 
 
I have quantitatively measured human pigmentary phenotypes including hair colour, 
skin colour and eye colour and then quantified the cutaneous erythemal and 
facultative pigmentary response after UVB radiation.  
I started out designing a study with quantitative methodology in mind to precisely 
define phenotypes and then relating these to genotypes. This study demonstrated that 
it is possible to use a very quantitative, reproducible and relatively economical way 
to define phenotype and to ascertain genotypes. 
Interestingly, it turned out that although phenotypes can be very precisely defined 
using quantitative methodology, sometimes simple phenotypic measures (e.g. 
freckling, skin type) may be sufficient to define phenotypes. In the case of MC1R for 
my study population sample, the phenotypic traits of freckling and skin type have 
already provided sufficient information. Ascertaining their MC1R genotypes may not 
add further useful information above that already provided for by phenotype. 
In this study I have developed further quantitative methodology and measures of 
tanning. I have further developed a quantitative / semi-quantitative method to 
measure eye colour, which could be used in future phenotype-genotype studies. 
I have elucidated the determinants of erythema and tanning in this population that 
erythema is dependent on skin colour and skin type whereas tanning is dependent on 
erythema. I have demonstrated the interrelationship between constitutive skin colour, 
erythema and tanning. 
I have correlated the phenotypic data with genotypes in my study population and 
found novel SNPs in several candidate genes associated with pigmentary traits. 
The key novel findings are: 
1) Hermansky-Pudlak Syndrome group of genes (e.g. HPS3) and KITLG with hair 
colour 
2) HPS3 and GNAS with eye colour 
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3) HPS3, HPS5, HPS7 and GNAS with skin colour 
Further testing could be repeated in another population to determine whether these 
SNPs are causal for the phenotypic traits or some of which may be false positives. 
This is already underway. 
This study has confirmed previously known associations (e.g. hair colour with MC1R 
and OCA2, eye colour with OCA2). 
These novel findings are interesting and suggest that the relationship between 
phenotypic traits and normal physiological variation in pigmentation and facultative 
pigmentation is very complex. 
New technological advances and the advent of genome wide scan to screen for 
phenotypic traits may identify new or novel pigmentation candidate alleles. The 
causality and functional importance of these newly identified variants may require a 
precise phenotypic definition of phenotype using a quantitative methodology in order 
to be able to compare results between studies and among populations. This could 
advance our understanding in the field of pigmentation (constitutive or facultative) 
and ultimately cutaneous malignancies. 
This study has furthered our understanding of human pigmentation and the cutaneous 
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Title: Pigmentation and the cutaneous response to ultraviolet radiation 
Derm Study Number: Derm/03/JLR/6/TW 
Patient Indentification Number for this study: 
 
CONSENT FORM – INITIAL STUDY 
 
Title of Project: Pigmentation and the cutaneous response to ultraviolet 
radiation 
 
Name of Researcher(s): Dr Terence H Wong 
 
1. I confirm that I have read and understood the information sheet number 
Derm/03/JLR/6/TW    (version 1.3) for the above study and have had the 
opportunity to ask questions. 
 
2. I understand that my participation is voluntary and that I am free to withdraw at any time without 
giving any reason, without my medical care of legal rights being affected. 
 
3. I understand that sections of any of my medical notes may be looked at by 
responsible individuals and the research sponsor, or from regulatory authorities 
where it is relevant to my taking part in research.  I give permission for these 
individuals to have access to my records. 
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4. I understand that this is non-therapeutic research from which I cannot expect to 
derive any direct benefit. 
 
5. I agree for notice to be sent to my General Practitioner. 
 
6. Procedures to be performed: measuring skin, hair and eye colour, sample of 
venous blood or buccal smear swab for genetic analysis (pigmentation genes e.g. 
MC1R and other genes important in skin inflammation and susceptibility to 
ultraviolet radiation and skin cancer), and sample of hair, UV irradiation. 
 
7. A separate consent form for substudy has to be completed in order to take part in 
the substudy. 
 
___________________________ ________________ ______________________ 
Name of Patient Date Signature 
 
Dr Terence Wong_____________ ________________ ______________________ 
Researcher Date Signature 
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Title: Pigmentation and the cutaneous response to ultraviolet radiation 
Derm Study Number: Derm/03/JLR/6/TW 
Patient Indentification Number for this study: 
 
CONSENT FORM – SUBSTUDY 
 
Title of Project: Pigmentation and the cutaneous response to ultraviolet 
radiation 
 
Name of Researcher(s): Dr Terence H Wong 
 
8. I confirm that I have read and understood the information sheet number 
Derm/03/JLR/6/TW    (version 1.2) for the above study and have had the 
opportunity to ask questions. 
 
9. I understand that my participation is voluntary and that I am free to withdraw at any time without 
giving any reason, without my medical care of legal rights being affected. 
 
10. I understand that sections of any of my medical notes may be looked at by 
responsible individuals and the research sponsor, or from regulatory authorities 
where it is relevant to my taking part in research.  I give permission for these 
individuals to have access to my records. 
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11. I understand that this is non-therapeutic research from which I cannot expect to 
derive any direct benefit. 
 
12. I agree for notice to be sent to my General Practitioner. 
 
13. Procedures to be performed: Retention of skin from suction blister for 
transmission studies and melanin analysis, measuring skin colour after 
noradrenaline iontophoresis. 
 
14. Two separate consent forms have to be completed in order to take part in the 
initial and substudy. 
 
___________________________ ________________ ______________________ 
Name of Patient Date Signature 
 
Dr Terence Wong_____________ ________________ ______________________ 





Pigmentation and the cutaneous response to ultraviolet radiation 
PIN: 
Volunteer Demographic details 
Name:     
Sex:    
Date of birth:   
Age (18-30):    
Address:   
Phone number:   
GP:     
GP Practice address:   
 
Background information 
  Exclusion criteria: 
 
with photosensitivity Y / N 
on drugs known to interfere with the cutaneous inflammatory response 
(such as high dose systemic steroids, cyclosporin, methotrexate and MMF) 
Y / N 
on drugs known to act on the adrenergic pathways 
(such as Tricyclics, MAOI and betablockers) (substudy only) 
Y / N 
who are breast feeding (substudy only) Y / N 
who are pregnant (substudy only) Y / N 
attempting to get pregnant before or during the study (substudy only) Y / N 
referred because of acute inflammatory skin disease Y / N 
 
  Skin type:   I  Always burn, never tans? 
     II  Burns easily, tans with difficulty? 
     III  Burns moderately, tans moderately? 
    IV  Burns minimally, tans easily? 
    V  Rarely burns, tans deeply? 
    VI  Never burns, tans deeply? 
 
  Natural hair colour:  Red / auburn / strawberry blond? 
     Blond / fair? 
     Brown / black? 
 
  Eye colour:   
 
  Past medical history:  Skin disorders? 
     Pregnant? 
 
  Drug history: 
 
  Allergies: 
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  Family history: 
 
 
  Sunbed use:   Y / N   How long? 
 
  Sunscreen:   Y / N 
 
  Holidays abroad:  Y / N   Where? 
 
  Sunny countries:  Y / N   Where? 
 
  Sunburn:   Y / N   UK / abroad? 
 
  Freckles:   Y / N  
 
 Freckling sites:   face / shoulders / chest / back / abdomen / arms / legs 
 
  Resident country: 
 
  Ethnic ancestry: 
 
  Place of birth:   
 
  Father’s place of birth: 
 
  Father’s hair colour: 
 
  Mother’s place of birth: 
 
  Mother’s hair colour: 
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Title: Pigmentation and the cutaneous response to ultraviolet radiation 
Dermatology subject project no: Derm/03/JLR/6/TW 
Version: 1.3 





1. Study title 
Pigmentation and the skin response to ultraviolet radiation (sunlight). 
 
2. Invitation 
You have been invited to take part in a research study.  Before you decide it is 
important for you to understand why the research is being done and what it will 
involve.  Please take time to read the following information carefully and discuss it 
with others if you wish.  Ask us if there is anything that is not clear or if you would 
like more information.  Take time to decide whether or not you wish to take part. 
 
3. What is the purpose of the study? 
People vary considerably in their sensitivity to the effects of sunshine. 
Understanding these differences is important because sunshine is the main cause of 
skin cancer, because ultraviolet radiation (the active component of sunlight) is used 
more and more to treat diseases such as psoriasis and atopic dermatitis, and finally 
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because there is greater scientific interest in understanding why humans vary so 
much in terms of hair, eye and skin colour. 
 
4. Why have I been chosen? 
We are asking you whether you would be willing to take part in this research 
project. It is important to emphasise at the outset that this is a research project and 
is not designed specifically to improve the therapy of any skin problem you have 
had or will have at some future date, and in the case of volunteers the research will 
provide no direct benefit to you.  We do believe however that the research project 
is important which is why we are asking people whether they are willing to help 
us. Medication that may have been prescribed for you may interfere with the tests 
we are carrying out. If therefore you are receiving cyclosporin or other systemic 
immunosuppressive drugs, or high dose systemic corticosteroids then 
unfortunately you may not be eligible for the present study. We will ask what 
medications, if any, you take. 
 
5. Do I have to take part?  
It is up to you to decide whether or not to take part.  If you do decide to take part 
you will be given this information sheet to keep and be asked to sign a consent 
form.  If you decide to take part you are still free to withdraw at any time and 
without giving a reason.  A decision to withdraw at any time, or a decision not to 
take part, will not affect receive the standard of care you receive.   
 
6. What will happen to me if I take part? 
Initial study 
This research study is divided into two parts. The initial study, if you are willing 
to take part, will involve attending the department on a maximum of eight 
occasions. We will measure your skin colour, hair colour and eye colour with a 
non-invasive instrument (modified camera). We would like a small sample of 
hair (equivalent to the amount of hair in an eyebrow but taken from the scalp) to 
determine to amount of melanin (pigment) present. In order to interpret the 
results, we would like to take a small sample (approximately four teaspoons) of 
venous blood or buccal cheek smear swab from you for genetic analysis 
(pigmentation genes e.g. MC1R and other genes important in skin 
inflammation and susceptibility to ultraviolet radiation and skin cancer). If 
relevant, we may ask you to return to do further tests involving shining 
ultraviolet light (sunlight) onto 10 small areas of skin on your body. We will give 
you a small amount of a steroid cream just to rub into the skin to speed up any 
resolution of redness if necessary. 
 
Substudy 
If you are willing to take part in our substudy, we will remeasure your skin 
colour after noradrenaline iontophoresis (in order to make the skin blanch / paler 
temporarily). We will perform suction blisters to obtain a small sample of skin 
for further tests in order to determine how transmissible (permeable to light) and 
to analyse the content of different pigments.  
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If you are willing to take part in both parts of the study, you will have to complete 
both consent forms. 
 
7. What do I have to do? 
There are no particular lifestyle restrictions for you to take part in this study. 
 
8. What drug or procedure is being tested? 
Not applicable 
 
9. What are the alternatives for diagnosis or treatment? 
Not applicable 
 
10. What are the side effects of any treatment received when taking part? 
Blood taking is associated with discomfort. Application of various doses of 
ultraviolet radiation is associated with the induction of redness, and swelling in 
some cases. Such redness and swelling will be associated with itching in some 
cases. Following application the skin may stay red for up to a few weeks and in 
some cases it may result in residual pigmentation which will fade over a few 
months. In order to minimise such irritation it is our normal practice to give the 
individuals a few grams of medium potency steroid (applied to the affected areas). 
All of the procedures involved are widely used in dermatological research. The 
contact numbers for this study are on front of information sheet. 
 
11. What are the possible disadvantages and risks of taking part? 
You will not be disadvantaged. The possible risks would be similar to the risk of 
having any minor skin wound, such as infection, bleeding, reopening of wound; the 
study will not impose any extra or further risks. The disadvantages of having a 
sample of venous blood taken from you is similar to any blood-taking procedure 
you may have had e.g. bruising and discomfort at the site. 
 
12. Pregnancy 
There are no problems with you taking part in the preliminary study, you may not 
be able to take part in the substudy which follows. It is possible that if treatment is 
given to a pregnant woman it will harm the unborn child. Pregnant woman must 
not therefore take part in the substudy, neither should women who plan to become 
pregnant during the study. Any woman who finds that she has become pregnant 
whilst taking part in the study should immediately tell the research doctor. 
 
13. What are the possible benefits of taking part? 
It is important to emphasise as stated earlier that there are no direct benefits of 
taking part in this research for you. You may derive some satisfaction from helping 
contribute toward advancement of medical science. You should also understand 
that there is discomfort involved such as the pain from the taking of blood or 
suction blisters. 
 
14. What if new information becomes available? 
Sometimes during the course of a research project new information becomes 
available. If this happens your research doctor will tell you about it and discuss 
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with you whether you want to continue in the study. If you decide to withdraw 
your research doctor will make arrangements for your care to continue. If you 
decide to continue in the study you will be asked to sign an updated consent form. 
If any new information would suggest to the research doctor that you should 
withdraw from the study then he will explain and discuss this with you. 
 
15. What if something goes wrong? 
Before conducting any research on humans considerable thought is given to likely 
benefits and disadvantages. We feel there are no significant risks to you if you 
agree to take part in this study. The University holds a clinical trial protection 
insurance policy which provides insurance cover in respect of the legal liability of 
the University in respect of accidental injury to a research subject arising out of a 
clinical trial undertaking in the name of the University. The University also holds a 
no fault insurance clinical trials protection policy which provides compensation to 
a research subject in respect of accidental injury arising out of a clinical trial 
undertaking in the name of the University. 
 
16. Confidentiality 
If you consent to take part in this research any of your records can be looked at by 
people from regulatory authorities to check that the studies are being carried out 
correctly and honestly. Your name, however, will not be disclosed outside the 
hospital or GP surgery. Any information about you which leaves the 
hospital/surgery will have your name and address removed so that you cannot be 
recognised from it. The results of the research study will be published in medical 
journals available in the public domain. 
 
17. Will my own doctor be told of my participation? 
We will inform a patient’s own doctor of participation in all our studies. If you do 
not give us this permission then you cannot take part in this study. 
 
18. What will happen to the results of the research study? 
We hope that the results of this study will contribute to improved treatments for 
patients with skin disease. Such results will be published in the medical literature 
so that other doctors and patients can benefit from our findings. 
 
19. Funding 
This study is funded by the Medical Research Council. Funding for the research is 
through a contract with The University of Edinburgh. Independent researchers do 
not benefit financially from your participation. 
 
20. Contact for further information 
 
Dr Terence Wong, 
Medical Research Council Clinical Research Fellow, 
Room 4.123, Dermatology, 
1st Floor, Lauriston Building, 
Lauriston Place, 
Edinburgh, EH3 9HA. 
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Secretary to Professor Jonathan Rees 
Room 4.018, Dermatology, 
1st Floor, Lauriston Building, 
Lauriston Place, 
Edinburgh, EH3 9HA. 
Telephone 0131 536 2041.  Fax 0131 229 8769. 
Email Karen.Muir@ed.ac.uk  
 
Alternatively, Dermatology on-call Registrar 07950 204464 or bleep number #6396. 
 




Human Hair Melanin Assay Results 
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Appendix 5. Human Hair Melanin Assay Results 
 
A.5.1. Results 
Absorbance at 400nm = Alkaline Soluble Melanin (ASM) ~ Phaeomelanin 
Absorbance at 500nm = Total Melanin (TM) ~ Eumelanin 
The ratio ASM/TM was calculated. 
A high ASM/TM value is consistent with higher phaeomelanin content. A low 
ASM/TM value is consistent with higher eumelanin content. 
 
























The above figure showed a high ASM/TM value with light coloured ee mouse hair, 
consistent with higher phaeomelanin content. The darker BL6 and F1 mice hair gave 
a lower ASM/TM value, consistent with higher eumelanin content. This confirmed 
that the melanin assay worked well with mouse hair. 
 




















The above figure showed a range of ASM/TM values for light hair coloured 
individuals. The 2 very dark hair individuals gave varied results. The experiments 
were repeated by another person in the laboratory and also gave inconsistent results 
(data not shown). The human hair melanin assay was found to give inconsistent 
results and not very useful and it was not pursued further.  
 
A.5.2. Discussion 
Possible explanations for this may include different amounts of phaeomelanin and 
eumelanin in human vs mouse hair, technical limitation with the melanin assay e.g. 
“Alkaline Soluble Melanin” still contained some eumelanin, not just phaeomelanin. 
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Appendix 6. SNPs selected from 33 candidate gene loci for Illumina genotyping 











































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































OCA2 exon 9 R305W C-T, OCA2 exon 13 R419Q G-A, OCA2 exon 21 I722T T-C (courtesy of and personal communication, Professor M. H. Brilliant)
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Appendix 7 
MC1R consensus sequence 
MC1R consensus sequence from Africa according to (Harding et al., 2000): 
GGAGGCCTCC AACGACTCCT TCCTGCTTCC TGGACAGGAC 
TATGGCTGTG CAGGGATCCC AGAGAAGACT TCTGGGCTCC 
CTCAACTCCA CCCCCACAGC CATCCCCCAG CTGGGGCTGG 
CTGCCAACCA   GACAGGAGCC  CGGTGCCTGG AGGTGTCCAT 
CTCTGACGGG  CTCTTCCTCA  GCCTGGGGCT  GGTGAGCTTG 
GTGGAGAACG CGCTGGTGGT GGCCACCATC GCCAAGAACC 
GGAACCTGCA CTCACCCATG TACTGCTTCA TCTGCTGCCT 
GGCCTTGTCG  GACCTGCTGG TGAGCGGGAG CAACGTGCTG 
GAGACGGCCG  TCATCCTCCT  GCTGGAGGCC GGTGCACTGG 
TGGCCCGGGC  TGCGGTGCTG  CAGCAGCTGG  ACAATGTCAT 
TGACGTGATC ACCTGCAGCT CCATGCTGTC CAGCCTCTGC 
TTCCTGGGCG  CCATCGCCGT GGACCGCTAC ATCTCCATCT 
TCTACGCACT  GCGCTACCAC  AGCATCGTGA CCCTGCCGCG 
GGCGCGGCGA  GCCGTTGCGG  CCATCTGGGT GGCCAGTGTC 
GTCTTCAGCA  CGCTCTTCAT  CGCCTACTAC  GACCACGTGG 
CCGTCCTGCT  GTGCCTCGTG GTCTTCTTCC TGGCTATGCT 
GGTGCTCATG GCCGTGCTGT ACGTCCACAT GCTGGCCCGG 
GCCTGCCAGC   ACGCCCAGGG CATCGCCCGG CTCCACAAGA 
GGCAGCGCCC  GGTCCACCAG  GGCTTTGGCC TTAAAGGCGC 
TGTCACCCTC  ACCATCCTGC  TGGGCATTTT  CTTCCTCTGC 
TGGGGCCCCT TCTTCCTGCA TCTCACACTC ATCGTCCTCT 
GCCCCGAGCA CCCCACGTGC GGCTGCATCT TCAAGAACTT 
CAACCTCTTT  CTCGCCCTCA TCATCTGCAA TGCCATCATC 
GACCCCCTCA  TCTACGCCTT  CCACAGCCAG  GAGCTCCGCA 
GGACGCTCAA  GGAGGTGCTG  ACATGCTCCT  GGTGA 
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